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IntroductIon & outlIne 
of the thesIs1
Begin at the beginning and go on till you come to the end: then stop.
The King, Lewis Carroll’s Alice in Wonderland11 INTRODUCTION & OUTLINE
1
INTRODUCTION
The Hematopoietic System
The  blood  is  one  of  the  most  intensely  studied  and  best  understood  human 
tissues. It performs many functions in the body and consists of red blood cells, 
white blood cells and platelets suspended in plasma. Red blood cells (also referred 
to as erythrocytes) are the most common type of blood cell and carry oxygen to 
the body tissues. White blood cells are much less numerous than red blood cells. 
Their function is to protect the body from infection. White blood cells consist 
of myeloid and lymphoid cells. The myeloid cell compartment is made up of 
granulocytes (neutrophils, basophils, eosinophils) and monocytes/macrophages 
that collectively combat infections from bacteria, fungi, and other parasites such 
as worms. Some of these cells also have the ability to remove dead or damaged 
tissues. The lymphoid cell compartment is made up of B- and T-lymphocytes. 
B-lymphocytes produce antibodies that bind to antigens, while T-lymphocytes 
can directly attack and destroy cells recognized as foreign to the body, including 
virus-infected cells and cancer cells. Platelets (also referred to as thrombocytes) 
are derived from fragmentation of megakaryocytes and play an essential role in 
the blood clotting process.
Many blood cells are short-lived and therefore must be constantly replenished. 
A  healthy  human  adult  requires  billions  of  new  blood  cells  on  a  daily  basis. 
The process by which these cells are produced is called hematopoiesis and is 
maintained by a small population of hematopoietic stem cells (HSCs).
Hallmark Properties of HSCs
The hematopoietic system is hierarchically organized with HSCs at the top of 
the pyramid and mature blood cells at the bottom of the pyramid. HSCs have 
two core properties, the combination of which makes them unique. First, they 
have  long-term  self-renewal  potential,  meaning  that  they  can  make  identical 
copies of themselves for long periods of time. Second, they have multi-lineage 
differentiation  potential,  meaning  that  they  can  differentiate  into  the  many 
specialized cell types that make up the blood system. HSCs generate intermediate 
cell types or progenitors that proliferate and become progressively more restricted 
in  developmental  potential,  until  ultimately  mature  blood  cells  are  formed   
(Figure  1).  Careful  control  of  the  balance  between  HSC  self-renewal  and 
differentiation is essential to maintain blood cell homeostasis. In a homeostatic 
system, the HSC self-renewal probability P is 0.5, indicating that on average half 
of the progeny of the HSCs preserves stem cell characteristics, whereas the other 
half initiates differentiation. If self-renewal of HSCs is impaired (P<0.5) the stem 
cell pool will exhaust, ultimately resulting in bone marrow failure. In contrast, if 
self-renewal of HSCs is increased (P>0.5) the stem cell pool will expand, ultimately 
resulting in blood cancer.1 12 CHAPTER 1
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HSCs are forced to constantly make fate decisions; they may remain quiescent, 
undergo  apoptosis  or  initiate  cell  division.  Once  the  decision  to  divide  has 
been made, they must choose whether to self-renew or to differentiate into a 
specific blood cell type. HSC fate decisions are controlled by a complex interplay 
between cell-autonomous (intrinsic) and cell-nonautonomous (extrinsic) signals. 
Yet, the exact mechanisms governing these decisions are still poorly understood. 
The continued quest for these mechanisms will not only be of major relevance 
for a fundamental understanding of normal hematopoiesis and developmental 
biology, but also for a better understanding of the pathogenesis and evolution 
of blood cancers. In addition, it will open new avenues for the design of ex vivo 
expansion protocols for HSCs, thereby increasing their clinical potential in cell 
replacement and gene therapy protocols. The delineation of the mechanisms 
underlying HSC fate decisions requires the phenotypic, functional and molecular 
characterization of HSCs.
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Figure 1. Hierarchical organization of the blood system. Hematopoietic stem cells (HSCs) 
give rise to more committed progenitors that in turn produce the different blood cell types.13 INTRODUCTION & OUTLINE
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Phenotypic Characterization of HSCs
Characterizing HSCs began by studies in rodents, which laid the foundation for 
studies in humans. The major challenge in HSC studies is that the stem cells 
themselves are rare, representing less than 0.01% of the cells within the bone 
marrow, and that the stem cells cannot be identified based on their morphology 
(size  and  shape),  but  solely  based  on  their  immunophenotype.  The  general 
consensus is that mouse HSCs lack the cell surface markers that are expressed 
on differentiated hematopoietic cells (so-called lineage or lin markers), but do 
express “stem cell antigen-1” (Sca-1) and c-Kit (collectively referred to as LSK).2;3 
The cells in this LSK population can be further subfractionated into long-term (LT) 
and short-term (ST) HSCs (both containing self-renewal capacity) and progenitors 
(containing low/no self-renewal capacity). LT-HSCs can be more precisely identified 
within the LSK population by selecting for those cells that are CD34−,4 Flk-2/
Flt3−,5;6 CD48− and CD150+,7 EPCR/CD201+,8 and different combinations thereof. 
Another approach to identify HSCs relies on their ability to efflux vital dyes such 
as Hoechst 333429 and Rhodamine 123.10-13 The prospective isolation of mouse 
HSCs by fluorescence-activated cell sorting (FACS) has facilitated the functional 
and molecular characterization of HSCs.
Functional Characterization of HSCs
HSC studies depend on several in vitro and in vivo assays to measure the quantity 
and/or quality of hematopoietic stem and progenitor cells. Several in vitro assays 
have been established that can measure the frequency of progenitors (colony-
forming  unit  in  culture;  CFU-C),  stem  cells  (long-term  culture-initiating  cell; 
LTC-IC) or both (cobblestone-area forming cell assay; CAFC).14;15 At present, the 
ultimate model used to demonstrate HSC activity is in vivo transplantation; the 
only assay that can measure both the long-term self-renewal and multi-lineage 
differentiation  capacity  of  HSCs.16;17  In  this  assay,  HSCs  are  transplanted  into 
myeloablated (usually irradiated) recipients after which their ability to produce 
multi-lineage progeny for prolonged periods of time is evaluated. It should be 
realized, however, that in all the above-mentioned assays HSCs are measured 
retrospectively.  By  the  time  HSC  activity  is  established,  the  original  HSC  will 
unavoidably be lost. 
The existence of true HSCs with long-term self-renewal activity and multi-lineage 
differentiation capacity has been irrefutably demonstrated by retroviral marking 
studies,18;19 limiting dilution20-22 and single purified cell assays.23-26 However, thus 
far it has remained difficult to quantify the exact number of HSCs that actively 
contribute to hematopoiesis or to simultaneously analyze the behavior of multiple 
individual HSCs in a competitive polyclonal setting. That type of analysis could 
help resolve some of the major outstanding questions in HSC biology, such as 
whether lineage-biased and dormant or hibernating HSCs really do exist,27-30 and 
how clonal relationships in the hematopoietic system are established. 14 CHAPTER 1
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Molecular Characterization of HSCs
Systems Biology
State-of-the-art  genome-wide  tools  have  become  available  to  elucidate  the 
intrinsic properties of HSCs. To identify genes that play a key role in regulating 
HSC  fate  decisions,  several  groups  have  embarked  on  genome-wide  mRNA 
expression  studies.  In  an  attempt  to  identify  a  HSC  molecular  signature,  the 
expression profiles of HSCs, embryonic stem cells and neural stem cells have 
been compared.31;32 Furthermore, mRNA profiles have been analyzed in HSCs 
from young versus old animals,33;34 in quiescent versus proliferating HSCs,35 and 
in  HSCs  versus  their  differentiated  progeny.36-39  However,  to  explain  complex 
biological phenomena it is not enough to study mRNA expression alone; it is of 
vital importance to measure – in the same sample – complementary biological 
variables. Only then HSCs can be studied from a systems perspective. 
More  recently,  novel  genome-wide  tools  have  been  developed  to  study 
alternative  splicing,  microRNA  expression,  protein  expression  and  post-
translational  modifications,  transcription  factor  and  cofactor  binding  sites, 
epigenetic  marks  such  as  histone  modifications  and  DNA  methylation,  and 
chromatin accessibility. All these types of analyses thus far remain challenging in 
HSCs, because of the limiting cell numbers available per mouse. Yet, technology is 
rapidly evolving and may soon provide a hitherto unprecedented amount of data 
on HSCs. The challenge that therefore lies ahead is to integrate all these different 
types of data using various bioinformatics and systems biology approaches. The 
ultimate goal will be to construct regulatory networks that allow us to model, 
predict and potentially control HSC fate. 
Systems Genetics
Quantitative  differences  can  be  observed  for  most  complex  behavioral  and 
physiological traits among individuals within any population. These differences 
can be due to both genetic and environmental factors. The mouse, with its long 
history of genetic research, has proven to be an excellent model to study the 
genetic basis for these quantitative differences. Specifically, the regular inbred 
mouse strains C57BL/6 (B6) and DBA/2 (D2) have been extensively studied. With 
respect to HSCs these strains differ for example in their pool size, proliferation 
rates, reconstitution kinetics, deterioration rate during aging and mobilization 
response.40-46 The underlying causes of variation in these quantitative traits must 
be encoded in the genomes of these mice. 
The use of the BXD recombinant inbred mouse panel has proven to be a 
useful strategy to pinpoint the genomic regions that could be responsible for the 
observed variation in HSC traits. This panel has been derived by crossing B6 and 
D2 mouse strains and then inbreeding progeny for many generations.47-49 As a 
result, the genomes of both parental strains have recombined and have become 
fixed (i.e. are homozygous) in a unique pattern in each of the BXD lines. The panel 15 INTRODUCTION & OUTLINE
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of BXDs has been extensively genotyped and phenotyped. In order to identify 
the genomic regions that influence the above-mentioned HSC traits an approach 
called quantitative trait locus (QTL) mapping could be employed. This approach 
makes use of statistical methods that search for associations between variation in 
the phenotypic trait and possession of a particular allele. In this manner, genomic 
loci  have  been  identified  that  influenced  the  pool  size,  proliferation  rate  and 
mobilization response of HSCs.50-55 
More recently, an approach called expression QTL (eQTL) mapping has been 
employed to delineate the genetic basis of gene expression. In this approach, 
variation in transcript abundance is considered to be a quantitative trait that can 
be mapped to genomic loci.56;57 This approach has been implemented by our 
laboratory on a genome-wide scale to study gene regulation in HSCs.58 Soon after, 
a combinatorial analysis of physiological QTLs and eQTLs led to the identification 
of Lxn as a gene involved in regulating HSC pool size,59 and EGFR signaling as a 
pathway involved in regulating HSC mobilization.60 Discoveries such as these have 
invigorated the field of HSC biology and have fuelled excitement to continue 
systems genetics studies on HSCs.
OUTLINE OF THE THESIS
The  overall  aim  of  the  research  described  in  this  thesis  is  to  improve  our 
understanding of the mechanisms governing stem cell fate decisions and lineage 
commitment within the hematopoietic system. We try to achieve this goal by 
exploiting two types of genetic variation in the mouse: 
I) naturally occurring genetic variation (chapters 2-6) 
II) Induced genetic variation (chapter 7)
chapter 2 introduces the concepts of classical QTL mapping and expression 
QTL mapping. It reviews past studies in which transcriptional profiling and/or 
genetic linkage analysis were performed on hematopoietic cells, and serves as an 
introduction to chapters 3-6. 
chapter 3 describes an eQTL mapping study on four hematopoietic cell types 
isolated from a panel of BXD recombinant inbred mouse strains. Thus far, most 
eQTL mapping studies that have been reported have analyzed single cell types or 
compared developmentally unrelated and distant cell types. This chapter reports 
the first study of eQTL dynamics across closely related cell types during cellular 
development. It covers the identification of consistently active (or “static”) eQTLs 
and cell-type-dependent (or “dynamic”) eQTLs.
chapter  4  introduces  a  method  that  infers  combinatorial  association  logic 
networks  in  multimodal  genome-wide  screens.  Traditional  eQTL  mapping 
methods detect direct associations between genetic loci and transcript levels. 16 CHAPTER 1
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However, when the genetic loci themselves interact, direct associations between 
the individual loci and transcript levels may become undetectable. To alleviate 
this problem, the method described in this chapter detects associations between 
transcript levels and the outputs of small Boolean logic networks that combine 
multiple genetic loci. 
chapter  5  illustrates  how  the  presence  of  genetic  variation  in  a  pedigree 
of  normal,  wild-type,  mice  can  be  exploited  to  (re)construct  gene  networks 
that  operate  in  successive  stages  of  cellular  development.  It  starts  with  the 
reconstruction of an experimentally validated gene network, and proceeds with 
the construction of a novel gene network for transcripts that are specific to the 
HSC-enriched cell population. Finally, a combinatorial analysis of classical QTL 
and eQTL data leads to the identification of a zinc-finger transcription factor as a 
candidate regulator of the size of the HSC pool. 
chapter  6  describes  a  microRNA  profiling  study  on  four  developmentally 
related hematopoietic cell types isolated from B6 and D2 mouse strains. It covers 
the identification of cell type-dependent and mouse strain-dependent microRNAs. 
Of special interest is an evolutionary conserved microRNA cluster that is most 
highly expressed in the HSC-enriched cell population and that is differentially 
expressed between mouse strains. To assess whether the differential expression of 
this cluster could be functional, we overexpressed it beyond its normal expression 
level, and found that this fixed hematopoietic cells in a primitive state. Finally, we 
identify the downstream mRNA targets through which this microRNA cluster may 
exert its effect.
chapter 7 introduces a novel cellular barcoding technique that can be used 
as a powerful tool to assay clonality in the hematopoietic system. This technique 
makes use of retroviral plasmids that are labeled with random sequence tags 
or  “barcodes”.  Upon  retroviral  integration,  each  vector  introduces  a  unique, 
identifiable and heritable mark into the host cell genome, allowing the clonal 
progeny of each cell to be tracked over time. We demonstrate the efficacy of the 
barcoding technique to track clonal dynamics in two distinct cell culture systems 
in vitro and in a hematopoietic transplantation setting in vivo, and emphasizes the 
importance of implementing barcoded vectors in all future clinical gene therapy 
protocols.
chapter  8  summarizes  and  discusses  the  results  obtained  in  the  previous 
chapters.17 INTRODUCTION & OUTLINE
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2AbSTRACT
Stem cells are unique in that they possess both the capacity to self-renew and 
thereby maintain their original pool, as well as the capacity to differentiate 
into  mature  cells.  In  the  past  number  of  years,  transcriptional  profiling 
of  enriched  stem  cell  populations  has  been  extensively  performed  in  an 
attempt to identify a universal stem cell gene expression signature. While 
stem cell-specific transcripts were identified in each case, this approach has 
thus far been insufficient to identify a universal group of core “stemness” 
genes ultimately responsible for self-renewal and multipotency. Similarly, in 
the hematopoietic system, comparisons of transcriptional profiles between 
different hematopoietic cell stages have had limited success in revealing core 
genes ultimately responsible for the initiation of differentiation and lineage 
specification.  Here,  we  propose  that  the  combined  use  of  transcriptional 
profiling  and  genetic  linkage  analysis,  an  approach  called  “genetical 
genomics”, can be a valuable tool to assist in the identification of genes and 
gene networks that specify “stemness” and cell fate decisions. We review 
past studies of hematopoietic cells that utilized transcriptional profiling and/ 
or genetic linkage analysis, and discuss several potential future applications 
of genetical genomics.23 MOLECULAR GENETIC APPROACHES TO STUDY HEMATOPOIESIS
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INTRODUCTION
Stem  cells  are  defined  by  their  capacity  to  self-renew  and  their  ability  to 
differentiate  into  mature  cell  types.  Stem  cells  can  be  divided  into  two  main 
categories: embryonic stem cells (ESCs) and “tissue-specific” stem cells. ESCs, 
which are derived from the blastocyst stage of the early embryo, are termed 
pluripotent because they are able to differentiate into cells of all three germ 
layers; ectoderm, endoderm and mesoderm. In contrast, tissue-specific stem cells 
are termed multipotent because they are only able to differentiate into a limited 
number of more closely related cell types. Tissue-specific stem cells have now 
been identified in a number of fetal and adult tissues, where they play essential 
roles in organogenesis, tissue homeostasis and repair. 
One  of  the  major  challenges  in  the  stem  cell  field  has  been  to  identify  a 
universal “stem cell signature”, that is, those genes that ultimately enable the 
hallmark stem cell features of self-renewal and pluripotency or multipotency. In 
addition, it is important to identify those genes that initiate differentiation and 
determine lineage specification. In this review, we discuss how these challenges 
might be addressed using the combinatorial approach of genetical genomics. In 
particular, we focus on hematopoietic stem cells (HSCs), one of the best studied 
stem cell systems, as a model to investigate cell fate decisions.
HSCs are rare cells in the bone marrow that both self-renew and generate 
differentiated blood cells. During the process of hematopoietic differentiation, 
the cells progressively amplify their numbers, lose their multipotency and become 
increasingly committed. Ultimately, HSCs are able to give rise to large numbers of 
cells of both myeloid (e.g. monocytes/ macrophages, granulocytes, erythrocytes 
and megakaryocytes/ platelets) and lymphoid lineages (e.g. T cells and B cells).1 
A simplified overview of hematopoiesis is depicted in Figure 1. Although HSCs, 
intermediate progenitors, and most mature blood cells are genetically identical 
and are only a few cell divisions apart from each other, they differ tremendously 
in both phenotype and function.
In search of a stem cell signature
Since HSCs share certain hallmark properties with other stem cell types, it was 
speculated that a universal stem cell signature, consisting of a common set of 
genes  whose  concerted  expression  grant  stem  cells  their  unique  properties, 
might exist. In an attempt to identify such a signature, the expression profiles of 
mouse ESCs, HSCs and neural stem cells (NSCs) were compared by two groups 
independently.2;3 Both studies revealed similarities and differences between these 
cell populations, and generated a list of over 200 stem cell-specific genes that 
mouse ESCs, HSCs and NSCs commonly expressed. Strikingly however, these two 
lists shared only six genes. Soon thereafter, a third independent expression profiling 
study comparing ESCs, NSCs and retinal progenitor/ stem cells was reported. 24 CHAPTER 2
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Figure 1. Simplified overview of hematopoiesis. Hematopoietic stem cells (HSCs) have 
self-renewal activity (represented as the arrow) and can therefore maintain their numbers. 
During hematopoietic differentiation, HSCs lose their self-renewal capacity and become 
increasingly lineage-committed (represented as the gradual loss of colors).
Comparing these three independently generated lists of “stemness” genes, only 
one gene (Itga6) was commonly identified.4 What could explain the lack of overlap 
between these lists? First, differences in methodology may be in part responsible 
(discussed in 5;6). Second, ESCs are pluripotent, while the other stem cell types in 
the described comparisons are more restricted in their developmental potential. 
These different stem cell populations were compared in a direct manner, although 
it  is  certainly  possible  that  pluripotency  and  multipotency  are  maintained  by 
different gene circuits. A third, more fundamental possibility is that a universal 
stem cell signature simply does not exist. ESCs, HSCs, NSCs and retinal stem 
cells may each have their very own transcriptional networks responsible for their 
unique stem cell properties. If this is the case, cross-tissue comparative stem cell 
transcriptome analyses are not particularly useful approaches to identify these 
stem cell type-specific signatures.
That  a  limited  number  of  factors  could  indeed  specify  “stemness”  was 
convincingly  shown  by  Takahashi  and  Yamanaka,  who  demonstrated  that  the 
forced expression of Oct4, Sox2, Klf4 and c-Myc and could reprogram mouse 
fibroblasts into pluripotent stem cells that were functionally equivalent to ESCs.7 
Subsequently, it was shown that some family proteins of the four factors could 
also reprogram fibroblasts, and that c-Myc was dispensable for this process.8;9 25 MOLECULAR GENETIC APPROACHES TO STUDY HEMATOPOIESIS
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The question whether terminally differentiated cells could also be reprogrammed 
was  resolved  when  fully  differentiated  mature  mouse  B  lymphocytes  were 
reprogrammed  to  pluripotency.10  Induction  of  pluripotency  was  also  recently 
demonstrated in human fibroblasts using various combinations of factors.11-13 The 
demonstration that more than one combination of factors could confer the same 
stem cell characteristics suggests that stem cell signatures may be “degenerate” 
(as in the “degenerate DNA code”). 
Thus, it is clear that “stemness” can be achieved by only a limited number of 
key stem cell regulators, presumably targeting larger collections of downstream 
genes in a hierarchical manner. Extracting such key regulators (or causes) from 
their downstream target genes (consequences) is not feasible using micro-array 
profiling approaches alone. 
In search of hematopoietic fate determinants
Transcriptional  profiling  has  also  been  utilized  extensively  in  an  attempt  to 
identify  genes  whose  expression  distinguishes  HSCs  from  their  downstream 
progeny.  Global  expression  analyses  have  revealed  that  stem  cells  exist  in  a 
“promiscuous”  state  where  multiple  lineage-specific  genes  are  co-expressed, 
albeit  at  very  low  levels.  Upon  differentiation,  “appropriate”  lineage-specific 
genes  are  up-regulated,  whereas  “inappropriate”  genes,  specific  for  other 
lineages, are down-regulated.14 Recently, Chambers et al generated an expression 
database of various hematopoietic cell types, including HSCs, erythroid cells, 
granulocytes, monocytes, natural killer cells, activated and naive T cells, and B 
cells.15 This comparative transcriptome analysis provided large lists of genes that 
are specifically expressed in one cell stage or cell type compared to another. 
However, it is improbable that the transition from one cell stage to another relies 
on the independent regulation of so many genes. More likely, activation of a 
limited number of key regulatory genes initiates a cascade of events, resulting in 
the altered expression of tens to hundreds of genes. 
Transcriptional profiling has proven to be a useful approach to identify cell 
stage  and  cell  type-specific  transcripts.  When  combined  with  other  genetic 
approaches, it may also have the potential to identify key regulatory genes.
HSCs and linkage genetics
It  has  become  clear  that  many  hematopoietic  characteristics  or  traits  are 
genetically  controlled,  since  they  differ  between  various  strains  of  genetically 
distinct laboratory mice. For example, a substantial strain-to-strain variation in 
the number of primitive hematopoietic cells and their turnover rates has been 
observed. Interestingly, an inverse correlation was detected between progenitor 
cell turnover rate and mouse lifespan.16 
Two  regular  inbred  strains  of  mice,  C57BL/6  (B6)  and  DBA/2  (D2),  have 
distinct differences in both their HSC traits and lifespan. Compared to B6 mice, 26 CHAPTER 2
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D2 mice have a shorter lifespan, a substantially higher HSC frequency, and their 
progenitors cycle at a much faster rate.16-19 In B6 mice the HSC frequency increases 
at a constant rate during the aging process,20-23 while in D2 mice it increases 
up to one year of age and then drops again.24;25 The observed natural variation 
between these regular inbred mouse strains offers a powerful tool to study the 
genetic basis of variation in these traits. The use of B6 x D2 (BXD) recombinant 
inbred mouse strains has been a particularly useful strategy to identify genomic 
regions affecting traits of interest. These inbred lines were developed by crossing 
the two inbred parental strains followed by repeated sibling-sibling mating for 
a  minimum  of  20  generations.  The  resulting  BXD  mouse  strains  each  carry  a 
genome that consists of a unique mosaic of homozygous B6 and D2 segments. 
At present, the BXD panel is composed of 80 different strains that all have been 
fully genotyped.26 Variation in any quantifiable trait can be associated with the 
segregation of parental alleles, and linkage genetics can map this variation to 
quantitative trait loci (QTLs), thereby identifying the genomic region(s) affecting 
that trait. An overview of the QTL mapping approach is depicted in Figure 2. 
Classical  QTL  analysis  has  permitted  the  identification  of  loci  that  are 
associated with variation in HSC traits. When HSC frequency was measured in the 
BXD reference panel using long-term culture initiating cell assays (LTC-ICs), two 
suggestive QTLs on chromosome 1 and one on chromosome 11 were identified. 
One of the loci on chromosome 1 was confirmed to affect HSC frequency in a 
congenic mouse strain.17 When HSC frequency was assessed using cobblestone 
area forming cell assays (CAFCs), the trait mapped to a region on chromosome 
18.18 Subsequently, variation in hematopoietic progenitor cell (HPC) frequency 
and HSC frequency were mapped in both young and old mice. This led to the 
identification of multiple QTLs, some of which were age- and differentiation stage-
specific. Regardless of age, loci on chromosomes 7 and 18 were found to regulate 
HPC and HSC frequency, respectively. An additional locus on chromosome 1 was 
found to affect HPC and HSC frequency specifically in young mice, whereas loci 
on chromosomes 2 and 18 were found to affect these frequencies specifically 
in  old  mice.27  A  congenic  mouse  model  was  later  used  to  confirm  that  the 
chromosome 2 locus indeed contained a regulator of HSC aging.28 Variation in 
the percentage change of HSC frequency during aging was mapped to putative 
loci on chromosomes 2, 14 and X.24 
Particularly interesting was the finding that variation in both turnover rate of 
primitive hematopoietic cells and mouse lifespan mapped to overlapping regions 
on chromosomes 7 and 11.29 This strengthened the hypothesis that mouse lifespan 
is in part dependent on progenitor turnover rate. 
Yet another trait in which various inbred strains of mice have shown to differ 
is their absolute number of Lin−Sca1++ cells and their responsiveness to early-
acting cytokines, such as kit ligand, flt3 ligand and thrombopoietin. A genetic 
linkage study in BXD recombinant inbreds led to the identification of three loci 27 MOLECULAR GENETIC APPROACHES TO STUDY HEMATOPOIESIS
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on chromosomes 2, 4 and 7 that affected the total number of Lin−Sca1++ cells 
and a locus on chromosome 2 affecting their proliferative response to cytokines. 
The fact that both traits mapped to the exact same region on chromosome 2 
suggests that the number of Lin−Sca1++ cells may depend on their responsiveness 
to cytokines.30 This hypothesis was reinforced when a QTL for the response of 
primitive  cells  to  transforming  growth  factor-β2  (TGF-β2)  was  identified  on 
chromosome 4 that overlapped with the previously identified QTL regulating the 
number of Lin−Sca1++ cells.31 
Furthermore, a strain-dependent variation was found to exist in the response 
to Granulocyte Colony-Stimulating factor (G-CSF); a growth factor that has the 
capacity to mobilize stem and progenitor cells from bone marrow into peripheral 
blood.32 When B6 (low responder), D2 (high responder), backcross and BXD mice 
were subjected to a genetic analysis, loci on chromosomes 2 and 11 (and possibly 
4 and 14) were found to control G-CSF induced mobilization.33 
An overview of the QTLs that have been reported to associate with various 
hematopoietic traits is shown in Table 1. Interestingly, multiple traits have been 
mapped to the same QTL regions (note the “QTL-dense” regions on chromosomes 
2 and 11), suggesting that they may be regulated by a common genetic element. 
It should also be noted that only a few QTLs have been independently replicated. 
In part, this is because relatively few laboratories have used quantitative trait 
genetics to study hematopoiesis. Secondly, it may be due to the inherently noisy 
quantitative nature of the traits under study as they are likely to be controlled by 
multiple QTLs that each have a limited effect. Finally, multiple in vitro and in vivo 
assays exist that measure the functional output of primitive hematopoietic cells. 
Although these assays are thought to have considerable overlap with each other, 
they may not be measuring exactly the same spectrum of cells. Thus, it is possible 
that these distinct cell subsets are controlled by different genetic elements. 
The  major  limitation  of  classical  QTL  mapping  approaches  in  recombinant 
inbred reference panels is that they are only able to identify genomic regions of 
interest, usually containing tens or even hundreds of genes. This poor resolution 
is due to the limited number of recombination events between the two sets of 
parental chromosomes. Of all the genes present within the QTL interval, it is 
hypothesized that only polymorphic variants can be responsible for variation in 
the observed phenotype. In most cases, this variability is in the form of single 
nucleotide polymorphisms (SNPs), and to a lesser extent in the form of deletions, 
insertions,  rearrangements  and  copy  number  variations.  Although  every  SNP 
has  a  potential  impact  on  gene  expression  levels  and  therefore  could  affect 
HSC biology, the vast majority of SNPs are “synonymous” or “silent”.34;35 This 
makes it difficult to identify the causal variant or polymorphism, and therefore 
the causal gene that influences the trait of interest. An additional complication is 
the possibility that multiple linked (possibly even neighboring) genes collectively 
cause  the  phenotype,  as  was  proposed  for  the  progenitor  cell  cycling  trait.36 28 CHAPTER 2
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A promising approach that may aid in the identification of causal genes – and the 
networks in which they operate – is the combination of transcriptional profiling 
with linkage genetics.
Transcriptional profiling and linkage genetics combined
As explained, neither transcriptional profiling alone, nor genetic linkage analysis 
alone, has been shown to be an effective approach to identify genes or gene 
networks  that  specify  “stemness”,  initiate  differentiation  or  govern  lineage 
specification.  However,  the  combination  of  both  approaches  may  aid  in  their 
identification.  Merging  the  fields  of  linkage  genetics  and  genomics  in  this 
particular manner has been referred to as “genetical genomics” 37 or expression 
quantitative  trait  locus  (eQTL)  analysis.38;39  The  genetical  genomics  approach 
considers  individual  gene  expression  levels  to  be  quantitative  traits.  In  cell 
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Figure 2. Overview of (expression) quan-
titative  trait  locus  mapping  procedure. 
Variation  in  phenotype  (here  shown  for 
six individuals) is correlated with variation 
in  genotype  (genotypes  at  a  single  chro-
mosome  are  shown  for  each  individual). 
The  genomic  location  where  these  two   
parameters  associate  most  strongly  is 
referred to as the (expression) quantitative 
trait locus or (e)QTL. In this case, the three 
genetically distinct individuals that have a 
high  value  for  the  phenotype  of  interest 
carry the light blue genotype at the (e)QTL 
position, whereas the three that have a low 
phenotypic  measure  carry  the  dark  blue 
genotype at that position. The phenotype 
can  either  be  a  classical  trait  (classical 
linkage) or the expression level of a gene 
(genetical genomics).29 MOLECULAR GENETIC APPROACHES TO STUDY HEMATOPOIESIS
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types isolated from genetically distinct individuals (e.g. BXD recombinant inbred 
mouse strains), linkage mapping can then be utilized to identify genomic regions 
affecting each gene expression trait (eQTL). The strategy of eQTL mapping is 
visualized in Figure 2. Hence, genetical genomics studies the genetic basis of 
variation in gene expression. When the genomic position of the gene and the 
eQTL which is associated with variation in its expression level coincide, the gene 
is considered to be cis-regulated. In contrast, when the eQTL associated with 
variation in its expression level maps to another position in the genome, the gene 
is considered to be trans-regulated. Cis-regulation is thought to arise from either 
local polymorphisms in the regulatory elements that alter gene expression levels, 
or alternatively to arise from polymorphisms in the coding region that affect mRNA 
stability  or  feedback  regulation  (Figure  3A).  Cis-regulation  can  also  originate 
from copy-number variability. Trans-regulation is thought to arise as a result of 
polymorphisms in the regulatory elements or coding region of a direct or indirect 
upstream regulator (Figure 3B). It should be emphasized that in this review the 
terms cis- and trans-regulation do not refer to the underlying molecular nature of 
the regulation, but only to the distance between the physical genomic position 
of a gene and its corresponding eQTL position. For this reason, it is possible that 
a gene can be classified as cis-regulated, even though it is actually regulated by 
one of its neighboring genes. To reduce the potential confusion between the 
type of regulation and the relative positions of genes and their eQTLs, the terms 
“local” and “distant” have also been proposed.40 
Brem et al were the first to report genetic mapping of global gene expression 
in a yeast cross.41 Since then, genetical genomics has been applied to genetically 
distinct  strains  of  Arabidopsis  thaliana,  Eucalyptus,  maize,  Caenorhabditis 
elegans, mice, rats38;42-47 and also to cells isolated from human individuals.48;49 
Collectively, these studies convincingly demonstrate the heritability of variation 
in transcript abundance and the presence of both cis- and trans-regulated genes. 
In addition, it is clear that the genetical genomics approach is broadly applicable 
to multiple species and cell types. A representative example of a genome-wide 
overview of genes and their eQTLs is depicted in Figure 3C. This eQTL regulator 
map was created by plotting the physical genomic position of variably expressed 
genes  and  the  genomic  positions  that  were  most  strongly  associated  with 
variation in their expression levels (eQTLs). Transcripts on the diagonal represent 
cis-regulated genes. Collections of transcripts that are identified as vertical bands 
or “transbands” represent genes that are located throughout the whole genome, 
but are thought to be transcriptionally affected by a common eQTL. If a certain 
genomic region harbors a higher frequency of eQTLs than expected by chance, it 
is termed an eQTL hotspot.38;41 The causal regulator within such an eQTL interval 
may be a signaling or transcription factor that affects the expression levels of its 
downstream targets. 30 CHAPTER 2
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Table 1. Quantitative trait loci (QTLs) associated with mouse hematopoietic traits.
Trait Chr Region (cM) Reference ID Ref. #
HPC frequency 1 38 Geiger et al. 2001 27
HSC frequency  1 38 Geiger et al. 2001 27
HSC frequency (LTC-IC)  1 52 Muller-Sieburg and Riblet 1996 17
Splenomegaly after G-CSF 1 53-75 Roberts et al. 2000 67
HSC frequency (LTC-IC)  1 99 Muller-Sieburg and Riblet 1996 17
HSC frequency  1 100 Geiger et al. 2001 27
Change in HSC frequency during aging 2 51 De Haan and Van Zant 1999 24
Lifespan 2 69 De Haan and Van Zant 1999 29
Progenitor cell mobilization by G-CSF  2 69? Hasegawa et al. 2000 33
HPC frequency (old) 2 72 Geiger et al. 2001 27
HSC frequency (old) 2 72 Geiger et al. 2001 27
No. Lin−Sca1++ cells 2 73.2-77.2 Henckaerts et al. 2002 30
Response of primitive cells to cytokines 2 73.2-77.2 Henckaerts et al. 2002 30
HSC frequency 3 24 Geiger et al. 2001 27
Lifespan 4 40.3 De Haan and Van Zant 1999 29
Response of primitive cells to TGF-β2 4 67-79 Langer et al. 2004 31
No. Lin−Sca1++ cells 4 77.5-79 Henckaerts et al. 2002 30
Progenitor cell cycling 4 78 De Haan and Van Zant 1999 29
Progenitor cell mobilization by G-CSF 4 ? Hasegawa et al. 2000 33
HSC frequency 5 20 Geiger et al. 2001 27
Progenitor cell cycling 7 0.5 De Haan et al. 2002 36
Progenitor cell cycling 7 6 De Haan and Van Zant 1999 29
Lifespan 7 6 De Haan and Van Zant 1999 29
HPC frequency 7 8 Geiger et al. 2001 27
HPC frequency 7 25 Geiger et al. 2001 27
HPC frequency 7 50 Geiger et al. 2001 27
HPC frequency (old) 7 50 Geiger et al. 2001 27
No. Lin−Sca1++ cells 7 51-53 Henckaerts et al. 2002 30
Progenitor cell cycling 9 61 De Haan and Van Zant 1999 29
Progenitor cell mobilization by G-CSF 11 3 Hasegawa et al. 2000 33
Progenitor cell cycling 11 29 De Haan et al. 2002 36
Progenitor cell cycling 11 31 De Haan and Van Zant 1999 29
Lifespan 11 31 De Haan and Van Zant 1999 29
HSC frequency (LTC-IC) 11 32 Muller-Sieburg and Riblet 1996 17
Change in HSC frequency during aging 14 12 De Haan and Van Zant 1999 24
HPC frequency (old) 14 13 Geiger et al. 2001 27
Progenitor cell mobilization by G-CSF 14 ? Hasegawa et al. 2000 33
HSC frequency 15 43 De Haan and Van Zant 1997 18
HPC frequency (old) 15 59 Geiger et al. 2001 27
HSC frequency 18 19 De Haan and Van Zant 1997 18
HSC frequency 18 27 Geiger et al. 2001 27
HPC frequency (old) 18 27 Geiger et al. 2001 27
HSC frequency (old) 18 27 Geiger et al. 2001 27
Change in HSC frequency during aging X 5 De Haan and Van Zant 1999 24
HSC frequency X 51 Geiger et al. 2001 27
Response of primitive cells to cytokines X ? Henckaerts et al. 2002 30
All traits were studied in C57Bl/6, DBA/2, backcross and/ or BXD recombinant inbred mice. Unless noted 
otherwise, traits were analyzed in young mice, and HPC and HSC frequencies were measured using CAFC 
assays. Italic font indicates traits and corresponding QTLs that are mentioned elsewhere in this review. Boxes 
indicate “QTL-dense” regions. (Note that not all of the reported genetic associations have met the most 
stringent statistical threshold for significant genome-wide linkage. Also note that in the past decade, the 
mouse genome map has undergone significant revisions, and therefore the precise genomic locations of 
the identified QTLs may be slightly inaccurate, especially in older publications. Nevertheless, for historical 
accuracy, this table shows QTL regions as specified in the original references.)
Abbreviations: CAFC, cobblestone area forming cell; G-CSF, granulocyte colony-stimulating factor; HPC, 
hematopoietic progenitor cell; HSC, hematopoietic stem cell; LTC-IC, long-term culture-initiating cell; TGF, 
transforming growth factor; ?, exact region not specified.31 MOLECULAR GENETIC APPROACHES TO STUDY HEMATOPOIESIS
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Associated with each eQTL are two important sets of genes: those regulated 
by the eQTL (transband genes if more than one) and those within the eQTL interval 
that are candidate regulators. These regulators can either directly or indirectly 
affect the abundance of the transband transcripts, raising the prospect of several 
levels of hierarchy within the regulatory network (Figure 3D). 
To identify the causal gene within each eQTL, the interval is first screened 
for genetic variability, since only those genes that are polymorphic can have a 
functional  impact  on  the  transcript  abundance  of  the  transband  genes.  Both 
regulatory  elements  and  coding  regions  must  be  analyzed  for  the  presence 
of  polymorphisms.  In  particular,  cis-acting  genes  are  high-priority  candidate 
regulators, as they may contain genetic variants that not only influence their own 
expression levels, but also those of the transband genes. Another category of 
genes which could affect the expression of the transband genes are those that 
are equally expressed, but carry polymorphisms in their coding regions, resulting 
in  the  generation  of  functionally  distinct  proteins  with  a  differential  ability  to 
regulate downstream targets. For example, these polymorphisms can alter protein 
functionality by being “non-synonymous” (amino acid changing) or alternatively by 
introducing alternative splicing. It should be noted that this category of candidate 
regulators would remain unnoticed in traditional micro-array experiments, since 
the expression levels of such transcripts would not necessarily be altered. 
While it is tempting to assume that trans-regulated genes preferentially map 
to  eQTL  intervals  containing  transcription  factors,  in  yeast  this  could  not  be 
verified.50 Another potential category of regulatory genes consists of signaling 
factors that can indirectly affect the abundance of the transband transcripts. 
Although  the  terms  cis-  and  trans-regulation  are  commonly  accepted 
descriptions of gene regulatory relationships, their biological relevance is only 
assumed. While it is clear that genetical genomics has great potential to identify 
novel regulatory pathways and increase our understanding of regulatory networks, 
functional validation of candidate regulators is ultimately necessary to confirm 
their biological activity.
HSCs and genetical genomics
Classical QTL mapping results in the identification of genomic intervals that affect 
traits of interest. This approach narrows down the number of candidate genes 
affecting such traits from around 30,000 (all genes in the genome) to tens or 
hundreds of genes (those located within that QTL interval). However, despite this 
major improvement, for a molecular biologist it would still require a huge effort to 
functionally test all the candidate genes in that interval. 
A complementary approach to assist in the identification of candidate genes 
affecting  stem  cell  traits  is  genetical  genomics.  Using  the  Affymetrix  gene 
expression platform we collected data for each of the inbred strains from the 
BXD  reference  panel  and  the  variation  in  transcript  abundance  in  primitive 32 CHAPTER 2
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Lin−Sca1+cKit+  cells  of  each  gene  was  mapped  to  an  eQTL.  Using  stringent 
significance  thresholds,  a  total  of  162  cis-regulated  and  136  trans-regulated 
genes  were  identified.  Runx1,  a  well-known  hematopoietic  regulator,51;52  was 
found to be strongly cis-regulated. Interestingly, two of its known downstream 
targets (Tcrb and Csf1r) were found to be co-regulated with Runx1, indicating 
the biological relevance of the networks that could be identified. The generation 
of this comprehensive eQTL dataset allowed the more detailed analysis of QTL 
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Figure 3. Cis- and trans-regulated gene expression. (A) Cis-regulation is expected to 
originate from polymorphisms (red triangles) in the regulatory elements (white circles) or 
the coding region (colored rectangle) of the gene itself (or possibly of a nearby gene). (B) 
Trans-regulation is expected to originate from polymorphisms in the regulatory elements 
or the coding region of a gene located distant from the gene whose expression it controls. 
Note that variation in expression of multiple genes can map to the same gene in trans. (C) 
Transcripts and their eQTLs are graphically depicted in a genome-wide eQTL regulator 
map. Plotted on the y-axis are the physical positions of all measured transcripts, whereas 
on the x-axis the genomic regions that are most strongly associated with variation in ex-
pression levels (i.e. eQTLs) of the corresponding transcripts are shown. When transcript 
and eQTL position coincide, the transcript is considered to be cis-regulated and plotted 
on the diagonal. The vertical transband refers to transcripts encoded by genes that are 
positioned throughout the whole genome, but map to the same eQTL position. Transband 
transcripts are suggested to be co-regulated. Potential transband regulators are located 
within the eQTL interval (where the transband meets the x-axis). Figure adapted from 42. 
(D) Co-regulated transband genes can be directly or indirectly targeted by the potential 
regulator, thereby creating a network that consists of multiple levels of gene regulation.33 MOLECULAR GENETIC APPROACHES TO STUDY HEMATOPOIESIS
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intervals that had previously been identified using the classical approach. Cis-
regulated genes within these intervals represent the best candidate regulators, 
as they may harbor genetic variants that affect both their own expression levels 
and the trait of interest. Within the QTL interval on chromosome 11 to which we 
had previously mapped a region associated with hematopoietic progenitor cell 
turnover, only eight cis-regulated genes were identified, thereby reducing the 
number of candidate genes for functional testing.42 
An example of the power of this combined approach was recently provided 
by  Liang  et  al.  Classical  QTL  analysis  had  previously  identified  regions  on 
chromosomes 3, 5 and 18 that associated with variation in HSC frequency.27 Using 
reciprocal congenic mouse strains, the chromosome 3 QTL interval in isolation 
was  subsequently  shown  to  be  sufficient  to  confer  this  stem  cell  phenotype. 
Thereafter, a detailed analysis of differentially expressed transcripts within the 
QTL interval, followed by functional confirmation, led to the identification of Lxn 
as a gene involved in determining HSC frequency.53 
It  should  be  noted  that  large  collections  of  expression  data  have  been 
deposited in the online database GeneNetwork (http://www.genenetwork.org) 
and are freely accessible to the research community.54 GeneNetwork contains 
genotypic, phenotypic and gene expression data from several species, including 
Arabidopsis thaliana, barley, mouse and rat. Within the mouse BXD reference 
population, expression data of multiple tissues (HSCs, regulatory T cells, various 
neural tissues, eye, liver, lung and kidney) are present, which permit the distinction 
between genes that are expressed or regulated in a tissue-specific manner from 
those that are equally expressed or regulated in multiple tissues.
Multi-dimensional genetical genomics
Genetical genomics has proven to be a valuable tool for the identification of 
genes and gene networks that operate in HSCs. Yet, its potential impact is only 
emerging and has not been fully exploited. Therefore, in this section we will 
address the future applications of genetical genomics. 
Adding the dimension of closely related cell types 
Genetical genomics has primarily been limited to single cell types. A more powerful 
approach would be to apply the same approach to closely related cell types. This 
would allow comparative analyses of gene regulatory networks between distinct 
but related cells. In the HSC field such multi-dimensional genetical genomics 
studies have not yet been performed. However, Li et al recently demonstrated the 
general validity of the approach through the application of genetical genomics 
to  Caenorhabditis  elegans  recombinant  inbred  strains  that  were  exposed  to 
different temperatures. Their results showed heritable variation in gene expression 
responses to these environmental changes.47 This has created a solid basis for 
future multi-dimensional genetical genomics approaches. 34 CHAPTER 2
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In the hematopoietic system, genetical genomics could conceivably be applied 
to different hematopoietic cell stages (e.g. primitive HSCs, committed progenitors 
and fully differentiated blood cells). Inclusion of this additional dimension would 
enable  the  study  of  cell  fate  decisions  during  the  process  of  hematopoietic 
cell differentiation. Whereas classical analysis of gene expression levels during 
differentiation  evaluates  the  dynamics  of  gene  expression,  analyzing  eQTLs 
during differentiation evaluates the dynamics of gene regulation, permitting the 
identification of genes and gene networks that are specifically active in one cell 
type and not in another. Although eQTL profiles of different species and different 
cell types within the same species have previously been compared, eQTL profiles 
have never been evaluated for highly purified cell types that are so closely related. 
By implementing a “subtractive genetical genomics approach” a distinction can 
possibly be made between common or “housekeeping” eQTLs and those eQTLs 
that are specific for only one cell stage. 
Multi-dimensional  genetical  genomics  would  also  be  a  powerful  tool  to 
study age-dependent changes in the HSC compartment. Previous studies have 
compared the transcriptional profiles of HSC-enriched populations from young 
and  old  murine  bone  marrow.  The  collections  of  genes  reported  to  be  up-
regulated in aged stem cells included those involved in inflammatory and stress 
responses55 and signal transducer activity and receptor activity,56 whereas those 
down-regulated during aging were genes involved in DNA repair and chromatin 
remodelling.55 While these studies revealed thousands of age-regulated genes, 
the ultimate causes of these expression perturbations remain unknown. Analyzing 
age-dependent  gene  expression  changes  using  multi-dimensional  genetical 
genomics  could  bring  the  identification  of  genes  causing  the  age-induced 
alterations – and thereby future therapeutic intervention strategies – one step 
closer. 
Adding the dimension of epigenetics
Epigenetic gene regulation has been suggested to play a key role in modulating 
stem  cell  fate.  Epigenetics  refers  to  heritable  gene  expression  changes  that 
occur  without  DNA  sequence  alterations,  and  includes  DNA  methylation  and 
histone  modifications  such  as  acetylation,  methylation,  and  ubiquitylation. 
These  modifications  can  result  in  either  gene  activation  or  gene  repression. 
That epigenetic gene repression appears to be involved in the maintenance of 
“stemness” became apparent when a number of developmental regulators were 
found to be epigenetically silenced in murine ESCs and activated upon induction 
of ESC differentiation.57;58 It is exciting to postulate that epigenetic modifiers might 
similarly define cellular fate and lineage commitment during hematopoiesis.  
Since  a  differential  epigenetic  conformation  of  the  genome  can  result  in 
variation in gene expression levels that can in turn affect stem cell traits, it is 
possible that such differential epigenetic states underlie some of the observed 
(e)QTL  effects.  At  this  time,  however,  there  is  insufficient  knowledge  on  how 35 MOLECULAR GENETIC APPROACHES TO STUDY HEMATOPOIESIS
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epigenetic modifications correlate with variation in gene expression levels on 
a genome-wide scale. To this end, a powerful approach would be to combine 
traditional  transcriptome  profiling  with  whole-genome  tiling  arrays  measuring 
chromatin-immunoprecipitation and DNA methylation. If these complementary 
array-based analyses were carried out in the same reference panel of genetically 
distinct individuals, not only variation in transcript abundance, but potentially also 
variation in epigenetic conformations could be mapped to genomic loci. In this 
manner, both the genetics of gene expression (i.e. “regular” genetical genomics) 
and the genetics of epigenetics could be studied simultaneously, thus revealing 
genes that directly or indirectly affect epigenetic gene states. An additional issue 
that  could  be  addressed  by  such  an  approach  is  to  estimate  the  percentage 
of variation in gene expression that can be explained by different epigenetic 
conformations. 
The level of complexity could be further increased by including different cell 
types in the analysis, such as the above-mentioned different hematopoietic cell 
stages, different stem cell types, stem cells derived from different species, or 
stem  cells  of  different  ages.  Through  a  “subtractive  QTL  analysis”  approach, 
cell type specific QTLs that affect transcript abundance and/ or epigenetic gene 
states might thus be identified. The emergence of such comparative analyses in 
the coming years will further the understanding of regulatory networks and how 
they affect cellular fate.
Adding the dimension of microRNAs 
It is possible that some of the upstream regulators located within (e)QTL intervals 
are  in  fact  not  protein-encoding  genes,  but  rather  microRNAs.  MicroRNAs 
are  small  non-coding  RNAs  complementary  to  one  or  often  multiple  mRNAs, 
and  their  main  function  appears  to  be  down-regulation  of  gene  expression. 
Certain  microRNAs  have  been  shown  to  be  differentially  expressed  between 
various  hematopoietic  cell  types,  suggesting  that  they  could  be  involved  in 
lineage specification,59 Polymorphisms in microRNA production sites can alter 
their specificity, whereas polymorphisms in regulatory elements can alter their 
expression  levels.  In  addition,  polymorphisms  in  microRNA  target  sites  can 
affect the binding of a microRNA and therefore their capability to silence target 
gene expression. Any of these microRNA sequence variants might underlie (e)
QTL effects. For example, polymorphic microRNA target sites located within a 
gene (often in the 3’ untranslated region) might underlie a cis-acting eQTL effect. 
Further, transbands could be explained by a polymorphic microRNA production 
site that is positioned within an eQTL interval, giving rise to a microRNA that may 
differentially affect the expression levels of its target genes. 
Efforts have already been made to overlap polymorphic microRNA target sites 
with eQTL intervals and known classical QTL intervals in an attempt to identify 
microRNAs that not only underlie variation in gene expression levels but also 
variation  in  cell  biological  traits.  Genes  positioned  in  (e)QTL  intervals  can  be 36 CHAPTER 2
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screened for polymorphisms in microRNA target sites in an online database at 
http://compbio.utmem.edu/miRSNP/.60 
Little is known about the factors that regulate the expression levels of the 
microRNAs themselves. Genome-wide microRNA profiling of cells isolated from 
genetically distinct individuals would assist is this regard, since through the use 
of genetic linkage, variation in microRNA expression levels can be mapped to 
genomic regions affecting microRNA expression levels. 
Adding the dimension of clinical data
The sequencing of the human genome and the development of transcriptome 
profiling technology have permitted new approaches to characterize hematologic 
malignancies at the molecular level. Gene expression profiles have been generated 
for malignancies such as diffuse large B-cell lymphoma, mantle cell lymphoma, 
acute  myeloid  leukemia,  acute  lymphoblastic  leukemia,  chronic  lymphocytic 
leukemia and multiple myeloma. All these malignancies could be classified into 
molecularly distinct subgroups on the basis of similarities in their gene expression 
profiles, and genes whose expression could discriminate between these distinct 
subgroups were identified (reviewed in 61). Although this subgroup classification 
has diagnostic, prognostic and therapeutic consequences, the disease-initiating 
or  causative  factors  are  still  not  known.  If  large  scale  clinical  data  and  gene 
expression profiles were combined with detailed genotypes of the patients, this 
would permit the use of genetical genomics and therefore the identification of 
QTLs  that  underlie  complex  diseases,  and  contribute  to  understanding  which 
genes, gene networks and biological processes are involved in both normal and 
malignant hematopoietic cell development.
That genetical genomics could be applicable to human data was demonstrated 
in two independent studies using previously genotyped lymphoblastoid cell lines 
from related individuals.48;49 In both studies the heritability of gene expression 
levels was shown and eQTLs were identified, but there were too many differences 
between the two approaches to compare them in a direct manner.62 Association-
based studies were also performed using lymphoblastoid cell lines from unrelated 
individuals.63;64  While  these  studies  demonstrated  the  potential  of  performing 
genetical genomics using human data, the clinical relevance of these approaches 
was limited since the studies were performed on transformed human cell lines, 
were limited in their samples sizes, and did not include any clinical phenotypes. 
 A more direct example of the clinical relevance of this approach was recently 
provided by Göring et al, who generated genome-wide transcriptional profiles 
of  normal  untransformed  lymphocytes  from  a  large  collection  of  genotyped 
individuals whose plasma cholesterol concentrations were also measured. Using 
a genetical genomics approach, VNN1 was identified as a gene affecting high-
density lipoprotein cholesterol concentrations.65 
In  a  second  clinically  relevant  example,  blood  and  adipose  tissues  were 
collected from a large group of subjects, after which genotypes, gene expression 37 MOLECULAR GENETIC APPROACHES TO STUDY HEMATOPOIESIS
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levels  and  clinical  traits  related  to  obesity  were  analyzed  in  a  combinatorial 
fashion. A substantial correlation was found between gene expression profiles 
of adipose tissue and obesity-related traits, but not between blood expression 
profiles  and  those  traits.  Importantly,  genes  and  gene  networks  that  were 
enriched in inflammatory and immune response pathways were identified that 
in part contribute to obesity in humans.66 These examples demonstrate how a 
multi-dimensional genetical genomics approach can aid in the understanding of 
human health.
CLOSING REMARkS
In  this  review,  we  describe  how  transcriptional  profiling  has  helped  to  define 
the molecular identity of HSCs and other cell types, and how the use of linkage 
genetics has permitted the identification of specific genomic regions that affect 
HSC  traits.  In  particular,  we  focus  on  the  “genetical  genomics”  approach  of 
combining  transcriptional  profiling  with  genetic  linkage  analysis,  and  discuss 
the potential added value of including additional dimensions in the analysis. All 
approaches are summarized in Figure 4. In the coming years, multi-dimensional 
genetical  genomics  has  the  potential  to  greatly  aid  in  revealing  regulatory 
networks that specify cell fate decisions not only in HSCs, but in a whole range of 
clinically relevant cell types.
Transcriptome profiling
Classical linkage
One-dimensional 
genetical genomics
Multi-dimensional 
genetical genomics
Multiple genotypes
Within organism
Gene expression One genotype
Within one or more cell types
Classical phenotype
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Within multiple cell types:
Developmental stages
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Figure 4. Overview of the described approaches (left), the sources of analysis (middle) 
and the phenotypic measures (right).38 CHAPTER 2
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3AbSTRACT
Genetical genomics is a strategy for mapping gene expression variation to 
expression quantitative trait loci (eQTLs). We performed a genetical genomics 
experiment in four functionally distinct but developmentally closely related 
hematopoietic cell populations isolated from the BXD panel of recombinant 
inbred mouse strains. This analysis allowed us to analyze eQTL robustness/
sensitivity  across  different  cellular  differentiation  states.  Although  we 
identified a large number (365) of “static” eQTLs that were consistently active 
in all four cell types, we found a much larger number (1283) of “dynamic” 
eQTLs  showing  cell-type-dependence.  Of  these,  140,  45,  531,  and  295 
were preferentially active in stem, progenitor, erythroid and myeloid cells, 
respectively. A detailed investigation of those dynamic eQTLs showed that in 
many cases the eQTL specificity was associated with expression changes in 
the target gene. We found no evidence for target genes that were regulated 
by distinct eQTLs in different cell types, suggesting that large-scale changes 
within functional regulatory networks are uncommon. Our results demonstrate 
that  heritable  differences  in  gene  expression  are  highly  sensitive  to  the 
developmental stage of the cell population under study. Therefore, future 
genetical genomics studies should aim at studying multiple well-defined and 
highly purified cell types in order to construct as comprehensive a picture of 
the changing functional regulatory relationships as possible.45 CELL-STAGE-SENSITIVITY OF EQTLS
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AUTHOR SUMMARY
Blood cell development from multipotent hematopoietic stem cells to specialized 
blood cells is accompanied by drastic changes in gene expression for which the 
triggers  remain  mostly  unknown.  Genetical  genomics  is  an  approach  linking 
natural  genetic  variation  to  gene  expression  variation,  thereby  allowing  the 
identification of genomic loci containing gene expression modulators (eQTLs). In 
this paper, we used a genetical genomics approach to analyze gene expression 
across  four  developmentally  close  blood  cell  types  collected  from  a  large 
number of genetically different but related mouse strains. We found that while a 
significant number of eQTLs (365) had a consistent “static” regulatory effect on 
gene expression, an even larger number were found to be very sensitive to cell 
stage. As many as 1283 eQTLs exhibited a “dynamic” behavior across cell types. 
By looking more closely at these dynamic eQTLs, we show that the sensitivity of 
eQTLs to cell stage is largely associated with gene expression changes in target 
genes. These results stress the importance of studying gene expression variation 
in  well-defined  cell  populations.  Only  such  studies  will  be  able  to  reveal  the 
important differences in gene regulation between different cell types.
INTRODUCTION
Genetical genomics uses quantitative genetics on a panel of densely genotyped 
individuals to map genomic loci that modulate gene expression.1 The quantitative 
trait loci identified in this manner are referred to as expression quantitative trait 
loci, or eQTLs.2 Most genetical genomics studies that have thus far been reported 
have  analyzed  single  cell  types  or  compared  developmentally  unrelated  and 
distant cell types.3-8 Here, we report the first application of genetical genomics to 
study eQTL dynamics across closely related cell types during cellular development. 
We show results that discriminate between eQTLs that are consistently active or 
“static” and those that are cell-type-dependent or “dynamic”. 
We used the hematopoietic system as a model to analyze how the genome 
of a single stem cell is able to generate a large variety of morphologically and 
functionally  distinct  differentiated  cells.  Differentiation  of  hematopoietic  stem 
cells towards mature, lineage-committed blood cells is associated with profound 
changes  in  gene  expression  patterns.  The  search  for  differentially  expressed 
genes, most notably for those transcripts exclusively present in stem cells and 
not in their more differentiated offspring, has been successful and has provided 
valuable  insight  into  the  molecular  nature  of  stem  cell  self-renewal.9-12  Yet, 
complementary approaches were needed to elucidate the dynamic regulatory 
pathways that are underlying the robust differentiation program leading to blood 
cell production. 46 CHAPTER 3
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We describe a genetic analysis of variation in gene expression across four 
functionally distinct, but developmentally related hematopoietic cell populations. 
Our  data  reveal  complex  cell-stage  specific  patterns  of  heritable  variation  in 
transcript  abundance,  demonstrating  the  plasticity  of  gene  regulation  during 
hematopoietic cell differentiation. 
METHODS
Recombinant inbred mice 
Female  BXD  recombinant  inbred  mice  were  originally  purchased  from  The 
Jackson Laboratory and housed under clean conventional conditions. Mice were 
used between 3 and 4 months of age. All animal experiments were approved by 
the Groningen University Animal Care Committee.
Cell purification
Bone marrow cells were flushed from the femurs and tibias of three mice and 
pooled. After standard erythrocyte lysis, nucleated cells were stained with either 
a panel of biotin-conjugated lineage-specific antibodies (containing antibodies 
to CD3e, CD11b (Mac1), CD45R/ B220, Gr-1 (Ly-6G and Ly-6C) and TER-119 
(Ly-76)),  fluorescein  isothiocyanate  (FITC)-conjugated  antibody  to  Sca-1  and 
allophycocyanin (APC)-conjugated antibody to c-Kit, or with biotin-conjugated 
TER-119 antibody and FITC-conjugated antibody to Gr-1. After being washed, 
cells  were  incubated  with  streptavidin-phycoerythrin  (PE)  (all  antibodies  were 
purchased from Pharmingen). Cells were purified using a MoFlo flowcytometer 
(BeckmanCoulter) and were immediately collected in RNA lysis buffer. Lineage-
depleted (Lin−) bone marrow cells were defined as the 5% of cells showing the 
least PE intensity. 
RNA isolation and Illumina microarrays
Total RNA was isolated using the RNeasy Mini kit (Qiagen) in accordance with 
the manufacturer’s protocol. RNA concentration was measured using a Nanodrop 
ND-1000  spectrophotometer  (Nanodrop  Technologies).  The  RNA  quality 
and  integrity  was  determined  using  Lab-on-Chip  analysis  on  an  Agilent  2100 
Bioanalyzer (Agilent Technologies). Biotinylated cRNA was prepared using the 
Illumina TotalPrep RNA Amplification Kit (Ambion) according to the manufacturer’s 
specifications starting with 100 ng total RNA. Per sample, 1.5 µg of cRNA was used 
to hybridize to Sentrix Mouse-6 BeadChips (Illumina). Hybridization and washing 
were performed by ServiceXS according to the Illumina standard assay procedures. 
Scanning was carried out on the Illumina BeadStation 500. Image analysis and 
extraction of raw expression data were performed with Illumina Beadstudio v2.3 
Gene Expression software with default settings and no normalization. The raw 47 CELL-STAGE-SENSITIVITY OF EQTLS
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expression  data  from  all  four  cell  types  were  first  log2  transformed  and  then 
quantile normalized as a single group.
Clustering of genes
For  cluster  analysis  we  retained  only  genes  having  a  minimal  fold  change  of 
2 (difference of 1 in log2 scale) in either direction in mean expression on the 
transition  from  Lin−Sca-1+c-Kit+  to  Lin−Sca-1−c-Kit+ and  on  the  transition  from 
Lin−Sca-1−c-Kit+ to TER-119+ or to Gr-1+. This filter reduced the dataset to 876 
probes. We then computed the distance matrix for this group of probes, using 
the  absolute  Pearson  correlation.  Using  this  distance  matrix,  we  applied  the 
hierarchical  clustering  algorithm.  From  the  resulting  tree,  8  different  clusters 
emerged from a manually chosen threshold. We then submitted each of these 
clusters to DAVID to identify enriched functional annotations.13 
Full ANOVA model for eQTL mapping
The expression data of the four cell types were firstly corrected for batch effect 
and then analyzed separately by the following ANOVA model:
yi = m + Qi + ei 
where yi is the gene’s log intensity on the ith microarray; m is the mean; Qi is the 
genotype effect under study; and ei is the residual error.
Next, expression data of the four cell types were combined and analyzed by a 
full ANOVA model including the cell type effect (CT) and the eQTL×CT interaction 
effect:
yij = m + CTj + Qi + (Q×CT)ij + eij
where yij is the gene’s log intensity at the ith microarray (i = 1,…n) and jth cell 
type;  CTj  is the jth cell type effect; (Q×CT)ij is the interaction effect between the 
ith eQTL genotype and  jth cell type, and eij is the residual error. The batch effect 
was included as one of the factors. For each probe, we performed a genome-wide 
linkage analysis to identify the two markers that showed the most significant main 
QTL effect and interaction effect, respectively. 
Local and distant eQTLs
We defined an eQTL as local if it was located within less than 10 Mb from the 
gene. All other eQTLs were considered distant.
Classification of eQTLs
The  ANOVA  yields  significance  p-values  for  the  main  QTL  effect  Qi  and  the 
interaction effect (Q×CT)ij  for each probe at each marker. A small p-value for 
the  interaction  effect  indicates  that  the  eQTL  effect  is  different  between  the 48 CHAPTER 3
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cell types. This significant difference can be due to very diverse patterns, with 
different biological interpretations. It is therefore necessary to classify interaction 
eQTLs based on these patterns. To achieve this classification, for every interaction 
eQTL we evaluated the strength of the effect in each cell type by calculating the 
difference between the mean expression of both genotypes. The cell type for 
which the effect was the strongest was labeled “High”. The cell type whose effect 
was most different from the strongest effect was labeled “Low”. The remaining 
two cell types were assigned to the group they resembled most closely. This 
classification allowed us to define 14 categories of interaction eQTLs. Additionally, 
we identified eQTLs that have a consistent effect across all four cell types. This 
category of consistent eQTLs consists of all probes satisfying the following three 
conditions: the gene has a significant main effect Qi at marker m; for the same 
marker m, the interaction (Q×CT)ij is not significant; the mean eQTL effect across 
cell types has a coefficient of variation smaller than 0.3.
Estimating the FDR for the main QTL effect
We permuted the strain labels in the genotype data 100 times, maintaining the 
correlation of expression traits while destroying any genetic association. Then we 
applied the full ANOVA model and stored the genome-wide minimum p-value 
for  each  transcript.  Based  on  the  resulting  empirical  distribution  of  p-values, 
we estimated that a threshold of –log10p = 6 corresponds to a false discovery 
rate14 of 0.02 for the main QTL effect. The 99.9th percentile of the number of 
significant eQTLs per marker (i.e., the minimum size of statistically significant 
“eQTL hotspots”) is 28.  
Estimating the FDR for interaction QTL effect
We estimated the residuals of the full ANOVA model after fitting all factors up to 
the main QTL effect at each marker for each transcript.15 Then we permuted the 
strain labels and applied the ANOVA model yij = Qi + CTj + (Q×CT)ij + eij to the 
permuted residuals at each marker for each transcript and stored the genome-
wide minimum p-value. Based on 100 permutations and the resulting empirical 
distribution of p-values, we estimated that a threshold of –log10p = 6 corresponds 
to a false discovery rate of 0.021 for interacting QTL effect. The 99.9th percentile 
of the number of significant eQTLs per marker (i.e., the minimum size of statistically 
significant “interaction hotspots”) is 8.  
Detection of swapping eQTLs
Swapping  eQTLs  are  those  transcripts  that  show  one  eQTL  in  one  cell  type, 
but another eQTL in another cell type. From the full model mapping described 
above, we obtained 1283 transcripts with a significant interaction effect between 
genotype  (first  marker)  and  cell  type.  After  taking  into  account  the  genetic 49 CELL-STAGE-SENSITIVITY OF EQTLS
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and interaction effects of the first marker, we scanned the genome excluding 
the region of the first marker (window size = 30cM) and tested if there was a 
significant interaction effect between genotype and cell type and whether this 
new interaction effect was classified in a different cell type category (see above 
Classification of eQTLs), which would indicate a swapping eQTL.
This means, for each transcript, a two-marker full model mapping was applied 
using the following model:
yij = m + CTj + Q*
i + (Q*×CT) ij + Qi + (Q×CT)ij +  Qi
*Qi + eij
where yij is the gene’s log intensity at the ith microarray (i = 1,…n) and jth cell type;   
CTj  is the jth cell type effect; Q*
i and (Q*×CT)ij are the main genotype effect at first 
marker and interaction effect between cell type and the genotype effect at this 
marker, where the first marker is defined as the marker with maximal interaction 
effect from previous one-marker full model mapping; Qi is the genotype effect 
of the second marker; (Q×CT)ij is the interaction effect between the ith genotype 
and  jth cell type, Qi
*Qi  is the epistasis effect and eij is the residual error. 
URLs
All raw data were deposited in the NCBI Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo/, accession number GSE18067). All processed data 
were deposited in the GeneNetwork (www.genenetwork.org). 
RESULTS
Genetic regulation of gene expression
We evaluated genome-wide RNA transcript expression levels in purified Lin−Sca-
1+c-Kit+ multi-lineage cells, committed Lin−Sca-1−c-Kit+ progenitor cells, erythroid 
TER-119+ cells, and myeloid Gr-1+ cells, isolated from the bone marrow of ~25 
genetically  related  and  fully  genotyped  BXD  –  C57BL/6  (B6)  X  DBA/2  (D2)  – 
recombinant inbred mouse strains.16 In this study, we exploit the fact that the 
purified cell populations are closely related, sometimes just a few cell divisions 
apart on the hematopoietic trajectory. The Lin−Sca-1+c-Kit+ cell population contains 
all stem cells with long-term repopulating ability, but also includes multipotent 
progenitors that still have lymphoid potential. Although long-term repopulating 
stem cells are known to only make up a fraction of the Lin−Sca-1+c-Kit+ population, 
for simplicity we will refer to this population as stem cells. The Lin−Sca-1−c-Kit+ 
cell population does not contain stem cells and lymphoid precursors, but does 
include  common  progenitors  of  the  myeloid  and  erythroid  lineages.17  Finally, 
TER-119+ cells and Gr-1+ cells are fully committed to the erythroid and myeloid 
lineages,  respectively.  Unsupervised  clustering  of  the  most  varying  transcripts 50 CHAPTER 3
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demonstrated that each of the four cell populations could easily be recognized 
based on expression patterns across all four cell types (Figure 1 and Table S1). 
We observed strong and biologically significant variation in gene expression 
during hematopoietic differentiation, independent of mouse strain. However, the 
genetical genomics strategy, in which we focus on inter-strain gene expression 
differences, allows for a far more comprehensive understanding of the genetic 
regulatory links underlying this variation. QTL mapping of gene expression traits 
allows us to identify eQTLs; genomic regions that have a regulatory effect on 
those  expression  traits.  Two  types  of  eQTLs  can  be  distinguished,  i.e.,  those 
that map near (less than 10 Mb from) the gene which encodes the transcript 
(local) and those that map elsewhere in the genome (distant).18 Together, local 
and distant eQTLs constitute a genome-wide overview of the gene regulatory 
networks that are active in the cell type under study. The strongest eQTLs were 
found for genes that were expressed only in mouse strains carrying one specific 
parental allele, suggesting that local regulatory elements are distinct between 
the  two  alleles.  Cases  of  such  allele-specific  expression  included  H2-Ob  and 
Apobec3. These transcripts were only detectable in strains that carried the B6 
allele of the gene (see Figures S1A–B). A global view of heritable variation in 
gene expression indicated that the strongest eQTLs are not associated with the 
most highly expressed genes, and that for most probes the expression difference 
between the B6 and D2 alleles is small (see Figures S1C–D).
Since the focus of this project is to study the influence of cellular differentiation 
state on regulatory links, we used ANOVA to distinguish between “static” eQTLs 
that show consistent genetic effects across the four cell types and “dynamic” 
eQTLs  that  are  sensitive  to  cellular  state  (i.e.,  eQTLs  that  have  a  statistically 
significant  genotype-by-cell-type  interaction).  We  further  partitioned  dynamic 
eQTLs  into  different  categories  on  the  basis  of  their  dynamics  along  the 
differentiation trajectory. 
Cell-type-independent static eQTLs
The first eQTL category comprises genes that have static eQTLs across all four 
cell types under study. Variation in Lxn expression is shown as a representative 
example (Figure 2A, left panel). Lxn expression has previously been shown to 
be higher in B6 stem cells compared to D2 stem cells, and to be negatively 
correlated with stem cell numbers.19 In our dataset Lxn showed clear expression 
dynamics  (it  was  most  highly  expressed  in  stem  cells),  and  was  indeed  more 
strongly expressed in cells carrying the B6 allele, but the expression difference 
between mice carrying the B6 or D2 allele remained constant across all cell types. 
In total, we identified 365 probes that displayed a static eQTL at threshold 
p < 10-6 (FDR = 0.02). Among the 268 locally-regulated probes in this category was 
H2-D1. The histocompatibility gene H2-D1 is known to be polymorphic between B6 
and D2 mice, and would therefore be expected to be in the static eQTL category. 51 CELL-STAGE-SENSITIVITY OF EQTLS
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The remaining 97 probes mapped to distant eQTLs, i.e., their heritable expression 
variation was affected by the same distant locus in all four cell types (Table 1). 
All probes that belonged to the static eQTL category are graphically depicted 
in an eQTL dot plot displaying the genomic positions of the eQTLs compared to 
the genomic positions of the genes by which the variably expressed transcripts 
were encoded (Figure 2A, right panel). Whereas in this plot local eQTLs appear on 
the diagonal, distant eQTLs appear elsewhere. In general, as has been reported 
before in eQTL studies, transcripts that were locally regulated showed strong 
linkage statistics. Not surprisingly, the statistical association between genotype 
and variation in transcript abundance for those transcripts that were controlled by 
distant loci was weaker. These genes are likely to be controlled by multiple loci, 
each contributing only partially to the phenotype, thereby limiting their detection 
and validation in the current experimental sample size. A list of all transcripts with 
significant static eQTLs is provided in Table S2.
cell-type-dependent dynamic eQtls
The second eQTL category comprises genes that have dynamic eQTLs across 
all four cell types under study. In total, we identified 1283 eQTLs (p < 10-6, FDR 
= 0.021) that showed different genetic effects in different cell types, indicating 
that eQTLs are highly sensitive to cellular differentiation state (Table 1). Within 
this dynamic eQTL category, the first four subcategories are composed of eQTLs 
that were preferentially active in only one of the four cell types we analyzed 
(Figures 2B–E). 
For example, Slit2 mapped to a strong eQTL that was active only in stem 
cells. Slit2 mRNA was only detected in the most primitive hematopoietic cell 
compartment  in  those  BXD  strains  that  carried  the  D2  allele  at  rs13478235,   
a SNP that mapped 629 kb away from the Slit2 gene (Figure 2B, left panel). Slit2 
encodes an excreted chemorepellent molecule that is known to be expressed in 
embryonic stem cells,20 to be involved in neurogenesis21 and angiogenesis,22 and 
to inhibit leukocyte chemotaxis.23 We found a total of 140 genes that have eQTLs 
that  are  preferentially/selectively  active  in  stem  cells  (Figure  2B,  right  panel, 
largest symbols, Table 1). These 140 genes included well-known candidate stem 
cell genes such as Angpt1, Ephb2, Ephb4, Foxa3, Fzd6, and Hoxb5. Interestingly, 
many transcripts with as yet unknown (stem cell) function were transcriptionally 
affected by stem-cell-specific eQTLs. Candidate novel stem cell genes include 
Msh5, and Trim47, in addition to a large collection of completely unannotated 
transcripts.
A total of 45, 531, and 295 eQTLs were found to be preferentially/selectively 
active in progenitors, erythroid cells, and myeloid cells, respectively (Table 1). Very 
distinct patterns of cell-type-specific gene regulation emerged when these eQTLs 
were visualized in genome-wide dot plots (Figures 2C–E). Using genome-wide 
p-value thresholds of p < 10-6, we identified 53 distantly-regulated transcripts 52 CHAPTER 3
3
Zinc finger,  PHD type
Mitochondrion
Ribonucleoprotein
DNA replication
Actin binding
Immune response
SH2 domain
SH3 domain
low
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Myeloid Erythroid Progenitor Stem
Immune response
Figure 1. Mean expression levels for all probes in the four cell types. Unsupervised 
clustering including all probes for the 96 RNA samples follows cell-type (top hierarchical 
tree), while clustering of the 876 most varying probes reveals distinct categories of genes 
that show cell-type-specific expression (left hierarchical tree). The heat map shows the   
expression patterns of those probes and selected enriched gene categories in each major 
cluster. Discriminatory genes are enriched in various functional classes, including SH2/SH3 
domain containing transcription factors for stem cells, mitochondrial genes for progenitor 
cells, genes involved in DNA replication and zinc fingers for erythroid cells, and immuno-
globulin type genes for myeloid cells (all p-values < 0.05). For genes that belong to each 
of these clusters, see Table S1.
in stem cells, 13 in progenitor cells, 400 in erythroid cells, and 132 in myeloid 
cells. In erythroid and myeloid cells most of these transcripts mapped to relatively 
few genomic loci; these trans-bands are statistically significant, as assessed by   
a permutation approach taking expression correlation into account (see Methods).24 
Typically, transcripts mapping to a common marker showed a directional bias 
towards either B6 or D2 expression patterns.
In  addition  to  the  relatively  simple  eQTL  dynamics  that  we  have  thus 
far  illustrated,  more  complex  eQTL  dynamics  were  also  detected  using  this 53 CELL-STAGE-SENSITIVITY OF EQTLS
3
Lxn
D3Mit241 − Chr 3  
o
o
o
o
o o
o
o o
o
o
o
o
o o
o
o
o
o
o
o
o o o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o o
o
o
o
o o
o
o
o o
o
o
o
o
o
o
o
o
o
o
o
o o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o o o
o
o
o
o
o
o
o
o o
Static A
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
eQTL position
T
r
a
n
s
c
r
i
p
t
 
p
o
s
i
t
i
o
n
Slit2
rs13478235 − Chr 5  
o
o
o
o
o
o
o o o
o
o
o
o
o
o
o
o
o
o o
o
o
o
o
o o
o
o
o
o
o o
o
o
o
o
o
o
o
o
o
o
o
o o
o
o
o
o
o
o o o
o o
o o
o o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o o o
o
o
o o
o
o
o o o o
o
o
o
o
o
o
o
o
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+ +
+
+ + +
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+
+
+ + +
+
+
+
+
+
+
+
+
+ + +
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+ + +
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+ + +
+
+
+
+ +
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+ + +
+ + + +
+ + + + + +
+ + + +
+ + + + +
+ + + +
+
+
+ + + + + +
+ + + + + + +
+
+ +
+ + + +
+ + + + + + +
+ + + +
+
+ + + +
+ + + +
+ +
+ + + + + + +
+
+ + + + +
+ + + + + + +
+ + + + +
+ + + + +
+ + + + + + + +
+ + + + + + + +
+ + + + + + + + +
+ + + + + + +
+ +
+
+
+ + + + + +
+ + + +
++ + + +
+ + ++ + + + + + +
+ + +
+ + + + + +
+ + + + + +
+
+ +
+
+ +
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+ +
+
+ + +
+ +
+ + + + +
+ +
++
+
+ + +
+ + + +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ ++ +
+
+
+
+ + +
+
+
+
+
+
+
+
+ + + +
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+ + + +
+ + +
+ + +
+
+
+ +
+ + +
+
+ + + + + + + + +
+
++
+ +
+
Stem-specific B
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
eQTL position
T
r
a
n
s
c
r
i
p
t
 
p
o
s
i
t
i
o
n
Snrpn
rs6345670 − Chr 7  
o
o
o
o
o
o
o
o
o
o
o
o
o o o
o
o
o
o
o
o
o
o o
o
o
o
o o o
o
o
o
o
o
o
o o o
o
o
o
o
o
o
o o
o
o
o
o o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o o
o
o o
o o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ + +
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+ + + +
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+ +
+
+ + + + +
+
+ +
+
+ + +
+
+ + + + +
+
+
+ +
+ +
+ +
+ + +
+ +
+
+ +
+
+ + +
+
+
+ +
+
+ +
+
+ +
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+ + +
+
+
+
+
+
++
+ + +
+ +
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+ +
+ +
+
+
Prog-specific C
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
eQTL position
T
r
a
n
s
c
r
i
p
t
 
p
o
s
i
t
i
o
n
rs3698182 − Chr 8  
Hbb−bh1
o
o o
o
o
o
o o o
o
o
o
o o o o
o
o o o
o o o
o
o
o
o
o
o
o
o
o o
o
o
o
o
o
o
o
o
o
o
o
o o o
o
o
o
o
o
o
o o o
o
o o
o
o o
o
o
o
o
o
o
o
o
o
o o
o
o
o o
o
o
o
o
o
o
o o
o o
o
o
o o o o o
o
o
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+ + +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ + + ++
+ + +
+ + + + + + +
+ + +
+ +
+
+ + + +
+ +
+
+ +
+ + + + + +
+ + +
+
+
+
+
+
+ +
+
+
+
+ + + +
+
+ + +
+ +
+ + +
+ + +
+
+
+
+ + +
+
+
+
+
+ +
+
+
+
+
+ +
+
+ + +
+ + + + + + +
+ + + + + +
+ + +
+ +
+
+ +
+ + + + + +
+
+ + +
+
+ + + + +
+
+
+ +
+
+
+ +
+ + +
+ + +
+
+
+
+ +
+ +
+
+ +
+
+ +
+ + +
+ + +
+ +
+
+ +
+ + + ++ + + +
+ + + +
+
+
+ +
+ + + + +
+
+ + + +
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+ + + + + +
+ +
+
+ + + + + + + + + + + +
+
+
+ + + + + + + +
+
+ + + + +
+ + +
+
+
+
+
+
+
+
+
+
+
+
+
+
+ + +
+
+
+
+
+ + +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+
+
+
+
+
+ +
+
+
+
+
+ +
+
+ +
+
+ +
+
+ +
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+ + + +
+ + +
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+ +
+
+ +
+ +
+ + + + + +
+
+
+ +
+
+ +
+
+
+
+
+ + +
+ +
+
+ + +
+
+ + + + + + + + + +
+ + + + + + + + +
+ +
+ + + +
+
+ +
+
+ + + + + +
+ + +
+
+
+
+ + + + + +
+
+ +
+ + + + +
+ + + + + ++ + +
+
+ + + +
+ + + +
+ + +
+
+
+
+
+
+
+
+
+
+
+
+ + +
+ +
+
+ +
+
+ +
+
+ +
+
+
+
+ +
+
+
+ +
+
+
+ +
+
+ +
+
+
+
+ + +
+ + + + + + + +
+ +
+ +
+
+
+ +
+ + + +
+
+ + + +
+
+ + + +
+
+ + + + + +
+ +
+
+ +
+
+
+
+ +
+
+
+ + + + + + +
+
+
+ +
+
+
+ +
+
+ + + +
+
+ + + + +
+ +
+
+
+ +
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+
+ +
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+ +
+
+
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+ + +
+ +
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+ +
+
+ +
+
+
+ + + + + +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ + +
+
+
+
+ + +
+
+ +
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+
+
+
+
+
+
+
+ +
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+ +
+ ++ +
+ +
+
+ +
+ +
+
+
+
+ + + +
+
+
+ +
+ + + + +
+
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
+
+
+
+
+ + + + + + ++ + + + + + + + + + + + +
+ + + + + + +
+
+ + + + + + + + + + + + + + + + + + + + + ++
+ + + + + +
+
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + ++ + + + + + + + + + + + +
+
+ + + + + + + + + + + + + + + + + + + + + + + +
+
+
+ + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + +
+
+ + + + + +
+ + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + +
+
+ + + +
+ + + + + + + + + + + + + + + + + + + + + + + + +
+
+ + + +
+ + + + + + + + + + ++ + + + + + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + ++ +
+ + + + + + + + + + + + + + + + +
+
+ + +
+ + + + + + + + + + +
+
+ +
+
+ + + + + + +
+ + + + + + + +
+
+ + + + + + + + + + + + + + +
+
+
+ +
+
+ + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + + + + +
+ +
+
+ + + + + + + + + ++ + + + + + + + + + + + + + + +
+ + + + + + + + + + +
+
+ + + + + + + + + + + + + + +
+ + + + + + + + + + + + + + + + + + + + +
+ + + + + + + +
+
+
+ ++ + + + + + + + +
+ + + + + + + + + + +
+ + + + + + + + +
+
+ + +
+ + + + + + + + + + +
+ + + + + + + + + + + + + + + + +
+ + + + + + + +
+
+ + + + + + + +
++ + + + + + + ++ + + +
+ + + + + + + + + + + + + +
+ + + + + + + + + + + + +
+ + + + + ++ + + + + + + +
+ + + + + +
+
+ + +
+ ++ + + + + + + + +
+ + + + + + + +
+
+ + + + + + + + +
+
+ + + + +
+ + + + + + + + + + +
+ + + + + + + + + + + + +
+
+ +
+
+
+
+
+
+
+ +
+ + + +
+ +
+
+
+
+ +
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+ +
+ +
+
+ +
+ +
+ + + +
+
+
+
+
+ + +
+ + + +
+ +
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+ + +
+ + +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ + +
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+ +
+
+ +
+
+
+ +
+
+ +
+
+
+
+
+
+ +
+
+
+ +
+
+
+
+ +
+
+
+
+
++
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+ + + + + + +
+ +
+ + +
+ +
+
+ + + + +
+ + + + + + + + +
+ +
+ + + +
+
+ + +
+
+ +
+ + +
+ + + + +
+ + +
+ + + + + + + + + + + +
+ + +
+ + + +
+ + + +
+
+
+
+ + + +
+ + + +
+
+ +
+ + +
+ + + +
+
+
+ +
+ +
+
+
+
+
+
+ + +
+ +
+
+
+ +
+ + + +
+
+
+
+
+ +
+
+
+
++
+
+ +
+
+
+
+ +
+ +
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
++
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+ +
+ +
++
+
+
+
+
+
+
+ + + + + + + + + +
+ + +
+ + + + + +
+ +
+
+
+ + + +
+ + + +
+ + + + + +
+ + +
+ + +
+ +
+
+ +
+ + + +
+ + + +
+
Erythroid-specific D
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
eQTL position
T
r
a
n
s
c
r
i
p
t
 
p
o
s
i
t
i
o
n
rs6259521 − Chr 19
Foxd4
o o o
o
o
o o
o
o o
o
o o
o
o
o o o
o
o o o o
o o o o o o o
o
o o
o
o
o
o
o
o
o
o o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o o
o
o o o o o
o
o
o o o o o o o o o o o o
o o o o
o
o
o o o o
o
o
o o
o
o
+
+
+
+
+ + +
+
+
+
+
+
+
+
+ +
+
+
+ +
+
+
+ +
+ +
+ + +
+
+
+
+
+
+
+
+ + +
+ +
+
+ +
+
+ +
+
+ + +
+ + + +
+
+
+
+ + + +
+ + + + +
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+ + + + + + + + + + + + + + + + + + + + + + + +
+ + + + + + + + + +
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ + +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+ +
+ + + +
+
+ + + +
+
+
+ +
+ + + + +
+ + +
+
+
+
+
+
+ +
+ + +
+
+
+ +
+ +
+
+ + +
+
+
+ +
+
+
+
+
+ +
+ + + + +
+
+
+
+
+
+ + + + + +
+ +
+ + + + +
+ + + + +
+
+
+
+ +
+
+
+ + +
+ +
+ + +
+
+
+
+
+ + +
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+ +
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+ +
+
+
+
+ + +
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+ +
+
+ +
+
+
+
+
+ +
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ + +
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+ +
+
+
+
+
+ +
+
+
+ + + + + +
+ + + + + + + ++ + + + +
+ + + + + + + + + + + + + +
+
+ + +
+
++ + + + + + + + +
+
+ + +
+ + + + + +
+ + + + + + + + + + +
+ + + + + + + + + + + + + +
+
+ + + + + + + + + + +
+ ++ + + + + + + +
+ + + + + + + +
+ + + + + + + + + + + + + +
+ + + + + + + + + + + +
+ + + +
+ + + + + +
+ + + +
+ + + + +
+ +
+ + + + +
+
+
+ + + + + + +
+ + + + + + + + + + + + + +
+ + + + + + + + + +
+
+ + + + + + +
+ + + + + + + + + + + + +
+ + + + + + ++ + + + + + + + + +
+
+ + + + + + +
+ + + + +
+
+ + + + + +
+ + + + + + + + + + +
+ +
+
+ + + + +
+ + + + + + + + + +
+ + + + +
+ + + + + + + + + +
+ + + + + + + + + +
+
+ + + + + + +
+ + + + + + + +
+ + + + + + + + + + + +
+ + + + + + +
+ + + +
+ + + +
+
+ + + + +
+ + +
+ +
+ + +
+ +
+
+
+
+ + +
+
+
+
+
+
+
+
+
+
+
+ + + + + + + +
+ +
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+ +
+ + +
+ + +
+ +
+
+ + + + + + + +
+ + +
+ + + ++ +
+
+ + + + + +
+ +
+ + + + +
+ +
+ + + + + + +
+
+
+
+
+
+
+
+
+
++ +
+
+
+
+
+
+
+ + + + +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+
+
+
+
+
+ +
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+
+
+
+
+ +
+ +
+
+
+
+
+
+
+
+
+
+
+
+ + + +
+ + + + + + + + + +
+ ++
+ + +
+ + +
+ + + + +
+ + + + + + ++ + +
++ + +
+ + + + ++
+ ++ +
++ +
+ +
+
+
Myeloid-specific E
eQTL position
T
r
a
n
s
c
r
i
p
t
 
p
o
s
i
t
i
o
n
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
F
+
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+ + +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+ + + + + +
+
+
+ +
+
+ + + + +
+
+
+ + +
+
+ + +
+ + + +
+ +
+ + + +
+
+
+ + + + + + +
+ + + + + + + +
+ + + ++ + +
+
+
+ + ++
+ +
+ + + + +
+ + + +
+
+ + +
+
+ + + +
+ + + +
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+ + +
+ +
+
+ + + +
+
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+ +
+
+
+
+
+
+ +
++
+
+
+
+
+ +
+ + +
+
+ +
+
+ + +
+ ++
+
+ +
+
+ + + + + ++
Stem & Prog-specific
T
r
a
n
s
c
r
i
p
t
 
p
o
s
i
t
i
o
n
eQTL position
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
Rpo1−2
rs13469412 − Chr  2
o
o o
o
o
o
o o o
o
o o
o
o
o
o
o
o
o
o
o o o o o
o
o
o o
o
o
o
o
o
o
o
o
o o
o
o o o o o o
o
o
o
o o
o
o o o o o o o o
o o o o o
o
o o
o o
o o
o o o o
o
o
o
o
o
o o o o
o o
o
o
o
o o
o
o
o o
+ +
+
+ +
+
S P E M S P E M
S P E M S P E M
S P E M S P E M
+
+
+ +
+ +
+
+ + +
+
+
+
+ + + + +
+
+
+
+
+ + + +
+
++
+
+
+
+
+
+
+ +
+
+
+ + +
+
+ +
+ +
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+ +
+
+
+ ++
+
+
+ + + +
+ + +
+
+
+ +
+
+
+
+ +
+ +
+ + +
+
+
+ +
+
+
+ +
+ +
+
+ +
+
+
+
+
+ +
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+ +
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+ +
+
+
+
+
+
+
+
+ +
+
+
+
+
+ + + + + + +
+ + + + +
++ + + + +
+ +
+
++ + +
+ + + + + + + + +
+ + + + + + + + + + + +
+ + + +
+ + + + +
+
+
+ + + + +
+ + + + + + + + + + + +
+ + +
+ + + + + ++ + +
+ + + + +
+ + + + + + + +
+ +
+
+ + + + + + + +
+ + + + + + +
+ + + + +
+ + + + + + + +
+ + + + + + + + +
+ + + + + + + + + +
+ + +
+
+
+ +
+ ++ + + + + + +
+
+ + + + +
+ + + +
+ + + + + + + ++ + +
+ + + + +
+ + + + + + +
+ + + +
+ +
+ +
+
+
+ +
+
+
+
+ +
+ +
+
+ +
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+ + +
+
+
+
+
+
+
+
+
+
+
+ +
+ +
++
+ +
+
+
+ +
+
+
+ + +
+ + + +
+ +
+ ++ + +
+
+ + +
+ + +
+ + + + +
+ +
+
+
+
+
+
+
+
+ +
+
+
+
+
++
+
+
+
+
+ +
+
+
+
+
++ +
+
+ +
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+ +
+
+ +
+
+
+ +
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+ +
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ +
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ + + + + +
+ + + + +
+ + + +
+ + + +
++
+ + + + +
+ + + + +
+ + + ++ + + + + + +
+ + + + + + ++ + + + +
+ + + + + + + +
+ + + + + + +
+ +
+ + + + + + + ++ + + + + + +++
+
+
+
+ + + + +
+ + +
+ + + + + ++ + + + +
8
9
1
0
1
1
6
.
5
7
.
5
8
.
5
6
.
6
7
.
0
7
.
4
9
7
.
5
7
.
0
6
.
5
8
.
0
8
7
9
1
1
1
0
7
Figure 2. Identification of static and dynamic eQTLs. (A) Genome-wide identification 
of cell-type-independent static eQTLs. (Left panel) Lxn mRNA levels were analyzed in all 
4 cell types. Each circle represents an individual sample (strain). The yellow line shows 
mean expression levels across all strains. The red and blue lines indicate mean Lxn expres-
sion levels in strains that carry the B6 or D2 Lxn allele, respectively. The genetic effect 
of parental alleles on Lxn expression levels was consistent in all cell types. (Right panel) 
Individual probes that detected a transcript that was consistently controlled by the same 
eQTL in all 4 cell types. The y-axis indicates the physical position of the encoding gene, the 
x-axis provides the genomic position of the marker with strongest linkage statistics. Vertical 
gray and white bandings indicate different chromosomes, ranging from chromosome 1 
to X. The size of each symbol reflects the strength of the genetic association: eQTLs with 
p-values < 10-8 are represented by the largest crosses, p-values between 10-6 and 10-8 are 
shown with medium crosses, while small crosses refer to eQTLs with p-values between 10-4 
and 10-6. The color coding (red and blue) indicates the parental allele of the eQTL that 
caused a higher gene expression (B6 is red and D2 is blue). (B–E) Genome-wide identifica-
tion of transcripts that are controlled by cell-type-specific eQTLs. (Left panels) Expression 
data for some transcripts that were affected by cell-type-specific eQTLs (B: Slit2 in stem 
cells, C: Snrpn in progenitor cells, D: Hbb-bh1 in erythroid cells and E: Foxd4 in myeloid 
cells). (Right panels) Genome-wide distribution of eQTLs that were preferentially/uniquely 
detected in each of the four cell populations. (F) Transcripts that were controlled by eQTLs 
in both stem and progenitor cells. An example is Rpo1-2. Full lists of all genes belonging 
to the eQTL (sub)categories shown here are provided in Table S2.54 CHAPTER 3
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approach. For example, Rpo1-2 is a transcript that shows a strong local eQTL 
in the two non-committed lineages included in our study, but shows a much 
weaker genetic effect in erythroid and myeloid cells (Figure 2F). Whereas in mice 
carrying the B6 allele of Rpo1-2 the overall expression of the gene decreased 
substantially  during  differentiation  of  progenitor  to  erythroid  cells,  in  mice 
carrying the D2 allele expression slightly increased. This observation hints at 
complex regulatory mechanisms underlying the expression of this gene. Full lists 
of genes in each dynamic eQTL subcategory described thus far are supplied 
in Table S2. Additional subcategories and their exact definitions are explained 
more extensively in the Methods section, and complete results of all dynamic 
eQTLs are available in Table S3. 
detailed analysis of static and dynamic eQtls
eQTL dynamics can be caused by transcription factors being switched on/off upon 
cellular differentiation, or by a transcription factor showing changed specificity 
due to variations in regulatory input. We found that most (>75%) of the dynamic 
eQTLs  are  active  in  only  one  of  the  four  cell  types  under  study  (Figure  3A).   
Table 1. Overview of static and dynamic eQTLs (p<10-6): number of probes and associated 
markers.
eQTL category eQTL subcategory # probes # markers # probes / # markers
Static All Local 268 161 1.66
Distant 97 76 1.28
Total 365 213 1.71
Dynamic All Local  642 282 2.28
Distant 641 276 2.32
Total 1283 445 2.88
Stem-specific Local  87 66 1.32
Distant 53 42 1.26
Total 140 105 1.33
Progenitor-specific Local  32 27 1.19
Distant 13 12 1.08
Total 45 39 1.15
Erythroid-specific Local  131 90 1.46
Distant 400 164 2.44
Total 531 223 2.38
Myeloid-specific Local  163 121 1.35
Distant 132 72 1.83
Total 295 179 1.6555 CELL-STAGE-SENSITIVITY OF EQTLS
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A more detailed analysis revealed that in the majority of cases the genes with a 
cell-type-specific eQTL were also most highly expressed in that particular cell type   
(Figure  3B).  Next,  we  explored  whether  we  could  find  transcripts  that  were 
regulated by distinct eQTLs in different cell types (see Methods). Such eQTL 
“swapping” would indicate major changes in transcriptional regulatory networks. 
We could find no evidence for such cases. However, given our limited population 
size we have a low power to detect multiple eQTLs, so swapping eQTLs may still 
exist but remain undetected in our experimental setting. 
It has been described that not all local eQTLs in genetical genomics experiments 
reflect actual expression differences between mouse strains, but rather indicate 
differential hybridization caused by polymorphisms in the sequences recognized 
by the probes.25 For this reason, we divided both the static and dynamic eQTL 
categories in local and distant eQTLs, and indicated the number of probes that 
hybridized to sequences that are known to contain polymorphisms (Figure 3C). As 
expected, the static eQTL category contained a higher number of such potential 
false local eQTLs. If these false positive eQTLs could be removed, the relative 
abundance of dynamic eQTLs would be higher, indicating that our study may 
even conservatively underestimate the level of eQTL dynamics. 
DISCUSSION
We found that many eQTLs are highly sensitive to the developmental state of the 
cell population under study. Even when the purified cells were only separated by 
a few cell divisions, eQTLs demonstrated a remarkable plasticity. Furthermore, we 
provide evidence that the cell-stage-sensitivity of eQTLs is often intertwined with 
gene expression variation during development. We did not identify target genes 
that  were  regulated  by  distinct  eQTLs  in  different  cell  types,  suggesting  that 
large-scale changes within transcriptional regulatory networks are not common. 
The fact that eQTLs appear to be highly cell-type-dependent highlights the 
importance  of  using  well-characterized  purified  cell  types  in  eQTL  studies.  In 
particular, eQTL studies of physiological or disease processes26-29 should target 
the relevant cell type as precisely as possible, i.e. they should use cells or tissues 
directly  involved  in  the  patho-physiological  process.  This  could  even  mean 
that several different cell types need to be separately studied, in particular if 
developmental  trajectories  are  affected.30  Using  unfractionated  bone  marrow 
cells, we would have missed many of the diverse and dynamic patterns that we 
uncovered here, both at the expression level and at the genetic regulatory level. 
Even so, the four cell populations that we studied are still heterogeneous and 
further subfractionation of these populations based on different sets of markers 
would have resulted in even more precise regulatory maps.
Many  genetical  genomics  experiments  have  used  highly  heterogeneous 
samples, in which mRNA from a variety of different cell types was pooled.4;5;31-34 56 CHAPTER 3
3
In such mixed samples it is usually impossible to ensure that the contribution 
of individual cell types to the mixture is the same across samples. As a result, 
important parts of the variation in gene expression could arise from different sample 
compositions. For example, if in whole brain samples a heritable morphological 
or developmental trait leads to an increased size of some brain regions, this can 
cause apparent hotspots for transcripts that are specific for those particular regions. 
Our data provide a valuable tool for studying the exact consequences of sample 
heterogeneity on eQTL mapping: a further study could simulate a collection of 
samples made of computed mixtures of different hematopoietic cells in defined 
proportions. Clearly, cell purification strategies are essential to identify those cell-
type-specific eQTLs that would otherwise be “masked” in heterogeneous cell 
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Figure 3. Quantitative overview of static 
and dynamic eQTLs. (A) Pie charts present-
ing all 365 static and 1283 dynamic eQTLs 
that were detected with p < 10-6. Dynamic 
eQTLs are subdivided in all 14 categories 
of interaction eQTLs. (B) Matrix showing the 
four  cell-type-dependent  dynamic  eQTL 
categories  and  the  cell  type  in  which  the 
gene  was  expressed  most  highly.  (C)  All 
static  and  dynamic  eQTLs  are  subdivided 
in local and distant eQTLs. Shown is which 
number of eQTLs was detected by Illumina 
probes that hybridize to sequences that are 
known  to  contain  polymorphisms  (SNPs) 
between the two parental strains. Abbrevia-
tions: S, stem cells; P, progenitor cells; E, 
erythroid cells; M, myeloid cells.57 CELL-STAGE-SENSITIVITY OF EQTLS
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populations. Therefore, future genetical genomics studies should be realized on 
as many cell types or cellular differentiation states as possible, and ideally even 
on the scale of individual cells. 
All  data  presented  in  this  paper  were  deposited  in  the  online  database 
GeneNetwork  (www.genenetwork.org),  an  open  web  resource  that  contains 
genotypic, gene expression, and phenotypic data from several genetic reference 
populations  of  multiple  species  (e.g.  mouse,  rat  and  human)  and  various  cell 
types and tissues.35;36 It provides a valuable tool to integrate gene networks and 
phenotypic traits, and also allows cross-cell type and cross-species comparative 
gene expression and eQTL analyses. Our data can aid in the identification of 
candidate modulators of gene expression and/or phenotypic traits,37 and as such 
can serve as a starting point for hypothesis-driven research in the fields of stem 
cell biology and hematology.
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4AbSTRACT
motivation: We propose an efficient method to infer combinatorial association 
logic  networks  from  multiple  genome-wide  measurements  from  the  same 
sample.  We  demonstrate  our  method  on  a  genetical  genomics  dataset, 
in which we search for Boolean combinations of multiple genetic loci that 
associate with transcript levels. 
results: Our method provably finds the global solution and is very efficient 
with runtimes of up to four orders of magnitude faster than exhaustive search. 
This enables permutation procedures for determining accurate false positive 
rates and allows selection of the most parsimonious model. When applied to 
transcript levels measured in myeloid cells from 24 genotyped recombinant 
inbred mouse strains, we discovered that nine gene clusters are putatively 
modulated by a logical combination of trait loci rather than a single locus.   
A literature survey supports and further elucidates one of these findings. Due 
to our approach, optimal solutions for multi-locus logic models and accurate 
estimates  of  the  associated  False  Discovery  Rates  become  feasible.  Our 
algorithm therefore offers a valuable alternative to approaches employing 
complex,  albeit  sub-optimal  optimization  strategies  to  identify  complex 
models. 63  INFERRING COMBINATORIAL ASSOCIATION LOGIC NETWORKS
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INTRODUCTION
To explain complex biological phenomena it is of vital importance to measure 
– in the same sample – all relevant (complementary) biological variables, and to 
measure these at a genome-wide scale. For this reason, many multimodal screens 
have  been  performed  that  have  complemented  transcriptional  profiling  with, 
among others, copy number variation measurements, transcription factor binding 
assays, methylation status profiling or genotype calls.1-4
A common aim in analyzing these multimodal datasets is to find associations 
between the biological variables measured to infer their regulatory role. Consider, 
for instance, a study in which expression profiles and genome-wide genotype data 
were obtained in hematopoietic cells from a panel of fully homozygous recombinant 
inbred mouse strains (Figure 1A). This ‘genetical genomics’ approach enables the 
determination of expression quantitative trait loci (eQTLs) characterized by strong 
associations between the genotype and the observed expression levels.5;6 In the 
absence of a strong direct association between the genotype and gene expression, 
real multi-locus interactions may still be present, due to epistatic interaction.7;8 
Such interactions may not be detectable as (marginal) direct associations between 
the genotype and gene expression (Figure 1B). 
To alleviate this, approaches which evaluate the joint association of multiple loci 
and a phenotype of interest are required. Several approaches have been proposed 
to attack this problem. These approaches differ mostly regarding the way the 
associations are modeled and the strategy employed to solve the combinatorial 
optimization problem. Some approaches follow what could be loosely termed 
a two-stage approach, where all two-locus models are first evaluated, which, in 
stage two, are used in a greedy search to yield multi-locus models.9;10 Approaches 
employing more advanced strategies to traverse the space of possible models 
are represented by a genetic programming approach11 and Markov Chain Monte 
Carlo  (MCMC)  approaches  associated  with  Bayesian  analyses.12;13  Since  two-
stage approaches have been demonstrated to be suboptimal14 and advanced 
search strategies such as MCMC are very sensitive to their implementation and 
parameter settings and are not guaranteed to be optimal, an approach which 
finds a provably global solution to a selected model within reasonable time is 
highly desirable. Of particular interest is the method of Ljungberg et al15, which is 
used for the Pair-Scan analysis that is available on The GeneNetworki. Ljungberg 
et al. stress the importance of performing a global search rather than relying on 
greedy searches by (pre)selecting markers based on their marginal effects. To deal 
with the computational complexity associated with such an optimization problem, 
the authors present a method to find global optima of a linear regression problem 
for up to three predictors that is fast enough to be employed in permutation 
procedures. 
i http://genenetwork.org64 CHAPTER 4
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Figure 1. Schematic overview of data and association inference. (A) A panel of BXD mice 
that is densely genotyped and expression profiled. The genotype data can be considered 
as binary vectors by choosing a binary encoding of the alleles (in the figure D=TRUE and 
B=FALSE) and putting thresholds that divide the genome into loci such that each locus 
differs in at least one element from its neighbors. The cartoon shows that good associa-
tion is obtained between Locus 5 and Gene 7 because elevated expression is consistently 
observed in conjunction with the D allele of Locus 5. (B) Interaction among genetic features 
may destroy direct associations between individual loci and genes. The cartoon shows that 
configurations exist in which the gene expression can only be predicted by considering two 
loci simultaneously (using Boolean XOR logic). (C) By inferring CAL networks, interaction 
among genetic features is taken into account in the association inference. Inferring CAL 
networks is achieved by selecting the input loci with the selection function   and combining 
these with the appropriate Boolean function  , such that the association (as measured by 
a scoring function f ) between the network output and the gene of interest is maximized. 65  INFERRING COMBINATORIAL ASSOCIATION LOGIC NETWORKS
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In  contrast  to  the  class  of  additive  models  employed  by  Ljungberg  et  al. 
(and  many  other  approaches),  we  follow  others11;12;16  and  employ  Boolean 
combinatorial logic to explicitly incorporate interactions in the eQTL inference. 
To  this  end,  we  infer  combinatorial  association  logic  (CAL)  networks  that 
combine the observed genotypes through AND (∧), OR (∨) and XOR (⊕) functions 
by searching for associations between the result of the Boolean operation and 
the gene expression. The Boolean AND function can be used if altered expression 
is  consistently  observed  in  combination  with  a  particular  combination  of  two 
alleles (which do not necessarily have to be equal), but remains unchanged in 
all other genotype configurations. An example of a situation in which this may 
be observed is the case of two parallel pathways that only promote transcription 
of  their  downstream  target  when  the  genes  in  these  pathways  have  specific 
alleles. Conversely, we may also consistently observe differential transcription in 
the strains for which either one of two loci is of a certain genotype. This may, 
for instance, be observed in case of a cascaded signaling pathway: a silencing 
mutation in one of the alleles can repress the entire pathway, regardless of which 
gene in the cascade contained this mutation. Boolean  OR (∨) and  XOR (⊕) are 
capable of capturing this behavior (Figure 1B).
Like the search for optimal predictors in the additive model, inferring optimal 
predictors  of  a  Boolean  function  is  a  challenging  computational  problem, 
especially considering that more complex combinations of these functions are 
also possible. Moreover, we noted that the objective function that needs to be 
optimized is highly discontinuous and nonlinear so that standard optimization 
techniques, such as Genetic algorithms, Simulated Annealing and MCMC do not 
provide an optimal solution. Nevertheless, an efficient and –most importantly – 
global solution is highly desirable, since this allows permutation procedures with 
which significance estimates of the discovered associations can be realized.15 
In the following we will mathematically prove that, under reasonable conditions, 
CAL network inference provides an efficient way to obtain globally optimal multi-
locus models that associate multiple genomic loci with the expression of target 
genes. We illustrate our approach on the genetical genomics dataset from Gerrits 
et al.,17 and using these data show that 100% accuracy is achieved at runtimes that 
are a fraction of those required for exhaustive search. Furthermore, we observe 
that using this approach complex associations are revealed that otherwise would 
have gone unnoticed. As such, our approach offers a useful alternative to the 
commonly used additive models and suboptimal search strategies.
METHODS
CAL network search
The construction of a CAL network that predicts the expression profile from a set of 
binary predictors can be formulated as an optimization problem. Interesting logic 66 CHAPTER 4
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networks are those for which maximal association between the network output 
and the gene expression is obtained. Let g be the (T×1) vector, with T the number 
of samples, containing the expression values of a gene, and L the (T×L) matrix of 
binary predictors, e.g. the genotypes, where L is the number of predictors. A CAL 
network ℒ is defined in terms of  (L;n):𝔹L→𝔹N, a selection function that selects 
N columns from L, and  (I):𝔹N→𝔹, a Boolean logic function that specifies the 
network topology. In the latter, (T×N) matrix I is a concatenation of the columns 
selected by  , i.e. I=(in(1),...,in(N)), where n is a (N×1) vector containing the indices of 
the selected columns. Consequently, CAL network ℒ maps the genotype matrix L 
to a (T×1) output vector y as follows:
(1)
The association between g and y is quantified with an association measure f (g,y):
(2)
For notational convenience, we used x0={g(τ):y(τ)=0,∀τ∈(1,...,T)} and x1={g(τ):y(τ)=1,∀τ 
∈(1,...,T)}, i.e. vector g is split into x0 and x1 according to the Boolean values in y. 
Furthermore,  0 ( 1), s  (s ) and n0 (n1) are defined as the sample mean, the sample 
variance and the number of elements in x0 (x1), respectively. Note that Equation 
(2) is equal to the absolute value of the t-statistic, except when n0 or n1 becomes 
too small, which ensures high f-values are only obtained in case x0 and x1 have at 
least η elements. 
The  inference  of  CAL  networks  is  a  computationally  challenging  problem. 
Primarily, because the feature selection problem, i.e. finding the optimal vector 
n, critically depends on the number of features that are considered. In the case of 
genetic markers, this easily runs in the several hundreds to thousands. Moreover, 
the optimal subset of markers is heavily dependent on how these markers are 
combined, i.e. dependent on the optimal Boolean function  . Altogether, one 
frequently has to rely on greedy search strategies that easily get stuck in local 
optima  or  near  exhaustive  searches  that  are  computationally  too  expensive, 
especially when employed in permutation procedures required to assess statistical 
significance. 
Our solution to this problem hinges upon two observations. First, in most 
practical datasets the sample size is relatively small, especially when compared 
to the number of features. This means that we can limit ourselves to considering 
only  small  CAL  networks  with  few  inputs,  since  larger  networks  are  prone  to 
overfitting, which makes them less informative. For this reason, and because most 
networks have many equivalent topologies that do not need to be evaluated due 
to symmetry, the set containing all unique and meaningful network topologies   67  INFERRING COMBINATORIAL ASSOCIATION LOGIC NETWORKS
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{ j:j=1,2,···} is relatively small (in the order of 10-100, depending on the desired 
topology). Consequently, the set of optimal input vectors { :j=1,2,···}, associated 
with each  j , can be found by fixing  j and maximizing for each  j separately:
(3)
Second,  we  observe  that  Equation  (3)  still  represents  a  complex  optimization 
problem that can be significantly simplified by employing an approximation to 
the association measure, denoted by  . In the following, we show that maximizing 
 is equivalent to maximizing f, but the maximization of the former can be very 
efficiently realized by using a branch and bound search. Before defining   we 
define the Boolean vector yopt as the solution for which f reaches a global maximum 
independent of the network topology, i.e. yopt=argmaxy f(g,y). Note that yopt can 
be easily determined by sorting the gene expression vector g and evaluating all 
positions for a threshold t that splits g into x0 and x1 (Figure 2A). For  , we use the 
weighted Hamming similarity between yopt and the network output y:
(4)
where w(τ)>0∀τ denotes the weight for sample τ, and I(·) is the indicator function, 
evaluating to ‘1’ if the τth element of vectors yopt and y are equal. 
For an example gene expression vector, Figure 2B shows 500 random samples of   
( ,  f  )-pairs,  in  case  all  weights  are  equal  to  one.  Although  the  trend  of  this 
distribution is monotonically increasing, the spread around the trend is substantial. 
This is undesirable because a maximum in   is only guaranteed to correspond to a 
maximum in f in case there is a direct one-to-one relation between them. Clearly, 
this is not the case in Figure 2B, since each value of   corresponds to many values 
of f. However, by optimizing the weights such that the difference between   and f is 
minimal, a near one-to-one relation can be obtained, as exemplified by Figure 2C. 
With the proper adjustments, detailed below, it is thus ensured that maximizing   
is equivalent to maximizing f. The major advantage of maximizing    instead of f is 
that in the former each sample has an independent contribution to the association 
measure. This can be readily exploited using a branch and bound search, so that it 
is possible to avoid the expensive evaluation of the association measure.
Optimizing Equation (3)
Here, we show that optimizing Equation (3) can be achieved by first determining   
∗=maxn( ), where   was defined in Equation (4). After this the search for f∗=maxn f
is readily solved by searching in the neighborhood of  ∗. 
For  a  single  sample  τ,  let  V(τ)  be  the  set  of  input  combinations  such  that 
y(τ)=yopt(τ)∀ ∈V(τ), where y=ℒ(L; , ).ii Figures 3A-C show how V(τ) can be inferred 
ii Since we optimize Equation (3) for each  j separately, we omit its subscript if its meaning is 
inconsequential.68 CHAPTER 4
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from L and the truth table of  . For a set of samples C, the input combinations 
∈V(C) for which all τ∈C reach the optimal output yopt are found by taking the 
intersection of all the individual sets of input combinations, i.e. V(C)=∩τ∈C V
 (τ). Note 
that, under the assumption that each sample has at least one non-zero locus, 
V(τ)≠∅∀τ. In other words, for individual samples there always exists a combination 
of inputs for which the network can reach the desired optimal output yopt. However, 
for an arbitrary combination of samples this is clearly not the case. If we observe 
that V(C)=∅, this means that for the collection of samples in C there does not exist 
a valid combination of inputs. Moreover, if V(C)=∅, all supersets of C will also result 
in the empty set. Finally we note that, by choosing a convenient binary encoding, 
V(τ) and V(C) can be computed very efficiently by means of bitwise XNOR and AND 
operations, respectively (see Figure 3D and Figure S1 for details). 
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Figure 2. Association versus approximated association. (A) Example gene expression 
vector (circles) split in x0 and x1 according to yopt. The magenta line denotes the association 
measure f, defined in Equation (2), as a function of a threshold t that splits the expression 
vector in x0 and x1. The blue triangles indicate the error weights w(τ) that result after opti-
mizing them. (B and C) 500 random samples that are generated by introducing up to seven 
bit-flips in yopt to show the relation between   and f. The red dot indicates   and f values 
for yopt. (B) shows the samples in case the weights are assumed equal. Although the trend 
of the data is monotonically increasing, a large spread around this trend is observed. (C) 
shows the same samples in case the weights are optimized, resulting in a near one-to-one 
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With these definitions in mind, we propose the following lemma:
Lemma 1.
(5)
Proof. Let C∗=argmaxC ∑∀τ∈C w(τ), i.e. C∗ is the set of solutions for which  ∗ is 
obtained. Since it is required that V(C∗) ≠∅, there must be at least one solution 
 such that yopt(τ)= y(τ)∀τ∈C∗. Since for C∗ the optimum in   is obtained, it must 
also hold that yopt(τ)≠ y(τ)∀τ∉C∗. This means that Equation (4) can be rewritten as 
follows: ∑∀τw(τ)I(yopt(τ)= y(τ))=∑∀τ∈C w(τ), proving the statement in this lemma.          
As argued by Lemma 1, Equation (4) is thus maximized by having as many 
samples in C as possible, while taking into account their respective weights w(τ). 
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Figure 3. Computation of solution sets for each sample. (A) Example data from Figure 
1A. (B) The topology and the truth table of the Boolean function   under investigation. (C) 
Explanation by example of the calculation of  (τ), the set of all possible input combinations 
to   such that yopt(τ)=y(τ). This panel shows how  (1) is determined. Since yopt(1)=1, the rows 
from the truth table for which y=1 are applicable, i.e., r={2,4,6,7}. According to r=2, the 
desired output for τ=1 is obtained by selecting any of the loci that are ‘0’ for inputs i1 and 
i2, and loci that are ‘1’ for input i3. Accordingly, for i1 we may select from the set: {l1,l2,l4}. 
This can be efficiently calculated by taking the XNOR (evaluates to ‘1’ when both inputs 
are equal) between row τ=1 from the data matrix and the row r=2 from the truth table, 
as shown in (C). Observe that the result is an efficient encoding of all the possible input 
combinations that satisfy yopt (1) while using r=2 from the truth table. In general, we denote 
this set by  r
(τ), and its binary encoding by  r
(τ). To determine the complete set of valid input 
combinations for τ=1, rows 4, 6 and 7 need to be considered in a similar fashion.  (1) is 
now determined by taking the union of the subsets, i.e.  (1)= 2
(1) ∪ 4
(1) ∪ 6
(1) ∪ 7
(1), which, in 
binary form, may be represented by a concatenation of  2
(1), 4
(1), 6
(1) and  7
(1). (D) This panel 
shows the valid input combinations for τ=1 and τ=3 in binary representation (i.e.  (1) and
(3)). For any set of samples C the input combinations for which the output equals yopt can be 
obtained by taking the intersection of the individual sets. In binary representation, this is 
equivalent to taking the row-wise Cartesian product (row-wise product of all combinations 
of rows), as is shown in the panel.70 CHAPTER 4
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Before we will show that Equation (5) fits a branch and bound framework, we 
first make the observation that for the relation between   and f the following holds:
  (6)
where y1 and y2 are two Boolean vectors. Note that, for ζ =0, Equation (6) reduces 
to the requirement for strict monotonicity, and that for larger ζ >0 this requirement 
is increasingly relaxed. Even though this seems trivial, the value of this relation 
becomes clear by considering that if there exists a strong positive correlation 
between   and f , there may in fact exist a small ζ for which Equation (6) is true. 
Based  on  Lemma  1  and  Equation  (6),  we  observe  that  solutions  that  are 
suboptimal in terms of   may still be optimal in terms of f, since ζ can be non-zero. 
In the following, let {yi:i=1,2,···} and {Ci:i=1,2,···} be all the network outputs and the 
sample sets for the solutions for which holds that  ∗−ζ≤ (yopt,yi)≤ *, respectively. 
Finally, let ζ be chosen such that Equation (6) holds. Our main theorem can now 
be formulated as follows:
Theorem 2.
(7)
Proof.  First,  assume  that  Equation  (6)  holds  for  ζ=0,  and  thus  (yopt,yi)= ∗∀i. 
Furthermore, from Equation (6) it follows that in this case there exists a direct one-
to-one relation between   and f. Consequently, a maximum in   is guaranteed to 
correspond to a maximum in f and V(Ci) must contain  ∗. This is true because from 
Lemma 1 it follows that V(Ci)≠∅. For non-zero values of ζ, the one-to-one relation 
does not hold. However, from Equation (6), it follows that all values of f for which 
the corresponding   lies outside the interval [ ∗−ζ, ∗] are strictly smaller than the 
value of f corresponding to  ∗. Thus, it must be the case that the maximum of f 
is constrained to solutions for which   lies in the interval [ ∗−ζ, ∗]. Therefore, the 
union of the sets of solutions that lie in this interval will contain  ∗.                       
From Theorem 2 it naturally follows that:
CoroLLary 3.
(8)
where  . Notably, if there exists a small ζ for which Equation (6) 
holds, the number of solutions in V(Q) is limited, and hence  ∗ is easily determined 
by an exhaustive search over all possible solutions in V(Q). In the following, we 
show that in practice the set V(Q) is small by choosing w such that ζ is small.
Estimating the weights
Ideally, vector w is chosen such that ζ is minimal. For practical purposes, it is 
sufficient to choose w so that ζ is small, which can be realized by minimizing 
the difference between   and f. For this purpose, we sample the ( ,f )-relation 71  INFERRING COMBINATORIAL ASSOCIATION LOGIC NETWORKS
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by generating N random instances yn by introducing up to m random bit-flips 
in yopt (shown in Figures 2B and C). The N corresponding association measures 
fn  and  Hamming  similarities  are  collected  in  vector  f=[f(g,y1),f(g,y2),···]T  and 
matrix  =[(yopt↔y1)T,(yopt↔y2)T,···]T, respectively. In the latter, ↔ denotes the XNOR 
operation, which evaluates to ‘1’ in case its arguments are equal. Notably, m 
(the number of bit-flips) should be chosen such that the region of interest of the 
distribution of f is sampled. Since we are interested only in network outputs that 
associate well with the gene expression, we can choose m rather small to focus 
only on the right tail for which a good fit between   and f is obtained. We found 
that smaller residuals were obtained by converting log-transformed f-values to 
z-scores, i.e.  =z(lnf). Furthermore, to deal with the intercept, the matrix F is mean 
centered, denoted by  . Using the vector   and matrix   we can find the weights 
w by constraint linear least squares minimization:
(9)
where wε > 0 is a small scalar that ensures each sample receives a non-zero weight. 
Figure 2 illustrates a typical example showing that the trend of the relation is 
monotonically increasing, and the spread around the trend is marginal, indicating 
that Equation (6) indeed holds for a small ζ. 
Estimating ζ  
The parameter ζ can be estimated by randomly resampling the ( ,f )-relation using 
the obtained weights and measuring the spread around the trend in the data 
in the   direction (Figure 2C illustrates this schematically). To this end, lowess 
smoothing was performed to obtain the trend in the data.18 Subsequently, the 
spread around this trend was obtained by applying a sliding window in the       
direction and defining ζ as the maximum spread across all window positions.
Branch and bound search tree
Equation (5) naturally fits a branch and bound framework with a backtracking 
search tree in which each node corresponds to a particular set of samples C (shown 
in Figure S2). Although this tree exhaustively represents all possible sample sets 
C, the search is very efficient since most nodes can be pruned from the search 
tree. First of all, if V(C) becomes equal to the empty set, all child nodes of node 
C can be discarded because these will also result in the empty set. Secondly, as 
a result of the search tree topology, for each node C we can define an upper 
bound   and lower bound  . The upper bound   is defined as the value 
of   that would be obtained assuming all its subnodes do not result in the empty 
set (best case scenario):
(10)72 CHAPTER 4
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where Csub denotes the collection of all samples in the subnodes of C. The lower 
bound   is defined as the value of   that would be obtained assuming all 
subnodes will result in the empty set (worst-case scenario):
(11)
A vast reduction of the search space is realized by considering the following 
branch and bound principle: any node Cα can be pruned if there exists a node Cβ, 
for which the following is true:
(12)
Thus, if we encountered a branch whose worst-case error is better than the best-
case error of another branch, we can safely discard the latter. 
After the complete search tree is traversed, the set V(Q) is determined by the 
union of all the nodes that resulted in a non-empty V(C). In Equation (12), the 
parameter ζ is included to ensure that set V(Q) includes  ∗ (Theorem 2). An optimal 
leaf ordering is obtained when the samples are sorted based on their weight w(τ). 
This ensures that   decreases as quickly as possible, in effect pruning the tree 
early in the search. Also note that most V(C) will contain many duplicates when 
symmetries in the topology of   are considered. By filtering these from V(C) before 
evaluating the succeeding node results in an additional search speed-up.
Tolerance level
A final, yet influential, search-space reduction is achieved by only considering 
solutions for which a certain minimum level of association is achieved. This is 
realized by enforcing that  low can never be below a user defined tolerance level. 
In other words, for this bounded  low, we can write:  low= max( tol, low). As a result, 
branches for which  low ≤  tol can be pruned even before the search is started. The 
search procedure is explained by example in Figure S2.
Estimating the False Discovery Rate
Because our primary interest lies with the interpretation of the selected genotype 
markers and combinatorial logic, it is of critical importance to assess frequency of 
false positives amongst the networks called significant. Due to the efficiency of 
the proposed method, it is possible to employ a permutation procedure to obtain 
a null-distribution for each  j. From this distribution it is possible to estimate the 
False Discovery Rate and the associated q-values by using the method proposed 
by  Storey  and  Tibshirani.19  Not  surprisingly,  in  many  cases,  multiple  network 
topologies  yield  significant  associations  with  the  same  gene.  The  q-values, 
available  for  each  of  the  solutions,  provide  a  convenient  way  of  performing 
selection of the most parsimonious model by accepting only the topology for 
which the q-value is minimal.73  INFERRING COMBINATORIAL ASSOCIATION LOGIC NETWORKS
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URL
The  MATLAB  code  of  the  prototype  implementation  is  available  on:  http://
bioinformatics.tudelft.nl/ or http://bioinformatics.nki.nl/. 
RESULTS
Genetical genomics dataset
The  genetical  genomics  dataset  used  to  demonstrate  our  method  contains 
genome-wide  RNA  transcript  measurements  performed  on  four  related 
hematopoietic  cell  populations.17  These  were  isolated  from  the  bone  marrow 
of ~25 BXD recombinant inbred mouse strains that were derived by crossing 
C57BL/6J  (B6)  and  DBA/2J  (D2).20  A  typical  analysis  of  these  data  includes 
determining eQTLs, i.e. regions in the genome for which the genotype across 
strains associates well with RNA transcript levels. 
We inferred associations only for the myeloid cell population, as for this cell 
type data for the largest number (T=24) of unique BXD strains were available. The 
expression data were pre-processed as described in the Supplementary Methods. 
Because the CAL networks inferred for highly correlated genes are equivalent, 
rather than starting the optimization for each gene separately, we constructed 
gene clusters and searched for CAL networks for the centroids of each gene 
cluster. To ensure only tightly correlated probes were clustered, we employed a 
stringent cut-off (correlation distance cut-off 0.2). This resulted in 6139 clusters 
that were used to determine eQTLs. 
Genotype information for the strains was retrieved from The GeneNetworkiii. 
Genotype  markers  that  were  highly  similar  across  strains  and  on  the  same 
chromosome  were  also  grouped  into  clusters  to  prevent  the  algorithm  from 
finding many combinations of genotype markers that are equivalent (such as the 
markers in linkage disequilibrium). This resulted in 453 marker clusters (L=453). 
The cluster centroids were defined as the majority vote of the individual markers 
in  the  cluster  and  were  used  as  putative  inputs  to  the  network  (see  also  the 
Supplementary Methods and Figures S3 and S4). 
For setting the tolerance level ftol no straightforward method exists. Preferably, 
the tolerance level is set close to the final significance threshold to minimize the 
effort spent on finding optima for gene clusters that can never be significant. We 
settled for a tolerance level equal to the 75th percentile of the f  opt distribution 
(ftol=7.6),  obtained  by  computing  the  f-values  associated  with  each  yopt.  Gene 
clusters for which the maximum f-score is below this tolerance level (i.e. in case 
f opt < ftol) were not included in the CAL network search, to result in a set of 1525 
high-potential gene clusters.
iii http://www.genenetwork.org/dbdoc/BXDGeno.html (Accessed: 02 April 2009)74 CHAPTER 4
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Algorithm performance
From the methods section it follows that, under the condition that an appropriate 
value for ζ is found, our algorithm produces an optimal solution. We empirically 
validate this claim by comparing solutions of the proposed algorithm with the 
global optimum obtained with an exhaustive search. To ensure realistic conditions 
we do this using the real data described above. 
For each gene expression vector we performed our CAL network search as 
described with seven network topologies containing AND, OR and XOR logic as 
well as a more complex combination of these Boolean functions. A rather low 
tolerance level (ftol=4) was used, which turned out to capture most of the solution-
space (>80% for all topologies). The solutions obtained were compared with the 
optimal solutions determined by means of an exhaustive search for the same 
seven Boolean logic functions using GRID computing facilities. The accuracy is 
expressed as the percentage of times that the algorithm finds the same solution 
as the exhaustive search. 
Figure  4A  shows  the  resulting  accuracy.  We  observe  that  for  solutions 
with  f-scores  between  5  and  6  already  >95%  accuracy  is  achieved,  while  for 
solutions with f-scores of 6 and higher, virtually 100% accuracy is achieved for 
each topology. For comparison, Figure 4A also gives the 75th percentiles of the 
solution distributions for each topology. Because solutions of interest (putatively 
significant solutions) are required to have f-scores substantially higher than the 
75th percentile, we can conclude that our method achieves 100% accuracy for a 
reasonable operating range (solutions with f-scores between 4 and 5 – where the 
accuracy is below 95% – are well below the 75th percentile for all networks). 
While comparing our method to the method presented in Mukherjee et al,12 
using simulated gene expression vectors and a predetermined random network 
(ground  truth),  we  found  that  our  method  reaches  higher  true  positive  rates 
(see  Supplementary  Results).  These  results  illustrate  the  benefit  of  searching 
for solutions for each of the network topologies separately, and employing a 
significance estimate to enforce parsimony. 
Obtaining the same accuracy as an exhaustive search is only useful if this is 
achieved for runtimes that are substantially lower. To asses this, we randomly 
selected 200 gene expression vectors from the 1525 gene clusters and measured 
runtimes for both our CAL network search as well as the exhaustive search. Figures 
4B-D show these runtimes for a range of conditions. The boxplots represent the 
results obtained with the CAL network search and the horizontal lines the runtimes 
for the exhaustive search. 
Figure 4B compares runtimes for different network topologies. Clearly, the 
branch  and  bound  algorithm  significantly  outperforms  the  exhaustive  search 
under all experimental conditions with differences in runtime of up to four orders 
of magnitude. For the three input networks in particular, the runtime required 
for exhaustive search (more than five hours per gene per network) prohibits any 75  INFERRING COMBINATORIAL ASSOCIATION LOGIC NETWORKS
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further permutation procedures. The CAL network search, on the other hand, 
is able to find the solution in a matter of seconds, thereby enabling the large 
number of permutations required to obtain reliable significance estimates. 
Compared  to  the  variance  in  runtime  of  the  exhaustive  search,  which  was 
negligible, the variance of the CAL network search is quite high. This is expected 
as our CAL network search finishes rapidly when a good solution presents itself 
early in the search, while more time is needed to conclude that no acceptable 
solution  is  present.  For  a  similar  reason,  the  more  complex  networks,  those 
containing XOR logic, have higher median runtimes. On no occasion, however, 
does this increase runtimes above 100 seconds for any of the networks. 
To evaluate performance as a function for dataset size we artificially increased 
the number of predictors and the number of samples (Figure 4C). In addition, 
runtimes for different tolerance levels were examined (Figure 4D). The number of 
predictors was increased by horizontally concatenating the original matrix L with 
copies of L containing 10% random bit-flips. The sample size was increased by 
vertically concatenating matrix L as well as all gene expression vectors g with copies 
of L and g, respectively. In case of the latter, normally distributed noise was added 
to the copies with σnoise=0.1σg. We observe that for both the exhaustive search as 
well as the CAL network search runtimes increase substantially as the number of 
predictors increases. In case of the CAL network search this is explained by the 
fact that many very good solutions are present due to the increased imbalance 
between the number of predictors and the sample size. It is expected, yet not 
quantitatively established, that better performance is observed when this balance 
is restored. The increase in runtime as a result of an increased number of samples 
is  moderate,  with  a  median  runtime  considerably  lower  than  an  exhaustive 
search for only two input networks. Likewise, increasing the tolerance level only 
moderately speeds up the CAL network search, demonstrating that runtime is 
robust for the setting of this parameter.
Combinatorial expression Quantitative Trait Loci
We performed the CAL network search for the set of 1525 high potential gene 
clusters. The complete search (e.g. for all gene clusters and all topologies) was 
repeated 100 times using a permuted version of the gene-expression vectors. For 
each topology, this resulted in a null-distribution containing 152500 values, which 
was used to estimate q-values for each of the resulting solutions. We considered 
network topologies with a maximum of three inputs listed in Figure S5. Notably, 
we included two single-input networks to account for direct positive and negative 
association, respectively, which is equivalent to positive association with the D2 
and B6 allele, respectively. This ensures that the algorithm has the option of 
choosing the least complex model in case an eQTL is capable of explaining a 
significant portion of the variance in the expression of the gene cluster. 76 CHAPTER 4
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Figure 5A gives an overview of the number of gene clusters for which the 
output of a CAL network significantly (at the 10% FDR level) associated with its 
expression (red bars). To obtain additional confidence in the significance threshold 
we calculated q-values for ten additional permutations of the whole dataset. For 
none of the network topologies did the mean number of significant gene clusters 
across the ten permutations exceed 0.6, indicating that the expected number of 
false discoveries is conservatively kept under control. The yellow bars indicate 
the number of significant gene clusters after model size selection based on the 
q-value as detailed in the Methods section. It appears that most of the gene 
clusters for which association is observed can be explained by one of the single 
input networks. For nine gene clusters (corresponding to 17 genes), however, a 
CAL network was capable of explaining significantly more of the variance than 
one of the single input networks or any one of the other CAL networks. 
The  network  topologies,  q-values  and  association  scores  of  the  significant 
CAL networks are given in Figure 5B. Not surprisingly, for all gene clusters at the 
output of these networks, the combination of loci is vastly superior in explaining 
the variance in expression over any of the markers in isolation. Interestingly, many 
of these genomic regions would have been missed, as in seven of the networks 
the best markers do not coincide with one of the inputs of the CAL network. 
The  sets  of  markers  that  were  found  as  the  optimal  inputs  for  the  seven 
topologies were mapped onto the genome. Combinatorial eQTLs (ceQTL) were 
then defined as stretches of consecutive markers. A genome map of the (c)eQTLs 
is given in Figure 5C, showing the eQTLs (red and blue crosses for positive and 
negative association, respectively) and ceQTLs (colored symbols) on the x-axis 
versus the genomic positions of the probes measuring expression on the y-axis. 
The  numbers  near  the  ceQTL  symbols  correspond  to  the  inputs  of  the  CAL 
networks depicted in Figure 5B. 
Before we zoom in on one of the CAL networks in more detail, some general 
observations can be made. In particular, we note that in some cases overlap 
exists  among  the  markers  selected  at  the  inputs  of  the  CAL  networks  and 
between other network inputs and eQTLs. In seven instances, the identified 
ceQTLs coincide with eQTLs (connected by black dashed lines in the figure). 
Some of these eQTLs are located in cis. The finding of CAL networks that share 
one of their inputs (ceQTLs) with an eQTL suggests that the local genotype 
associated  with  the  eQTL  is  involved  in  the  regulation  of  a  local  gene  (cis-
regulation), but in addition collaborates with the other CAL input locus/loci to 
regulate the CAL network output gene(s). Furthermore, two of the CAL networks 
(ranked sixth and ninth) share a ceQTL between the inputs (connected by red 
dashed lines). It is not inconceivable that a gene present in this ceQTL is indeed 
involved in the regulation of the target genes of both networks, but that the 
interaction partners through which this regulation is established differs for both 
target genes. 78 CHAPTER 4
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Among the list of output genes of the nine most significant CAL networks is 
Lilrb4 (ranked third). Lilrb4 encodes a leukocyte immunoglobulin-like receptor 
that is expressed on the surface of mast cells, neutrophils, and macrophages. 
It plays a key role in counter-regulating the inflammatory response to prevent 
pathologic excessive inflammation.21 
Figure 6 shows small regions around the ceQTLs that were selected as inputs 
for the CAL network of Lilrb4. For each region the association was measured 
between the expression of Lilrb4 and the individual markers (blue lines). The red 
lines, on the other hand, give the association score for the network output. Clearly, 
the association between the logical combination of inputs and the expression of 
Lilrb4 is markedly higher than considering any of the markers in isolation. The 
regions for which the red curves reach their maximum correspond to the ceQTLs.
The Boolean heat map, displayed at the bottom of Figure 6, outlines the 
genotype of one particular combination of genetic markers in the ceQTLs across 
the BXD mouse strains. The bottom two rows of this heat map give the optimal 
network output and predicted output, respectively. For the Lilrb4 network the 
optimal network output is exactly recapitulated by the CAL network. For Lilrb4 
elevated expression is exclusively observed in case of B6 alleles in both the ceQTL 
regions of Chromosomes 7 and 19. 
To  focus  our  attention  to  the  most  interesting  genes  in  the  ceQTLs  we 
performed a literature search using Ingenuity Pathway Analysis (Ingenuity Systems, 
www.ingenuity.com). Interestingly, we found a substantial number of interactions 
between genes localized in the ceQTLs and Lilrb4. For example, the literature 
search revealed a link between Apba1 (located in the ceQTL region on Chr 19) and 
Lilrb4. Both protein products have been described to bind ITGB3.22;23 In addition, 
the  search  revealed  a  link  between Psenen  (Chr  7  ceQTL)  and  Apba1  (Chr  19 
ceQTL). Both protein products have been described to bind PSEN1 and PSEN2.24;25 
While literature is able to link the genes in the ceQTLs to Lilrb4 and thereby 
gives the first clues as to how the expression of Lilrb4 may be regulated, we do 
not exclude that other interactions (not yet represented in literature) exist. In any 
case, the result of our method should provide a set of testable hypotheses that 
can be validated in the laboratory.
the network topologies listed in (B). Horizontal grey lines connect the inputs and the output 
of the CAL network. Because probes were clustered, it occurs that the ceQTLs map to 
multiple probes in case these probes were part of the same cluster. The numeric labels near 
the colored symbols correspond to the input of the network. Notably, some probes seem 
to be predicted by more ceQTLs than there are inputs to the CAL network reported. This 
occurs when there are multiple combinations of markers that show the same association 
with the gene expression level of the network output, and can be explained by similarity 
among markers. The cis-band (diagonal) is clearly visible, and in one occasion contains a 
ceQTL. Overlap among ceQTLs from different networks is marked by red dashed lines, 
overlap between ceQTLs and eQTLs by black dashed lines.80 CHAPTER 4
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DISCUSSION
Unraveling (transcriptional) regulatory networks by inferring complex associations, 
for instance between genotype and gene expression, necessitates algorithms that 
take into account possible (allele-specific) interactions. For this purpose, we have 
proposed a method to efficiently infer CAL networks, i.e. small logic networks 
in which allele-specific interactions are modeled by Boolean functions. To find 
the best possible fit of the model given the data, a computationally challenging 
optimization  problem  had  to  be  solved.  This  was  achieved  by  rewriting  the 
optimization such that it could be effectively solved by a customized branch and 
bound algorithm. Proof and empirical evidence for optimality of the solution, under 
appropriate conditions, was given. At the same time, differences in runtimes of up 
to four orders of magnitude were observed when compared to exhaustive search. 
Because the CAL network search is able to find the optimal solution in a matter 
of seconds a permutation procedure becomes feasible, which can be employed 
to obtain estimates of the False Discovery Rate. This is a major advantage as   
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Figure 6. Input regions of the CAL network for Lilrb4. The line graphs give the f-score 
for association between the output gene and the individual markers (blue) and the network 
output (red). The latter was computed by taking the maximum f-score of the network using 
the marker under evaluation for one input and any of the other markers for the second 
input of the network. Where possible the IDs of the genetic markers are given, but some 
were omitted for readability. The dot plots give the expression values separated by network 
output (right) and the best markers in the inputs (left). Finally, for one particular combina-
tion of markers the genotype for all strains is depicted as a Boolean heat map. In these 
diagrams, the NOT gates were already incorporated.81  INFERRING COMBINATORIAL ASSOCIATION LOGIC NETWORKS
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the resulting q-values allow selection of the most parsimonious model and enable 
ranking the network topologies in terms of their complexity. 
We demonstrated our algorithm on a genetical genomics dataset, and found 
that, from the 1525 gene clusters (2913 genes) that resulted after selection of 
high potential genes, nine gene clusters (17 genes) were significantly associated 
(at 10% FDR level) through a logical combination of genomic loci rather than 
a single eQTL. Notably, without incorporating the complex interactions, these 
associations would have gone unnoticed. Many of the discovered input regions 
were found to overlap eQTLs or were shared inputs of CAL networks explaining 
the expression of other genes, suggesting that these regions, indeed, are involved 
in transcriptional regulation.
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5AbSTRACT
Hematopoietic  cell  differentiation  is  accompanied  by  profound  changes 
in  gene  expression  patterns.  To  identify  the  regulatory  mechanisms  that 
underlie  these  expression  changes, we  previously  performed  a  combined 
analysis of variation in gene expression across four developmentally related 
hematopoietic cell populations and across mouse strains (C57BL/6, DBA/2, 
and  their  recombinant  inbred  strains).  This  genetic  analysis  provided  a 
genome-wide overview of cell-type-specific transcripts and the genomic loci 
that were most likely to control their expression levels. Here, we illustrate how 
the presence of genetic diversity in a pedigree of normal, wild-type, mice can 
be exploited to construct gene networks that operate in successive stages of 
cellular development. We start with the reconstruction of an experimentally 
validated gene network, and proceed with the construction of a novel gene 
network for transcripts that are most specific to hematopoietic stem cells. 
Finally, we identify Zfp521 as a strong candidate regulator of hematopoietic 
stem cell pool size, and uncover the network members through which this 
factor may operate.87  ZFP521: A NOVEL REGULATOR OF HEMATOPOIETIC STEM CELLS
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INTRODUCTION 
Hematopoietic stem cells (HSCs) are at the apex of the hematopoietic hierarchy. 
They possess self-renewal activity in order to maintain their original pool, as well as 
the capacity to differentiate into mature blood cells. Genome-wide gene expression 
studies of different stages of hematopoietic development have provided insight 
into the molecular nature of HSC self-renewal, lineage specification, commitment 
and differentiation.1-4 However, the regulatory mechanisms underlying the gene 
expression changes during hematopoiesis remain largely elusive. The search for 
these mechanisms has transformed into a virtual “holy grail” of experimental 
hematology,  as  the  dissection  of  these  mechanisms  would  not  only  provide 
insight into normal and malignant hematopoiesis, but would also pave the way 
for effective HSC expansion protocols.
The size of the HSC pool is subject to extensive variation among inbred mouse 
strains and a genetic basis for much of this variation is now well established. 
Specifically,  C57BL/6  (B6)  and  DBA/2  (D2)  mouse  strains  show  a  remarkable 
difference in HSC numbers.5-7 BXD (offspring of B6 and D2) recombinant inbred 
mouse strains have proven to be a useful panel in which to identify the genetic 
determinants  underlying  this  variation.  Using  a  quantitative  trait  locus  (QTL) 
mapping approach multiple genomic loci have been identified that regulate HSC 
pool size.7-9 In order to identify the quantitative trait genes (QTGs) underlying this 
trait, and to study the genetic basis of variation in gene expression, we previously 
performed  an  expression  QTL  (eQTL)  study  in  four  distinct,  but  hierarchically 
related hematopoietic cell populations isolated from the BXD panel.10 
In the current study, we exploit the naturally occurring genetic diversity in the 
BXD panel to construct gene networks. We show that a combined analysis of 
variation in gene expression across cell types and variation across mouse strains 
provides a platform for gene network construction. Also, we show that it allows 
us  to  evaluate  the  complex  dynamics  of  gene  regulatory  relationships  during 
differentiation. We validate our approach by reconstructing an experimentally 
verified gene network, and continue with constructing a novel gene network for 
transcripts that are specific to HSCs. Finally, a combinatorial analysis of classical 
QTLs and eQTLs points to a zinc-finger transcription factor as a strong candidate 
regulator of HSC pool size.
METHODS
The data presented in this report are based on previously published microarray and 
eQTL mapping data.10 Briefly, in that study Lin−Sca-1+c-Kit+ cells, Lin−Sca-1−c-Kit+ 
cells, TER-119+ cells and Gr-1+ cells were isolated from the bone marrow of ~25 BXD 
recombinant inbred mouse strains. Total RNA was isolated, labeled and hybridized 
to Sentrix Mouse-6 BeadChips (Illumina). The raw expression data from all four cell 88 CHAPTER 5
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types were first log2 transformed and then quantile normalized as a single group. 
All raw data were deposited in the NCBI Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo/,  accession  number  GSE18067).  All  processed  data 
were deposited in the GeneNetwork (http://www.genenetwork.org).11 
Mapping of eQTLs
As previously described,10 the expression data of the four cell types were corrected 
for batch effect and then analyzed separately by the following ANOVA model:
yi = m + Qi + ei 
where yi is the gene’s log intensity on the ith microarray; m is the mean; Qi is the 
genotype effect under study; and ei is the residual error.
For each probe, we performed a genome-wide linkage analysis and identified 
the marker that showed the most significant eQTL. We defined an eQTL as local 
if it was located within less than 10 Mb from the gene. All other eQTLs were 
considered distant.
Extraction of shared eQTLs
We used a relaxed threshold of −log10 p > 3 and retrieved all the markers within 
the eQTL confidence intervals defined with a 1.5 eQTL drop-off value. When 
two transcripts had overlapping confidence intervals, they were considered to be 
co-mapping. 
RESULTS
Dynamics of gene expression
We evaluated genome-wide gene expression levels in Lin−Sca-1+c-Kit+ multilineage 
cells, committed Lin−Sca-1−c-Kit+ cells, TER-119+ erythroid cells and Gr-1+ myeloid 
cells  isolated  from  a  large  panel  of  BXD  recombinant  inbred  mouse  strains. 
Since we profiled multiple developmentally related cell stages, we were able to 
illustrate the dynamics of gene expression along either the erythroid (Figure 1A) 
or myeloid differentiation trajectory (Figure 1B). The 120 transcripts (represented 
by  138  probes)  that  were  consistently  up-regulated  during  erythropoiesis 
included well-known erythroid-specific genes such as Epor, Klf1, Kel, Ank1, Gypa, 
Tfrc, and Gata1, and the 29 transcripts (represented by 29 probes) that were 
consistently  up-regulated  during  myelopoiesis  included  Cebpe,  Ccnd3,  Idh1, 
and Fcgr3. We identified 163 transcripts (174 probes) that were repressed during 
erythroid development, and 88 transcripts (92 probes) that were repressed during 
myeloid development. Only 52 transcripts were consistently repressed in both 
differentiation trajectories. These transcripts included the well-known stem cell 89  ZFP521: A NOVEL REGULATOR OF HEMATOPOIETIC STEM CELLS
5
genes Meis1, Hoxa5, Hoxa7, Dnmt3b, and Cd34, but also many poorly annotated 
transcripts. Genes belonging to each of the different gene expression quadrants 
are provided in Table S1.
Reconstruction of an experimentally validated network
Unraveling the gene regulatory networks that control important cell fate decisions 
has become a focal point in the field of hematology. Such networks are often 
visualized as networks composed of nodes (representing genes, proteins and/or 
metabolites) and edges (representing molecular interactions). In the hematopoietic 
system,  interactions  between  several  key  transcription  factors  have  been 
experimentally validated. Antagonistic interactions between two key regulators, 
namely  the  Gata1  and  Pu.1  transcription  factors,  are  thought  to  control  the 
erythroid versus myeloid fate choice in common myeloid progenitors as indicated 
by  both  gain-  and  loss-of-function  studies  in  cell  line  systems.12;13  Moreover, 
experiments in transgenic mice as well as cell line model systems suggested that 
the key HSC regulators Tal1 (also known as Scl) and Gata2 together with Ets-
family transcription factors such as Pu.1 and Fli1 can form a triad network motif 
characterized by extensive positive feedback loops which might be important in 
maintaining the undifferentiated state in primitive hematopoietic cells.14-16 Since 
Gata1 together with Zfpm1 (also known as Fog1) is known to repress Gata2, it is 
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Figure 1. Mean expression levels for all probes in the four cell types. (A) Gene expression 
trajectory during erythroid differentiation. Gene expression patterns are shown as cells dif-
ferentiate from Lin−Sca-1+c-Kit+ to Lin−Sca-1−c-Kit+ to TER-119+ cells. Each dot refers to the 
mean intensity of a single probe across all BXD strains. Dotted lines indicate 2-fold change 
thresholds. The bold and colored dots refer to those transcripts that met the criteria of the 
respective quadrants. For example, the 138 transcripts for which expression increased 2-fold 
as cells differentiated from Lin−Sca-1+c-Kit+ to Lin−Sca-1−c-Kit+ (x-axis), and again 2-fold from 
Lin−Sca-1−c-Kit+ to TER-119+ (y-axis), are shown in red. (B) As in panel A, but here mean gene 
expression levels during myeloid development to Gr-1+ cells are shown.   90 CHAPTER 5
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likely that there will be cross-talk between these two subcircuits at intermediate 
stages of hematopoietic differentiation (Figure 2A).17  
Given  that  the  generation  of  the  above  network  models  relied  on  assays 
that  experimentally  perturb  the  normal  equilibrium  of  regulatory  interactions, 
we reasoned that our expression dataset in genetically diverse, yet wild-type, 
primary hematopoietic cell types should provide an ideal resource to probe the 
nature of any proposed interactions in the four cell types sampled in the current 
study. To identify correlations between pairs of genes within and between the 
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Figure 2. Network dynamics. (A) Experimentally validated transcription factor interactions 
in each of the four cell types, based on previously published data. Lin−Sca-1+c-Kit+ cells are 
shown in black (top), Lin−Sca-1−c-Kit+ cells in grey (middle), TER-119+ cells in red (bottom 
left), and Gr-1+ cells in blue (bottom right). (B) Observed correlation between variation in 
Gata1 and Tal1 expression levels across cell types and across mouse strains. In this scatter 
plot, each dot represents Gata1 and Tal1 expression levels for a single BXD strain in a 
single, indicated, cell type. (C) Correlation between Gata1 and Pu.1 expression. (D) Cor-
relation coefficients of all predicted gene pairs in the validated network as shown in panel 
A. Red and blue lines connect positively and negatively correlated pairs of genes, respec-
tively. Solid lines indicate absolute correlation coefficients larger than 0.2, and the width of 
the lines reflect the strength of the correlation.91  ZFP521: A NOVEL REGULATOR OF HEMATOPOIETIC STEM CELLS
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two subcircuits, we plotted gene expression levels across all mouse strains in 
each of the four cell types (Figures 2B—C), determined the associated linear 
correlation  coefficients,  and  superimposed  these  correlation  measures  on 
the  predicted  network  model.  This  analysis  confirmed  many  of  the  proposed 
positive and negative interactions, either as positive or as negative correlations   
(Figure 2D). Remarkably, both the strength and the direction of correlations were 
highly dynamic across the four cell populations. For example, while the predicted 
antagonistic relationship between Gata1 and Pu.1 in Lin−Sca-1−c-Kit+ cells was 
indeed observed, the corresponding correlations were positive in Lin−Sca-1+c-Kit+ 
and myeloid cells. Our analysis therefore not only revealed a priori unexpected 
dynamics of regulatory interactions but also provided a novel strategy to pinpoint 
specific cell types along a differentiation cascade where particular interactions 
may be critical.  
Construction of gene networks in hematopoiesis
Having established that the combined analysis of variation in gene expression 
across cell types and across mouse strains is able to confirm genetic interactions of 
known key transcription factors, and reveal complex dynamics of gene regulatory 
relationships during differentiation, we proceeded to expand our analysis to explore 
novel regulatory networks. To this end, we performed hierarchical clustering of all 
genes that were consistently up- or down-regulated during erythroid or myeloid 
development (bottom left and top right quadrants in Figures 1A—B), based on 
inter-strain  correlation  of  variation  in  expression  in  Lin−Sca-1−c-Kit+  cells.  One 
could hypothesize that the coordinated up- or down-regulation of collections 
of transcripts during cellular development results from a limited number of key 
instructive decisions. If this were the case, strong correlation structures of co-
regulated transcripts should exist. Indeed, we detected multiple modules of co-
varying transcripts for each set of consistently up- or down-regulated transcripts 
(Figure 3A). 
To reveal whether such modules of transcripts were under common genetic 
control,  we  performed  eQTL  clustering  of  those  52  transcripts  (55  probes 
representing 52 transcripts) that were consistently down-regulated during both 
erythroid and myeloid differentiation (Figure 3B). A genetic analysis in Lin−Sca-
1−c-Kit+  cells  revealed  co-localization  of  eQTLs  for  multiple  transcripts,  which 
suggests shared regulatory relationships. Interestingly, a substantial number of 
the 52 transcripts were regulated by loci on chromosomes 1, 5, 9, 12, and 18. This 
is consistent with earlier QTL studies which documented that these chromosomes 
contain loci that control the pool size or the turnover of primitive hematopoietic 
cells.6-8;18;19 
To construct a regulatory network for these 52 transcripts, we used GeneNetwork 
to  create  an  association  network  based  on  their  pairwise  Pearson  correlation 
coefficients (Figure 3C). In order to extract shared eQTLs, for each transcript we not 92 CHAPTER 5
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Figure 3. Gene network construction. (A) Hierarchical clustering of those transcripts that 
were consistently down- or up-regulated during erythroid and/or myeloid differentiation 
(as defined in Figures 1B—C). Clustering was based on variation in transcript abundance 
across BXD strains in Lin−Sca-1−c-Kit+ cells. Positive and negative correlations are shown 
in red and blue, respectively. Several modules of co-regulated genes (indicated by the 
colored squares next to the heatmap) were identified. The rightmost panel clusters 52 
transcripts (represented by 55 probes) that were down-regulated during both erythroid and 
myeloid commitment. (B) Genetic analysis of the 52 transcripts shown in panel A identi-
fied shared eQTLs. This plot shows a genome-wide heatmap of all 52 transcripts where 
the color coding indicates strength of the genetic association and variation in expression. 
Significant eQTLs are indicated with red and blue colors for B6 or D2 alleles increasing 
expression, respectively. The color coded bar left to the figure refers to the clusters of cor-
related transcripts in panel A. (C) Association network of the 52 transcripts (shown in panel 
A) in Lin−Sca-1−c-Kit+ cells. Edges show Pearson correlation coefficients <-0.4 or >0.4, their 
lengths being inversely correlated with the correlation coefficients. In this configuration the 
total stretching of the edges is minimized. Edge colors indicate strengths and directions of 
the correlation coefficients. Edges are shown in bold when two transcripts are co-mapping 
to the same locus. Three transcripts (Egfl7, Slc18a2, and Zfp521) are (at least in part) locally 
regulated (encircled in bold black). In these cases, directionality of regulatory input (“who 
regulates who”) is indicated with an arrow (pointing away from the potential regulator). 
Colors of boxes represent the correlation clusters to which the transcripts were assigned 
in panel A. (D) Genome-wide QTL plot of variation in stem cell pool size shows significant 
linkage to a locus on chromosome 18 (GeneNetwork Trait ID: 10056).
only identified its maximal eQTL, but all eQTLs above a relaxed threshold of p < 
10-3. Two transcripts were considered to be co-mapping when they had overlapping 
eQTL intervals. The results of this analysis were superimposed on the association 
network (Figure 3C). When one of the transcripts was regulated locally, direction 
of causality could be established, as a locally regulated gene is predicted to be 
upstream  of  a  distantly  co-regulated  gene.  Interestingly,  many  transcripts  were 
transcriptionally controlled by a locus on chromosome 18, containing Zfp521 (one 
of the 52 transcripts that were consistently down-regulated during differentiation). 
Variation in Zfp521 expression mapped to two loci on chromosome 18, one of 
which contained the gene encoding Zfp521 itself. Strikingly, the classical trait HSC 
pool size had previously been mapped to this exact same locus (Figure 3D), thereby 
pointing to Zfp521 as a candidate regulator of this trait.9 
Zfp521 was discovered in 2003 as a common retroviral integration site (and was 
termed ecotropic viral integration site 3 or Evi3) in murine B-cell lymphoma and 
encodes a Krüppel-like zinc finger protein.20 Since then, the expression of the human 
homolog of Zfp521, EHZF, has been shown to be restricted to CD34+ progenitor 
cells, and to be expressed in many acute myeloid leukemias.21 That Zfp521 has 
a functional role in immature cells became apparent when overexpression of EHZF 
in primary human CD34+ cells was described to result in inhibition of differentiation 
and in the accumulation of progenitors in vitro.22 Our data confirm a central role for 
the transcription factor Zfp521 in regulating transcripts that are specific to the most 
primitive hematopoietic cells, and identify candidate network members through 
which this factor may regulate HSC pool size.94 CHAPTER 5
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DISCUSSION
To  decipher  the  regulatory  mechanisms  that  underlie  the  changes  in  gene 
expression  that  accompany  hematopoietic  cell  differentiation,  we  analyzed 
gene expression variation in cell types isolated from genetically distinct mouse 
strains. We show how naturally occurring genetic diversity across mouse strains 
can be exploited to construct gene regulatory networks. We started with the 
reconstruction  of  an  experimentally  verified  gene  network  and  illustrate  how 
hematopoietic differentiation could be the result of cell-type dependent rewiring 
of transcriptional connections. This rewiring is observed as switches in correlation 
patterns, and indicates reversal of regulatory polarity due to cell-type-specific 
transcriptional co-factors. We proceeded with the construction of a novel gene 
network for transcripts that were most highly expressed in HSCs, and identified 
the zinc finger transcription factor Zfp521 as a central player in this network. 
Strikingly,  a  subsequent  combinatorial  analysis  of  classical  QTLs  and  eQTLs 
identified Zfp521 as a strong candidate regulator of HSC pool size. 
HSCs  are  known  to  be  controlled  by  both  intrinsic  and  extrinsic  cues.  In 
this  report,  we  show  that  HSCs  may  be  intrinsically  controlled  by  Zfp521. 
However, Zfp521 has also recently been shown to regulate the rate of osteoblast 
differentiation and bone formation.23;24 This finding points to a dual role of Zfp521 
in regulating HSCs: 1) intrinsically and 2) extrinsically via the HSC niche. Based 
on these findings, it would be of great interest to study the HSC niche in the 
BXD mouse panel. Analyzing the properties of the niche and genome-wide gene 
expression in the niche would have the potential to unravel (genetic) interactions 
between HSCs and their micro-environment. 
HSC pool size is controlled by multiple genes and is therefore considered   
a genetically complex trait. Variation in this trait has been mapped to multiple QTLs 
on chromosomes 1, 3, 5, 11, 18 and the X chromosome.7-9 The main challenge for 
dissecting complex traits lies not in the identification of QTLs that underlie these 
traits, but in the identification of the QTGs that underlie them. Previously, Lxn was 
identified as a QTG located in the Chr. 3 QTL interval.25 Here, we report Zfp521 
as a strong candidate QTG in the Chr. 18 QTL interval. It is likely that future 
studies will reveal additional factors that contribute to the natural variation in HSC 
numbers. The identification of such factors would be of substantial significance 
for the fundamental understanding of normal and malignant hematopoiesis, and 
for exploiting the full clinical potential of HSCs.95  ZFP521: A NOVEL REGULATOR OF HEMATOPOIETIC STEM CELLS
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6AbSTRACT
Hematopoietic stem/progenitor cell (HSPC) traits differ between genetically 
distinct mouse strains. For example, DBA/2 mice have a higher HSPC frequency 
compared to C57BL/6 mice. We performed a genetic screen for microRNAs 
that are differentially expressed between LSK, LS−K+, erythroid and myeloid 
cells  isolated  from  C57BL/6  and  DBA/2  mice.  This  analysis  identified  131 
microRNAs that were differentially expressed between cell types and 15 that 
were differentially expressed between mouse strains. Of special interest was 
an evolutionary conserved miR-cluster located on chromosome 17 consisting 
of  miR-99b,  let-7e  and  miR-125a.  All  cluster  members  were  most  highly 
expressed in LSKs and down-regulated upon differentiation. In addition, these 
microRNAs were higher expressed in DBA/2 cells compared to C57BL/6 cells, 
and thus correlated with HSPC frequency. To functionally characterize these 
microRNAs in HSPCs, we overexpressed the entire miR-cluster in BM cells 
from 5-FU treated C57BL/6 mice and initiated assays to quantify CFU-GM 
self-renewal, CAFC frequencies, and LT-HSCs. BM cells overexpressing the 
miR-cluster  showed  increased  replating  capacity  in  CFU-GM  assays  and 
dramatically increased day-35 CAFC activity. Furthermore, mice reconstituted 
with  miR-cluster-overexpressing  cells  displayed  severe  hematopoietic 
phenotypes. Finally, we performed genome-wide gene expression arrays and 
identified  candidate  functional  targets  through  which  this  miR-cluster  may 
modulate HSPC fate. 101  MICRORNA CLUSTER 99B/LET-7E/125A REGULATES HSPCS
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INTRODUCTION
Hematopoietic  stem  cells  (HSCs)  sustain  life-long  blood  production,  and  are 
characterized  by  their  remarkable  self-renewal  capacity  and  multi-lineage 
differentiation potential. HSCs give rise to progenitors that differentiate into the 
various blood cell types. Many characteristics of the hematopoietic stem and 
progenitor cell (HSPC) compartment display mouse strain-dependent variation. 
For example, compared to C57BL/6 (B6) mice, DBA/2 (D2) mice have a higher 
HSPC frequency and cycling rate.1-4 The observed natural variation between these 
regular inbred mouse strains can be exploited to identify potential modulators of 
such HSPC traits. Useful in this respect has been the generation of BXD (progeny 
of B6 x D2) recombinant inbred mouse strains.5;6 Each of these strains represents 
a unique, but stable genetic mosaic of B6 and D2 alleles. By making use of these 
strains, variation in many different HSPC traits has been mapped to genomic 
regions (reviewed in  7). Previously, we analyzed mRNA expression variation in 
developmentally related cell types isolated from the BXD mouse panel.8;9 In those 
studies, we identified groups of genes that were differentially expressed across 
mouse strains and therefore potentially causal for the variation in HSPC traits.
MicroRNAs  are  evolutionary  conserved  small  (~22-nucleotide)  non-coding 
RNAs that fine-tune gene expression by base-pairing with target mRNAs, leading 
to  mRNA  destabilization  or  translational  repression.10-12  Each  microRNA  can 
coordinately target hundreds of different mRNAs,13 and each mRNA can harbor 
multiple microRNA target sites, creating complex microRNA/mRNA regulatory 
circuitries.  A  growing  body  of  evidence  has  implicated  specific  microRNAs  in   
the regulation of HSPC fate. For example, miR-181, miR-150, and the miR-17~92 
cluster  have  proven  to  be  essential  for  lymphoid  development,14-18  miR-223 
for  myeloid  development,19;20  and  miR-155  for  both  lymphoid  and  myeloid 
development.21-23  Dysregulated  expression  of  these  and  other  microRNAs  has 
been shown to contribute to the pathogenesis and progression of hematologic 
malignancies.24;25 
To determine whether the variation in gene expression and HSPC traits across 
BXD mouse strains could be due to natural variation in microRNA expression, 
we  embarked  on  a  genome-wide  microRNA  expression  study  of  Lin−Sca-1+c-
Kit+  (LSK),  Lin−Sca-1−c-Kit+  (LS−K+),  erythroid  and  myeloid  cells  isolated  from 
the B6 and D2 parental mouse strains. We identified both cell type-dependent 
and  mouse  strain-dependent  microRNAs.  Interestingly,  we  discovered  an 
evolutionary conserved cluster of microRNAs (99b/let-7e/125a) that is most highly 
expressed in HSPCs and that is differentially expressed between mouse strains. 
To assess whether the differential expression of this cluster could be functional 
we  overexpressed  it  in  HSPCs,  and  found  that  this  conferred  a  competitive 
advantage to these cells. However, we also found that mice reconstituted with 
these cells developed myeloproliferative neoplasms (MPNs). Finally, we identified 102 CHAPTER 6
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the candidate functional downstream targets through which the miR-cluster may 
be able to modulate HSPC fate.
METHODS
Mice
Female B6 (CD45.2) and D2 mice were purchased from Harlan and housed under 
clean  conventional  conditions.  Female  and  male  B6.SJL  (CD45.1)  mice  were 
bred at the Central Animal Facility of the University of Groningen. All animal 
experiments were approved by the Groningen University Animal Care Committee.
Cell purification
Bone marrow (BM) cells were flushed from the femurs and tibias of three to five 
mice and pooled. After standard erythrocyte lysis, nucleated cells were stained 
with a panel of Alexa Fluor 700-labeled lineage-specific antibodies (containing 
antibodies  to  CD3  (clone  17A2),  CD11b  (Mac1;  clone  M1/70),  CD45R/B220 
(clone  RA3-6B2),  Gr-1  (Ly-6G  and  Ly-6C;  clone  RB6-8C5)  and  TER-119  (clone 
TER-119)),  fluorescein  isothiocyanate  (FITC)-labeled  anti-Sca-1  (clone  E13-
161.7), phycoerythrin (PE)-labeled anti-c-Kit (clone 2B8), phycoerythrin-cyanine-7   
(PE-Cy7)-labeled anti-TER-119 (clone TER-119), and allophycocyanin (APC)-labeled 
anti-Gr-1 (clone RB6-8C5). Antibodies were purchased from BioLegend. Cells were 
purified using a MoFlo flowcytometer (BeckmanCoulter) and were immediately 
collected in RNAprotect cell reagent (Qiagen) for microRNA expression studies or 
RNA lysis buffer (Qiagen) for gene expression studies. Triplicates were generated 
for each of the 8 conditions (4 cell types, 2 mouse strains).
MicroRNA expression analysis
Total RNA was isolated using the miRNeasy Mini Kit (Qiagen) in accordance with 
the manufacturer’s protocol. 100 ng of total RNA was labeled and hybridized 
to Agilent 8x15K Mouse miRNA arrays, based on version 11 release of Sanger 
Inst miRBASE. Labeling, hybridization and washing were performed by Oxford 
Gene  Technology  using  the  Agilent  Mouse  microRNA  Microarray  Kit.  Data 
were extracted using Agilent Feature Extraction Software version 9.5.3.1. Data 
were thresholded at 1, log2-transformed and normalized to the 75th percentile 
(as  recommend  by  Agilent)  using  GeneSpring  GX11.0  (Agilent).  On  the  basis 
of Principle Component Analysis, 1 sample was removed from further analysis. 
The starting data set represented 577 non-control probes. False positives were 
excluded by only pursuing with those probes that were flagged as present in 
at least 2 out of 3 replicates in any 1 out of 8 conditions. The quality-filtered 
expression values were median-centered per microRNA and clustered (Euclidean 
distance,  complete  linkage)  using  Genesis.26  Signatures  were  identified  using 103  MICRORNA CLUSTER 99B/LET-7E/125A REGULATES HSPCS
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a manually chosen threshold. Two-way analysis of variance (ANOVA) was applied 
to  identify  cell  type-dependent  and  mouse-strain-dependent  microRNAs.   
A Benjamini-Hochberg false discovery rate correction was applied to control for 
multiple testing.
Retroviral vectors
Genomic  DNA  was  isolated  from  B6  cells  and  a  1.2  Kb  region  spanning  the 
miR-99b,  let-7e  and  miR-125a  stem  loop  sequences  was  amplified  (forward 
primer:  5’-CCTCGAGTGGACTGAGGAGAATTGAGTGCAAG-3’,  reverse  primer: 
5’-GCAATTGTGCCCTGAAGATCAGCAGGAAC-3’; Biolegio). The resulting PCR 
product was extracted from gel, TOPO-cloned into PCR4, cut from PCR4 using 
XhoI and MunI, and subcloned into the XhoI-EcoRI site of the MXW-pPGK-IRES-
EGFP vector (a Murine Stem Cell Virus-based vector).27 The miR-155 gene product 
and the MXW-pPGK-IRES-EGFP vector were a kind gift from Prof. Chen, Stanford 
University School of Medicine, Stanford, CA. Both the miR-cluster and miR-155 
fragments were sequence verified (StarSeq; see Supplementary Information). 
Retroviral overexpression of microRNAs in primary BM cells
Primary BM cells were isolated from B6 mice 4 days post intraperitoneal injection 
of 150 mg/kg 5-fluorouracil (Pharmachemie Haarlem), and cultured in StemSpan 
(StemCell Technologies) supplemented with 10% FCS, 300 ng/mL recombinant 
mouse  stem  cell  factor  (rmSCF;  Peprotech),  20  ng/mL  rmIL11  (R&D  systems),   
1  ng/mL  Flt3  ligand  (Amgen),  penicillin  and  streptomycin.  BM  cells  were 
transduced  by  transfecting  Phoenix  ecotropic  packaging  cells  with  1-2  μg  of 
pDNA  (MXW  empty  vector,  MXW-miR-cluster  99b/let-7e/125a  and  MXW-miR-
155) and 3-6 μl Fugene HD (Roche). Virus-containing supernatant harvested 48 
and 72 hours later was used to transduce 4-6x105 BM cells per 3.5 cm well. Three 
independent transductions were performed per condition per experiment. Five 
days after the first transduction, viable (negative for propidium iodide) EGFP+ 
cells were collected and tested in in vitro assays and collected in RNA lysis buffer 
(Qiagen) for gene expression studies. Non-sorted cells were tested in an in vivo 
BM transplantation setting.
Quantitative PCR validation
We  converted  selected  microRNAs  to  cDNA  using  the  TaqMan  MicroRNA 
Reverse Transcription Kit (Applied Biosystems). Next, real-time PCR with Taqman 
MicroRNA assays (Applied Biosystems) was performed using the iCycler system 
(Bio-Rad).  The  following  assays  were  used:  hsa-miR-99b  (assay  ID  000436), 
hsa-let-7e  (002406),  hsa-miR-125a-5p  (002198),  mmu-miR-155  (002571),  and 
snoRNA202  (001232).  The  comparative  delta-delta  Ct  approximation  method 
was used to analyze relative changes in gene expression.28 Each of the three 104 CHAPTER 6
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samples was analyzed in triplicate and normalized to the endogenous control 
snoRNA202.
CFU-GM and CAFC assays
A granulocyte-macrophage colony-forming unit (CFU-GM) assay was performed 
to  determine  the  number  of  progenitors  in  the  transduced  BM  population. 
EGFP+  cells  were  plated  in  methylcellulose  medium  supplemented  with  100 
ng/ml  recombinant  mouse  stem  cell  factor  (rmSCF;  Peprotech)  and  20  ng/ml 
recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-
CSF; R&D systems). After 6 days CFU-GM colonies were scored. Replating was 
performed to determine progenitor self-renewal capacity. The colonies from one 
plate were collected, washed three times with PBS, and all the cells were plated 
in new methylcellulose for an additional week. The cobblestone-area forming 
cell (CAFC) assay was performed as previously described.29 In this assay, early-
appearing cobblestones (day 7) are considered to represent progenitors and late-
appearing cobblestones (day 35) are considered to represent stem cells.30 CAFC 
frequencies were calculated using L-Calc (StemCell Technologies). For both of the 
in vitro assays at least two independent experiments were performed.
Primary BM transplantation
B6 BM cells were transplanted into lethally irradiated (9,5Gy, IBL 637 137Cs γ-source, 
CIS  Biointernational,  Gif-sur-Yvette,  France)  B6.SJL  recipients  without  prior 
sorting for EGFP expression. Per condition 9 mice (3 independent transductions 
x 3 mice) were transplanted with 5x106 cells each. At several time points post-
transplantation  blood  was  drawn  form  the  retro-orbital  plexus  and  blood  cell 
numbers were counted using a Medonic hematology analyzer (Boule Medical). 
Subsequently, erythrocytes were lysed in ammonium chloride solution and the 
remaining cells were stained with PE-labeled anti- CD45.2 (B6; clone 104), pacific 
blue-labeled anti-CD45.1 (B6.SJL; clone A20), APC-Cy7-labeled anti-Gr-1 (clone 
RB6-8C5),  PE-Cy7-labeled  anti-CD11b  (Mac1;  clone  M1/70),  pacific  orange-
labeled anti-CD45R/B220 (RA3-6B2; Invitrogen, Caltag Laboratories), and APC-
labeled anti-CD3ε (clone 145-2C11). Antibodies were purchased from BioLegend, 
unless otherwise specified. Data were acquired using an LSR II (BD Biosciences) 
and analyzed using FlowJo software (Tree Star). Three of the miR-cluster mice 
were sacrificed prior to the onset of morbidity (no signs of physical illness yet) 
at ~20 weeks post-transplantation, together with 3 empty vector and 3 miR-155 
mice. Four miR-cluster mice were sacrificed when they were moribund (6, 16, 19, 
and 21 weeks post-transplantation), 2 of which together with an empty vector 
mouse. Two miR-cluster mice were found dead at 15 and 30 weeks, preventing 
determination of the cause of death. Peripheral blood was drawn from the retro-
orbital plexus. Bone marrow cells were isolated from the 2 femurs, 2 tibias, and 
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were obtained by crushing the bones and filtering the resulting cell suspension. 
Spleens, livers, and lungs were isolated, and made into single cell suspensions. 
Cell  numbers  were  counted  using  a  Medonic  hematology  analyzer.  Cytospin 
preparations  were  made  from  BM,  spleen,  liver  and  lung  cells,  after  which   
May-Grünwald-Giemsa staining was performed. Also, these cells were stained 
using antibodies against CD45.2, CD45.1, Gr-1, CD11b, CD45R/B220, and CD3ε 
(as described in the previous section) and analyzed on an LSR II. Of each of the   
3  non-morbid  miR-cluster  mice  and  their  empty  vector  and  miR-155  controls 
viable EGFP+ cells were tested in CAFC assays, after which the miR-cluster and 
empty vector cells were also tested in a secondary BM transplantation.
Secondary BM transplantation
EGFP+ CD45.2+ BM cells from the primary miR-cluster and empty vector mice 
were transplanted in various cell doses in competition with freshly isolated wild 
type  CD45.1+  BM  cells  in  lethally  irradiated  recipients  (CD42.2).  Transplanted 
ratios were 4:1 (test to freshly isolated) for the empty vector-transduced cells and 
4:1 and 1:2 for the miR-cluster-transduced cells. For each of these ratios 15 mice 
(3 individual mice x 5 mice) were transplanted with a total of 5x106 cells each. 
The  competitive  repopulation  index  (CRI)  was  calculated  using  the  following 
formula: CRI = [(%EGFP+ CD45.2+ cells/ %CD45.1+ cells) / (ratio of EGFP+ cells/ 
CD45.1+ cells transplanted)]. Blood samples were taken on a 4 to 6 week basis to 
determine donor chimerism and CRI.
Downstream target analysis
Genome-wide  gene  expression  was  assessed  in  two  different  sample  types. 
First, BM samples transduced with empty vector, miR-cluster and miR-155 were 
profiled.  Second,  the  four  developmentally  related  hematopoietic  cell  types 
isolated from B6 and D2 mice that were profiled for microRNAs were also analyzed 
for  genome-wide  gene  expression  (independent  samples).  All  samples  were 
analyzed in triplicate. Total RNA was isolated using the RNeasy Mini Kit (Qiagen), 
after which RNA concentration, quality and integrity were measured using the 
Experion Automated Electrophoresis System (Bio-Rad). RNA was amplified using 
the Illumina TotalPrep RNA Amplification Kit (Ambion/Applied Biosystems) and 
hybridized to Sentrix MouseWG-6 v2.0 expression beadchips (Illumina) according 
to the manufacturer’s instructions. Hybridization and washing were performed by 
our in-house Genome Analysis Facility. Scanning was carried out on the iScan 
System (Illumina). Data were quality checked and extracted using GenomeStudio 
software (Illumina), without normalization or background subtraction. Data were 
thresholded at 1, log2-transformed and quantile normalized using GeneSpring 
GX11.0  (Agilent).  The  starting  data  set  represented  45.281  probes.  False 
positives were excluded by only pursuing with those probes that were flagged as 
marginal or present in all replicates in any 1 out of 3 or 8 conditions (depending 106 CHAPTER 6
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on experiment type; default detection p-values cut-off 0.8 for present and 0.6 
for absent were used for flags). Subsequently, a joint analysis of microRNA and 
gene  expression  data  was  performed  in  GeneSpring.  Predicted  (conserved) 
downstream microRNA targets were imported from the TargetScan database.31
URLs
All raw data were deposited in the NCBI Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo/). All processed microRNA and mRNA expression data 
on the four cell types from B6 and D2 mice were deposited on HemDb (http://
hemdb.org/;  currently  still  password-protected;  username:  guest,  password: 
hemdb).
RESULTS
Identification of cell type-dependent microRNA signatures
To identify cell type-dependent and mouse strain-dependent microRNAs in the 
hematopoietic system, we embarked on a microarray-based microRNA profiling 
study  of  four  developmentally  related  hematopoietic  cell  types  isolated  from 
the BM of B6 and D2 mice. We hybridized total RNA isolated from purified LSK 
multilineage cells, committed LS−K+ cells, erythroid TER-119+ cells and myeloid 
Gr-1+  cells  (Figure  1A)  to  Agilent  microRNA  arrays  and  evaluated  microRNA 
expression levels. In total, we analyzed 23 samples representing 4 different cell 
types and 2 different mouse strains. Of the 577 microRNAs profiled, 147 were 
expressed in at least 1 of these 8 conditions. To study the relationship between 
the  samples,  as  well  as  the  underlying  patterns  of  microRNA  expression,  we 
applied  an  unsupervised  two-way  hierarchical  clustering  method  using  the 
147  quality-filtered  microRNAs.  This  analysis  showed  that  the  cell  type  effect 
greatly exceeded the mouse strain effect (Figure 1B, top tree), and revealed 8 
distinct microRNA signatures (Figure 1B, left tree; Table S1). Of special interest is 
signature I consisting of microRNAs that are most highly expressed in LSKs and 
down-regulated upon differentiation. Signature I consists of miR-125a-5p, miR-
125b-5p, miR-126-3p, miR-130a, miR-155, miR-181d, miR-196b, miR-203, miR-
222, miR-31, miR-99a, miR-99b, and let-7e. Considering their expression pattern, 
these microRNAs may represent important factors that keep cells from leaving the 
stem cell state. Signature II consists of microRNAs that are most highly expressed 
in LS−K+ cells, signatures III and IV are specific to erythroid cells, and signatures VI 
and VIII to myeloid cells. Signature VII consists of microRNAs that are expressed 
in all cell types except for LSKs, and may therefore consist of microRNAs that 
are important for lineage specification, commitment and differentiation. Finally, 
signature V does not show a clear expression preference. We confirmed well-
known cell-type-specific microRNAs: e.g. miR-196b in signature I,32 miR-451 in 107  MICRORNA CLUSTER 99B/LET-7E/125A REGULATES HSPCS
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erythroid  signature  III,33  and  miR-223  in  myeloid  signature  VIII.19;20  The  entire 
microRNA expression dataset is available (Table S1 and in GEO), and queries for 
specific microRNAs can be done on www.hemdb.org.
Identification of mouse strain-dependent miR-cluster 99b/let-7e/125a 
An  analysis  of  variance  (2-way  ANOVA,  corrected  p-value  <0.05)  yielded  131 
differentially expressed microRNAs, all of which showed a cell type effect and of 
which 15 also showed a mouse strain effect (Figure 1C, Table S1). In total, 4 of 
the 15 mouse-strain-dependent microRNAs were present in signature I, namely 
miR-125a, miR-125b, miR-130a and miR-99b. They were all most highly expressed 
in the primitive cell compartment and down-regulated upon differentiation and 
generally higher expressed in D2 cells compared to B6 cells. These 2 criteria qualify 
those  microRNAs  as  potential  candidates  regulating  HSPC  traits.  Interestingly 
however, 2 out of these 4, miR-125a and miR-99b are part of an evolutionary 
conserved  microRNA  cluster  that  is  localized  on  chromosome  17:  miR-cluster 
99b/let-7e/125a (Figure 1D). The third member of this cluster, let-7e, shows an 
expression pattern comparable to the other 2 members (Figure 1E), but its strain 
effect did not reach statistical significance (corrected p-value = 0.064). In addition, 
miR-125b is present in two paralogous microRNA clusters that are located on 
chromosomes 9 and 16 (Figure 1F). Since the three paralogous microRNA clusters 
have identical seed sequences and therefore identical (predicted) downstream 
targets, it is the cumulative expression pattern of these three clusters that should 
be  taken  into  consideration.  The  chromosome  9  cluster  consists  of  miR-100, 
let-7a and miR-125b and the chromosome 16 cluster consists of miR-99a, let-7c 
and miR-125b. Although not all microRNA cluster members display a significant 
mouse strain effect, they all follow the same expression trend across cell types 
and mouse strains (Figure 1G). This view corroborates previous observations that 
proximal pairs of microRNAs (separated by <50 Kb) are generally co-expressed 
across tissues.34 
Overexpression of miR-cluster 99b/let-7e/125a retains HSPCs in  
a primitive state
To assess whether differential expression of these microRNA clusters could have 
functional  consequences  for  HSPCs,  and  could  be  causal  for  the  phenotypic 
differences between HSPCs from B6 and D2 mice, we performed a gain-of-function 
study for one of the three paralogous clusters: miR-cluster 99b/let-7e/125a. We 
cloned the entire cluster (in its natural genomic context) in a retroviral vector 
containing a constitutively active pol II promoter. We overexpressed the entire miR-
cluster 99b/let-7e/125a and also miR-155 (known to affect HSPC characteristics 
and  therefore  used  as  a  positive  control21)  in  BM  from  5-FU-treated  B6  mice 
(Figure 2A). Transduced cells were sorted and overexpression of the individual 108 CHAPTER 6
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members of the miR-cluster and miR-155 was validated using qPCR (Figure 2B). 
Concurrently, these cells were used to initiate colony-forming unit- granulocyte/ 
macrophage (CFU-GM) replating assays and cobblestone area-forming cell (CAFC) 
assays. The CFU-GM replating assay, in which we tested for myeloid progenitor 
self-renewal, revealed that both the miR-155 and the miR-cluster overexpressing 
cells had acquired the capacity to form secondary colonies upon replating (Figure 
2C). The CAFC assay, a surrogate in vitro assay to quantify the number of HSPCs,29;30 
revealed even more striking differences. At day 7, which is the time point at which 
normally progenitor cells show activity, no differences were observed between 
the control and microRNA-overexpressing cells. However, at day 35, which is the 
time point at which stem cells are considered to show activity, a striking difference 
in the number of CAFCs was observed. The miR-155 overexpressing cells gave 
~15-fold more CAFCs (1 in 26.000 for miR-155 versus 1 in 450.000 for control), 
whereas the miR-cluster overexpressing cells yielded a striking ~6.500-fold more 
CAFCs (1 in 70 for miR-cluster versus 1 in 450.000 for control) (Figure 2D). For the 
miR-cluster, a substantial amount of CAFC activity remained even up till day 70 (at 
that point still 1 in 50.000, data not shown). 
To  summarize,  BM  cells  overexpressing  miR-cluster  99b/let-7e/125a  or 
miR-155 showed increased replating capacity in CFU-GM assays and increased 
day-35 CAFC activity. Collectively, these data suggest that overexpression of the 
miR-cluster retains cells in a primitive state.
Figure 1. Genetic screen identifies cell type and mouse strain-dependent microRNAs. 
(A) MicroRNA expression was evaluated in four developmentally related cell types isolated 
from the BM of C57BL/6 and DBA/2 mouse strains. (B) Hierarchical clustering was performed 
using the 147 quality-filtered probes (Euclidean distance, complete linkage). Samples are in 
columns, microRNAs in rows. For each probe, data were median-centered, with the lowest 
and highest intensity values in blue and red, respectively. Of each of the 8 microRNA signa-
tures the average expression across cell types and mouse strains is shown (y-axis represents 
log2 expression ranging from –4 till 8). The number in the graphs indicates the number of 
microRNAs per signature. (C) Venn diagram showing the number of differentially expressed 
microRNAs between cell types and mouse strains. (D) An evolutionary conserved microRNA 
cluster, consisting of miR-99b, let-7e and miR-125a, located on mouse chromosome 17.   
(E) Expression of miR-cluster 99b/let-7e/125a members across cell types and mouse strains 
(axes: as in B). Shown is the mean +/− standard deviation. (F) Paralogous microRNA clusters 
on chromosomes 9 and 16. (G) Expression of miR-100, miR-99a and miR-125b across cell 
types and mouse strains (axes: as in B). For miR-125b only the cumulative expression of 
the chromosome 9 and 16 cluster could be assessed. Expression of let-7a and let-7c is 
not shown, as only the cumulative expression from multiple different genomic locations 
(including other chromosomes than 9, 16 and 17) could be assessed. Shown is the mean 
+/− standard deviation. LT, long-term; ST, short-term; CMP, common myeloid progenitor; 
MEP, megakaryocyte-erythrocyte progenitor; GMP, granulocyte-macrophage progenitor.110 CHAPTER 6
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Figure 2. Overexpression of miR-cluster 99b/let-7e/125a fixes HSPCs in a primitive 
state.  (A)  Schematic  representation  of  the  retroviral  vectors  used  to  overexpress  miR-
cluster 99b/let-7e/125a and miR-155. (B) Quantitative RT-PCR data showing the expres-
sion levels of the miR-cluster members and miR-155 upon overexpression relative to the 
endogenous control snoRNA202. Shown is the mean +/− standard deviation. (C) Colony-
forming unit-granulocyte/ macrophage data showing primary (1) and secondary (2) colony 
numbers. Shown is the mean +/− standard deviation. (D) Cobblestone area-forming cell 
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Sustained expression of miR-cluster 99b/let-7e/125a in HSPCs results 
in MPNs
We next assayed the microRNA-overexpressing cells in a long-term competitive 
repopulation experiment in vivo. To achieve this, miR-cluster 99b/let-7e/125a and 
miR-155 were overexpressed in B6 cells (CD45.2) after which 5x106 non-sorted 
cells were transplanted into lethally irradiated B6.SJL recipients (CD45.1). At 10 
weeks post-transplantation, blood cell counts revealed a significant reduction in 
white blood cells, red blood cells and platelets for mice reconstituted with miR-
cluster-overexpressing cells. Although the decrease was less dramatic, a similar 
effect could be observed for the mice reconstituted with miR-155-overexpressing 
cells (Figure 3A). At this point in time, chimerism was assessed by quantifying 
the percentage of EGFP+ cells within the CD45.2+ donor fraction. Whereas within 
10 weeks the chimerism levels of the control mice remained relatively stable at 
50%, those of the miR-155 mice increased from 15% to 45%, and those of the 
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Figure 3. Sustained expression of miR-cluster 99b/let-7e/125a disturbs hematopoiesis. 
(A) White blood cell, red blood cell and platelet counts at 10 weeks post-transplantation (n = 
8/9 mice per group). P values (**, 0.001<p<0.01; ***, p<0.001) are displayed (Mann-Whitney 
test). (B) Chimerism levels were assessed at 10 weeks post-transplantation by analyzing the 
percentage of EGFP+ cells in the donor fraction (n = 8/9 mice per group). The arrows indicate 
the increase in chimerism levels over the first 10 weeks post-transplantation. (C) Cell type 
distribution in the blood as assessed by FACS (n = 8/9 mice per group). Shown is the mean 
+/− SEM. (D) Survival of mice (n = 6 mice per group). The grey box indicates the time point 
analyzed in the other panels. WBC, white blood cells; RBC, red blood cells; PLT, platelets; 
GM, granulocytes/macrophages; B, B-lymphocytes; T, T-lymphocytes; O, other cell types.112 CHAPTER 6
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miR-cluster mice increased from 35% to 90%, indicating that in the latter two 
cases the microRNA-transduced cells had a competitive advantage over the non-
transduced cells (Figure 3B). Detailed FACS analysis revealed that the EGFP+ cells 
in the miR-cluster mice were enriched for granulocytes/macrophages (defined 
as being Gr-1+ and/or Mac-1+) at the expense of the number of B lymphocytes 
(B220+) (Figure 3C). Clearly, hematopoiesis was disturbed in these mice, and this 
appeared to be not without consequences, as all miR-cluster mice died within 30 
weeks post-transplantation (Figure 3D).
To obtain more insight into the type of hematologic malignancy in the miR-
cluster mice, we performed pathological analyses on 3 mice prior to the onset 
of morbidity at 20 weeks post-transplantation and on 4 mice when they were 
moribund  (6,  16,  19,  and  21  weeks  post-transplantation).  We  compared  our 
findings with analyses on mice reconstituted with empty vector and miR-155-
transduced cells. The peripheral blood analysis revealed that all the moribund 
mice displayed higher WBC counts compared to the non-morbid mice. Among 
these moribund mice, there was one clearly leukemic (and one potentially pre-
leukemic)  mouse  (Figure  4A).  Compared  to  the  empty  vector  mice,  the  miR-
cluster mice had whitish bones, lower BM cellularities, and increased spleen sizes 
Figure  4.  Sustained  expression  of  miR-cluster  99b/let-7e/125a  induces  MPNs  with   
occasional progression to leukemia. (A) PB WBC counts for empty vector, miR-cluster and 
miR-155 mice at time of sacrifice. Closed/black squares represent non-morbid miR-cluster 
mice, whereas open/red squares represent moribund miR-cluster mice. (B) Photographs of 
femur and tibia bones, BM cellularity (representing 2 femurs, 2 tibias and pelvic bones) and 
spleen weight for empty vector, miR-cluster and miR-155 mice at time of sacrifice. Closed/
black squares represent non-morbid miR-cluster mice, whereas open/red squares represent 
moribund miR-cluster mice. P values (*, 0.01<p<0.05; **, 0.001<p<0.01) are displayed 
(Mann-Whitney test). (C) Percentage EGFP+ cells in PB, BM and spleen (n=5 for EV, n=6 for 
CLUS, n=3 for 155). Non-morbid and moribund miR-cluster mice showed similar percent-
ages and were therefore combined. Shown is the mean +/− SEM. (D) Cell type distribution 
in PB, BM and spleen of empty vector, miR-cluster and miR-155 mice as assessed by FACS. 
Shown is the mean +/− SEM. Data for non-morbid and moribund mice are shown separately 
for PB (n=5 for EV, n=3 for non-morbid (N) CLUS, n=3 for moribund (M) CLUS, n=3 for 155) 
and combined for BM and spleen (n=5 for EV, n=6 CLUS, n=3 for 155), because the cell 
type distributions between these mice differed in PB, but not in BM and spleen. (E) Repre-
sentative May-Grünwald-Giemsa-stained cytospin preparations from BM and spleen cells. 
For the miR-cluster, two pictures are shown: one representative of a non-morbid mouse (N) 
and one of the clearly leukemic mouse (L). (F) Cobblestone area-forming cell (CAFC) data 
showing the number of HSPCs in the EGFP+ BM fraction of 3 individual empty vector, (non-
morbid) miR-cluster and miR-155 mice at ~20 weeks post-transplantation. (G) Competitive 
repopulation indexes (CRI) calculated for EGFP+ BM cells isolated from 3 individual empty 
vector and (non-morbid) miR-cluster mice at ~20 weeks post-transplantation, compared to 
freshly isolated BM cells. Transplanted ratios were 4:1 (test to freshly isolated) for the empty 
vector-transduced cells and 4:1 and 1:2 for the miR-cluster-transduced cells. Calculations 
were done 16 weeks after secondary transplantation. For the miR-cluster-transduced cells 
1 outlier with a CRI of 1.3 was removed from this analysis. WBC, white blood cells; GM, 
granulocytes/macrophages; B, B-lymphocytes; T, T-lymphocytes; O, other cell types.114 CHAPTER 6
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(Figure 4B). Subsequent FACS analyses revealed that the PB, BM and spleens of 
the miR-cluster mice were dominated by EGFP+ cells (Figure 4C) that were mostly 
of myeloid (defined as being Gr-1+ and/or Mac-1+) origin (Figure 4D). This latter 
finding was corroborated by morphological analyses of MGG-stained cytospin 
preparations (Figure 4E). The livers and lungs of the miR-cluster mice were also 
infiltrated by these EGFP+ myeloid cells (data not shown). Taken together, these 
data  show  that  all  miR-cluster  mice  suffered  from  MPNs  that  in  some  cases 
progressed to leukemia. In the miR-155 mice an opposite phenotype could be 
observed, as the EGFP+ cells in the PB, BM and spleens of these mice were mostly 
of lymphoid (defined as being B220+ or CD3+) origin (Figure 4D and 4E).
Competitive advantage provided by miR-cluster 99b/let-7e/125a 
decreases over time
To determine the quantity of HSPCs in the BM compartments of the non-morbid 
miR-cluster mice and their empty vector and miR-155 controls, we performed CAFC 
assays on EGFP+ BM cells. To recapitulate: before we transplanted these cells we 
found ~15-fold more day-35 CAFCs for miR-155-transduced cells and a striking 
~6.500-fold more day-35 CAFCs for the miR-cluster-transduced cells. At 20 weeks 
post-transplantation the miR-cluster-transduced cells still exhibited more day-35 
CAFC activity compared to empty vector-transduced cells, whereas this was not 
the case for the miR-155-transduced cells (Figure 4F). However, it should be noted 
that for the miR-cluster-transduced cells the fold increase in day-35 CAFC activity 
dropped from ~6.500 to ~400 in this 20 week time frame in vivo. 
To determine the quality of the HSPCs in the BM compartments of the miR-
cluster and empty vector mice, we performed a secondary BM transplantation. 
We evaluated the in vivo repopulating ability of CD45.2+ EGFP+ cells isolated 
from  the  BM  of  the  primary  recipients  by  transplanting  them  in  competition 
with  freshly  isolated  CD45.1+  BM  cells.  We  next  determined  the  competitive 
repopulation index (CRI), a relative measurement of the competitive ability of 
the CD45.2+ EGFP+ test cells to that of the freshly isolated CD45.1+ BM cells. 
A CRI value of 1 would by definition mean equal repopulation potential of both 
cell  populations.  At  16  weeks  post-transplantation,  we  found  CRI  values  of 
~0.06 for both the empty vector and miR-cluster-transduced test cells (i.e. their 
repopulation  potential  was  ~17-fold  lower  compared  to  freshly  isolated  cells) 
(Figure 4G). A CRI value of 0.06 is around what would be expected for control cells 
after a single serial transplantation.35 These data indicate that whereas the miR-
cluster-transduced cells may have had a profound initial competitive advantage in 
the primary recipients, this was lost in the secondary recipients.
To summarize, we found that overexpressing the miR-cluster in HSPCs indeed 
conferred a competitive advantage to engrafting hematopoietic cells in an in vivo 
transplant setting, ultimately resulting in MPNs with occasional progression to 
leukemia. Yet, this competitive advantage appeared to be of temporary nature.115  MICRORNA CLUSTER 99B/LET-7E/125A REGULATES HSPCS
6
In search of functional miR-cluster 99b/let-7e/125a targets
To understand the molecular mechanisms by which miR-cluster 99b/let-7e/125a 
is able to module HSPC fate, it is essential to identify the genes regulated by 
this  microRNA  triplet.  Many  different  computational  algorithms  have  been 
developed which can be used for microRNA target prediction. TargetScan is one 
of the most widely used algorithms and predicts 48, 712, and 572 evolutionary 
conserved targets for miR-99b, let-7e, and miR-125a, respectively.31 However, it 
remains challenging to select the functionally relevant targets from the long list 
of predicted ones. 
Our first strategy to narrow down the list of predicted targets to functionally 
relevant ones was to select only those targets whose expression reacts on changing 
microRNA  expression  levels.  To  achieve  this  for  the  miR-cluster  and  miR-155 
(included as a control again), we performed Illumina WG6 gene expression arrays 
on empty vector, miR-cluster and miR-155-transduced cells. Viable EGFP+ cells 
were FACS-purified 5 days after the first transduction (the exact time point at 
which the before-mentioned in vitro and in vivo assays were initiated). Of the 
45.281 probes, 25.808 were expressed in at least 1 of the 3 conditions (empty 
vector, miR-cluster, and miR-155). In this list of quality-filtered probes we identified 
912 predicted targets of the miR-cluster and 164 of miR-155. We then visualized 
the expression levels of these predicted targets upon overexpression of the miR-
cluster and miR-155 (Figure 5A). This analysis showed that the expression of most 
of the predicted miR-cluster targets was indeed mildly affected in the miR-cluster-
transduced cells, but not in the miR-155-transduced cells. In contrast, most of 
the miR-155 targets were only affected in the miR-155-transduced cells, but not 
in the miR-cluster-transduced cells. These results confirm previous reports that 
the primary function of microRNAs is to fine-tune gene expression (i.e. they do 
not function as master regulators). From the list of predicted miR-cluster targets 
we subsequently selected those probes that were at least 1.2 fold differentially 
expressed upon overexpression of the miR-cluster. This resulted in 9 probes that 
were up-regulated and 71 probes that were down-regulated upon miR-cluster 
overexpression.  These  latter  71  represented  64  genes  that  would  qualify  as 
candidate functional targets as they represent predicted targets that are indeed 
down-regulated  upon  miR-cluster  overexpression.  The  entire  gene  expression 
dataset is available (Table S2 and in GEO).
Our second strategy to narrow down the list of predicted targets to functionally 
relevant ones was to correlate the expression levels of the predicted miR-cluster 
targets  with  the  expression  of  the  miR-cluster  itself  in  primary,  unperturbed, 
hematopoietic  cells.  We  reasoned  that  the  naturally  occurring  variation  in 
microRNA expression should at least have consequences on the mRNA level in 
order to affect any HSPC traits. Therefore, we also performed Illumina WG6 gene 
expression arrays on the same four developmentally related cell types isolated 
from B6 and D2 mouse strains that were also profiled for microRNAs. Of the 116 CHAPTER 6
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45.281 probes, 26.594 were expressed in at least 1 of the 8 conditions (four cell 
types, two mouse strains). In this list of quality-filtered probes we identified 909 
predicted targets of the miR-cluster. We correlated their expression levels with 
the expression of the miR-cluster (average of three individual members) across 
the  8  different  conditions,  and  selected  the  96  most  anti-correlated  probes 
(Pearson similarity values between −0.6 and −1.0). These 96 probes represented 
Figure 5. Identification of candidate functional miR-cluster targets. (A) Visualization of 
expression of all quality-filtered predicted miR-cluster and miR-155 targets in miR-cluster-
transduced and miR-155-transduced cells. Shown are MvA plots comparing two samples. 
The log2 ratio of each probe (expression difference) is plotted versus the log2 mean for 
each probe. The red lines represent the best fit to the data. In these plots the predicted 
targets that are shared between the miR-cluster and miR-155 are not displayed. (B) Hier-
archical clustering (Euclidean distance, complete linkage) was performed using the qual-
ity-filtered predicted miR-cluster targets that were most anti-correlated with miR-cluster 
expression (Pearson similarity values between −0.6 and −1.0). Conditions are in columns, 
mRNA probes in rows. For each probe, data were median-centered, with the lowest and 
highest intensity values in blue and red, respectively. (C) Venn diagram identifying 11 genes 
that were both down-regulated upon miR-cluster overexpression in an artificial system and 
anti-correlated with miR-cluster expression in the natural system. In addition, the individual 
members of the miR-cluster are shown with their candidate functional targets.
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81 different genes. The entire gene expression dataset is available (Table S3 and 
in GEO). To visualize gene expression in the four cell types and two mouse strains 
queries for specific genes can be done on www.hemdb.org. 
Finally, we combined our list of 64 genes that were 1.2 fold down-regulated 
upon miR-cluster overexpression with our list of 81 most anti-correlated genes 
in unperturbed primary cells, and identified 11 overlapping ones (Figure 5C), 
namely Brpf1, Ccdc100, E2f2, Gas7, Klf13, Lbh, Mtus1, Ndst2, Riok3, Slc46a3, 
and Trabd. Two genes in the list of 11 candidate functional miR-cluster targets 
were identified by 2 distinct probes, making them especially strong candidate 
targets. The first one, E2f2, is a well-known critical regulator of the cell cycle 
and has already been experimentally validated as a direct target of the let-7 
family.36 It has previously been shown that the combined loss of both E2f1 and 
E2f2 in mice results in severely impaired hematopoiesis with impeded S-phase 
progression in hematopoietic progenitors, impeded erythroid maturation, and 
increased apoptosis during B-cell maturation.37;38 Clearly, these findings are in line 
with at least part of our observations regarding the miR-cluster gain-of-function 
phenotype. Interestingly, E2f2 is a predicted target of both let-7 and miR-155. 
Upon miR-155 overexpression E2f2 was also clearly down-regulated, potentially 
explaining some of the similarities in the miR-cluster and miR-155 gain-of-function 
phenotypes (e.g. both providing HSPCs with an initial competitive advantage in 
vivo). The second candidate functional miR-cluster target that was identified by 
two distinct probes is Riok3, a relatively unknown gene predicted to be targeted 
by  the  let-7  family.  Recently,  it  has  been  shown  to  be  essential  for  erythroid 
chromatin condensation and enucleation,39 suggesting that the down-regulation 
of  this  gene  in  our  miR-cluster  mice  could  have  contributed  to  the  observed 
impeded  erythroid  maturation.  Future  studies  are  needed  to  experimentally 
validate the candidate functional miR-cluster targets. 
DISCUSSION
In this report, we set out to determine whether the observed natural variation 
in HSPC traits across the genetically distinct mouse strains B6 and D2 could be 
due to natural variation in microRNA expression. We performed a genome-wide 
microRNA expression study of LSK, LS−K+, erythroid and myeloid cells isolated 
from  B6  and  D2  mouse  strains,  and  detected  natural  variation  in  microRNA 
expression  between  these  two  mouse  strains.  Of  special  interest  was  an 
evolutionary conserved miR-cluster located on chromosome 17 consisting of miR-
99b, let-7e and miR-125a. All cluster members were most highly expressed in 
LSKs and down-regulated upon differentiation and generally higher expressed in 
D2 cells compared to B6 cells. We found that overexpression of this miR-cluster 
conferred a competitive advantage to HSPCs, but also that mice reconstituted with 
these cells developed MPNs that occasionally progressed to leukemia. Finally, we 118 CHAPTER 6
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identified 11 candidate functional targets through which the miR-cluster could 
modulate HSPC fate.
While we were performing our final experiments, Guo et al. reported that 
mir-99b,  let-7e  and  miR-125a  were  enriched  in  long-term  HSCs  (LSK/CD34−/
Flk2−)  and  that  BM  cells  overexpressing  this  microRNA  triplet  displayed 
enhanced reconstitution after transplantation. More specifically, they found that 
overexpression of miR-125a alone, but not miR-99b or let-7e alone, could amplify 
the  HSC  pool.  This  result  was  shown  to  be  accomplished  by  decreasing  the 
level of apoptosis in hematopoietic progenitors through targeting pro-apoptotic 
genes such as Bak1.40 In our mRNA dataset on miR-cluster-overexpressing cells 
we could not confirm the down-regulation of Bak1. This discrepancy could be 
due to the fact that Guo et al. determined the down-regulation of Bak1 on the 
protein  level  instead  of  mRNA  level  and/or  that  they  determined  the  down-
regulation in cell lines instead of primary cells. Concurrently, O’Connell et al. 
reported that overexpression of miR-125b caused dose-dependent MPNs that 
progressed to a lethal acute myeloid leukemia (AML), and also provided evidence 
that miR-125b promotes hematopoietic engraftment of human HSCs.41 Soon after 
these two initial reports on the miR-125 family in HSCs appeared, Bousquet et 
al. reported that overexpression of miR-125b could not only cause MPNs, but 
also B-cell acute lymphoblastic leukemia and T-cell acute lymphoblastic leukemia. 
Also, they provided evidence that miR-125b confers a proliferative advantage to 
leukemic cells.42 Finally, Ooi et al. reported that overexpression of miR-125b in 
HSCs enhances their function and enriches for lymphoid-balanced and lymphoid-
biased HSCs. They also described that a skewing towards the lymphoid lineage 
could  be  observed  in  the  peripheral  blood  of  these  mice,  and  that  a  small 
subset of them developed a lymphoproliferative disease. In search of miR-125b 
targets, they performed a genome-wide mRNA expression study of miR-125b-
overexpressing LSKs isolated from transplanted recipients. They selected the top 
list of predicted targets that were down-regulated upon miR-125b overexpression 
and that had a link to apoptosis, and identified Bmf and Klf13 as downstream 
targets.43 Whereas in our dataset we could not confirm the down-regulation of 
Bmf upon miR-cluster overexpression, Klf13 did pop up in our list of 11 candidate 
functional  targets  (without  even  pre-selecting  for  apoptosis-related  genes).  In 
another study, Klf13 has already been experimentally validated as a direct target 
of the miR-125 family.44 
Collectively, our data and these recent reports point to an important role for 
the miR-125 family in hematopoiesis. It is interesting, yet confusing, to see that 
all the reports on the miR-125 family in HSCs describe distinct gain-of-function 
phenotypes (from no- to myeloid- to lymphoid malignancies). As suggested by 
O’Connell  et  al.  differences  in  overexpression  levels  probably  underlie  these 
phenotypic differences. The overexpression levels in our experiments were similar 
to those of O’Connell et al, probably explaining the similarity in both of our gain-
of-function phenotypes. The differences that remain between the two phenotypes 119  MICRORNA CLUSTER 99B/LET-7E/125A REGULATES HSPCS
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are likely to be due to miR-99b and let-7e that were in our case simultaneously 
overexpressed with the miR-125 family member.
An interesting observation was that overexpression of the miR-cluster conferred 
a striking initial competitive advantage to HSPCs, but that this advantage was lost 
over time. This observation relates to the differences in HSPC traits between B6 
and D2 mice. First, hematopoietic recovery by B6 and D2 stem cells has been 
studied in a competitive transplantation setting and has uncovered interesting 
kinetics. Whereas D2 hematopoiesis was predominant initially, it was eclipsed by 
B6 hematopoiesis over time.45 Second, 2.6% of B6 stem cells has been shown to 
be in S-phase of the cell cycle, versus a striking 24% of D2 stem cells.3 Together, 
these findings indicate that the increased proliferation rate for D2 stem cells may 
have provided them with an initial competitive advantage, but that this increased 
cycling rate also made them exhaust more rapidly. Because of the resemblance 
with the miR-cluster gain-of-function phenotype, we consider it plausible that the 
differential expression of miR-cluster 99b/let-7e/125a (and thus its targets) may 
at least be in part responsible for the observed variation in stem cell cycling and 
repopulation kinetics between B6 and D2 mouse strains. 
To conclude, we uncovered the existence of natural variation in microRNA 
expression  between  mouse  strains,  and  showed  that  this  may  contribute  to 
the observed natural variation in HSPC traits. We anticipate that future genetic 
studies will shed new light on how microRNAs modulate HSPC fate and on how 
they themselves are regulated.
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7AbSTRACT
Clonal  analysis  is  important  for  many  areas  of  hematopoietic  stem  cell 
research,  including  in  vitro  cell  expansion,  gene  therapy,  and  cancer 
progression  and  treatment.  A  common  approach  to  measure  clonality  of 
retrovirally  transduced  cells  is  to  perform  integration  site  analysis  using 
Southern blotting or polymerase chain reaction-based methods. Although 
these methods are useful in principle, they generally provide a low-resolution, 
biased, and incomplete assessment of clonality. To overcome those limitations, 
we labeled retroviral vectors with random sequence tags or “barcodes”. On 
integration, each vector introduces a unique, identifiable, and heritable mark 
into the host cell genome, allowing the clonal progeny of each cell to be 
tracked over time. By coupling the barcoding method to a sequencing-based 
detection system, we could identify major and minor clones in 2 distinct cell 
culture systems in vitro and in a long-term transplantation setting. In addition, 
we demonstrate how clonal analysis can be complemented with transgene 
expression and integration site analysis. This cellular barcoding tool permits 
a simple, sensitive assessment of clonality, and holds great promise for future 
gene therapy protocols in humans, and any other applications when clonal 
tracking is important.125 CELLULAR BARCODING TOOL FOR CLONAL ANALYSIS
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INTRODUCTION
Hematopoiesis involves the tightly coordinated process of blood cell production, 
and is maintained by a small number of hematopoietic stem cells (HSCs). Resolving 
the exact number of HSCs that actively contributes to hematopoiesis at any given 
time and tracking the contribution of individual HSCs to each of the different 
blood  cell  lineages  is  important  for  a  better  understanding  of  both  normal 
and malignant hematopoiesis. Performing such analyses in systems containing 
multiple HSC-derived clones has remained challenging because under normal 
circumstances  the  progeny  of  genetically  identical  HSCs  are  indistinguishable 
from each other. Therefore, analyzing the behavior of normal HSC clones has 
been  limited  to  measuring  their  behavior  on  an  individual  basis  by  limiting 
dilution1-3 or single purified cell4-6 assays. However, clonal analysis has also been 
successful in hematologic disorders in which abnormal cells often descend from 
a single common ancestor, and in which malignant clones could be identified by 
tracking unique genetic rearrangements, deletions or point mutations (reviewed 
in Gilliland et al7). 
The realization that unique genetic mutations could be exploited for clonal 
analysis, combined with the discovery that retroviral vectors could be used to 
introduce  new  genetic  material  into  HSCs,8-10  led  to  the  development  of  an 
alternative method to perform clonal analysis on hematopoietic cell populations. 
In recipients that received a transplant with retrovirally transduced HSCs, it was 
possible  to  distinguish  between  different  HSC-derived  clones  by  considering 
retroviral  integration  sites  as  unique  clonal  marks.11;12  In  this  type  of  analysis, 
genomic  DNA  is  fragmented  with  restrictases  that  cut  within  the  vector  and 
throughout the genome, resulting in fragments that consist of a small part of the 
vector and adjacent genomic DNA. Different integration sites thereby generate 
fragments  of  different  lengths  that  can  be  detected  by  Southern  blotting.13-15 
Alternatively, these fragments can be amplified with the use of polymerase chain 
reaction (PCR)-based approaches in which linear fragment ends are self-ligated 
(inverse PCR),16 or in which primer tags are attached to the fragment ends (e.g. 
ligation-mediated  PCR  and  linear  amplification-mediated  PCR).17;18  Although 
these  retroviral  marking  experiments  did  confirm  the  long-term  self-renewal 
activity  and  multilineage  differentiation  potential  of  HSCs,  the  methods  used 
have serious shortcomings and could therefore provide only a rough estimation of 
clonality. Southern blotting relies on restriction digestions; therefore, integrations 
without an appropriately positioned restriction site cannot be detected. Further,   
the method lacks sensitivity as well as discriminatory power to count the total 
number of integrated vectors. Although the PCR-based approaches are more 
sensitive, they still depend on restriction digestions and are prone to experimental 
error  because  of  unequal  PCR  amplification  caused  by  variations  in  template 
melting properties and relative differences in fragment length.126 CHAPTER 7
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To overcome these limitations, we constructed a retroviral plasmid library that 
consisted of vectors containing a variable random sequence tag or “barcode”. On 
stable chromosomal integration, this barcode introduces a unique, identifiable, 
and heritable mark into the genome, allowing the clonal progeny of the host cell 
to be tracked over time. Here, we couple the concept of cellular barcoding to 
a sequencing-based detection system, and show the efficacy of the barcoding 
method to track clonal dynamics in 2 distinct cell culture systems in vitro and in 
a hematopoietic transplantation setting in vivo. We also show that this cellular 
barcoding method can be complemented with transgene expression analysis and 
integration site analysis, providing additional layers of information.
METHODS
Mice
C57Bl/6  (CD45.2)  and  DBA/2  mice  were  purchased  from  Harlan.  C57Bl/6.SJL 
(CD45.1)  mice  were  bred  and  all  animals  were  housed  at  the  Central  Animal 
Facility of the University of Groningen. All animal experiments were approved by 
the Groningen University Animal Care Committee.
Construction of barcoded vector libraries
The SF91 vector was kindly provided by Prof. C. Baum (Hannover Medical School, 
Hannover,  Germany),  and  the  MIEV  vector  was  kindly  provided  by  Prof.  C. 
Jordan (University of Rochester, Rochester, NY). The barcode linker was created 
by annealing two 5’ phosphorylated primers (forward, 5’-GTACAAGTAANNAT-
CNNGATSSAAANNGGTNNAACNNTGTAAAACGACGGCCAGTGAG-3’; reverse, 
5’-GATCCTCACTGGCCGTCGTTTTACANNGTTNNACCNNTTTSSATCNN- 
GATNNTTACTT-3’;  Biolegio).  Primers  were  dissolved  in  0.5x  ligation  buffer 
(Fermentas) at a concentration of 100 µM. After heating the mixture for 5 min at 
95°C, the primers were allowed to anneal at gradually decreasing temperature. 
The annealed barcode linker was ligated into the BsrGI-BamHI site of the SF91 or 
MIEV vector (Figure 1A) at equimolar ratio. The resulting vector was transformed 
into 10-beta competent Escherichia coli cells (New England Biolabs) and grown 
overnight on LB plates supplemented with 50 μg/ml ampicillin (Sigma-Aldrich). 
Colonies were pooled by flushing plates with LB supplemented with 50 μg/ml 
ampicillin. After overnight culture, plasmid DNA was extracted using the GenElute 
HP Plasmid Midiprep Kit (Sigma-Aldrich). 
Validation of barcoded vector library
From  an  SF91  vector  library  created  by  combining  ~800  bacterial  clones, 
barcode sequences were amplified using primers directed against internal vector 
sequences  (SF91  eGFP  forward,  5’-CTGCCCGACAACCACTACCTG-3’;  SF91 127 CELLULAR BARCODING TOOL FOR CLONAL ANALYSIS
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WPRE  reverse:  5’-CCCTAAAAATGTAAATGATTGCCCCACC-3’).  The  resulting 
mixture of equal-sized PCR products (i.e. “crude” PCR product) was purified and 
sequenced by ServiceXS or StarSEQ using a primer directed against eGFP (eGFP 
forward: 5’-GCGATCACATGGTCCTGCTG-3’). The complexity of this SF91 library 
was validated by retransforming it into 10-beta competent E. coli (New England 
Biolabs). Single colonies were picked and grown in LB supplemented with 50 μg/
ml ampicillin and 30 μg/ml kanamycin (Sigma-Aldrich). Plasmid DNA from each 
bacterial clone was isolated using the GeneJET Plasmid Miniprep Kit (Fermentas) 
and  sequenced  using  the  same  primers  as  for  the  “crude”  PCR  sequencing. 
Pictogram  (http://genes.mit.edu/pictogram.html)  was  used  to  visualize  the 
combined monoclonal sequence traces.
Cell culture
The 32D (murine myeloid progenitor) cell line was cultured in RPMI-1640 medium 
with  L-glutamine  (PAA  Laboratories)  supplemented  with  10%  FBS,  penicillin 
and streptomycin (Invitrogen) and 10 ng/mL recombinant murine interleukin-3 
(R&D Systems). Bone marrow (BM) cells were isolated from mice 4 days after 
intraperitoneal injection of 150 mg/kg 5-fluorouracil (Pharmachemie Haarlem), 
and  cultured  in  StemSpan  (StemCell  Technologies)  supplemented  with  10% 
fetal bovine serum, 300 ng/mL polyethylene glycol-complexed recombinant rat 
stem cell factor (Amgen), 20 ng/mL rmIL11 (R&D systems), 1 ng/mL Flt3 ligand 
(Amgen), penicillin and streptomycin. 
Retroviral transduction procedure
The 32D cell line and primary BM cells were transduced as previously described.19 
Briefly, Phoenix ecotropic packaging cells were transfected with 1 µg of barcoded 
SF91 or MIEV vectors. Virus-containing supernatant harvested 24 and 48 hours 
later was used to transduce 2x105 32D cells or 7.5x105 BM cells per 3.5 cm well. 
Transduction efficiencies were determined by flow cytometry (FACSCalibur, Becton 
Dickinson) and were ~90% for 32D cells and 30-50% for BM cells. 32D cells were 
transduced with a barcoded SF91 vector library containing ~700 barcodes, BM 
cells for culture were transduced with a barcoded MIEV vector library containing 
~700 barcodes, and BM cells for transplantation studies were transduced with 
either  a  low  complexity  (LC)  or  high  complexity  (HC)  SF91  barcode  library 
containing ~50 or ~800 barcodes, respectively. 
Initiation of polyclonal and monoclonal cultures
Four days after the initial transduction, 2x104 eGFP+ 32D cells were sorted using 
a MoFlo flow cytometer (Beckman Coulter). The resulting polyclonal culture was 
maintained for 5 weeks; extensive barcode analysis was performed at weeks 2 
and 5. Monoclonal cultures were initiated by sorting single eGFP+ 32D cells into 
96-well round-bottom plates and culturing those for ~3 additional weeks; 2 of 128 CHAPTER 7
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these were selected for extensive barcode analysis. Polyclonal DBA/2 BM cultures 
were initiated with 8x105 transduced cells, without sorting for eGFP expression. 
These  cultures  were  maintained  for  5  weeks;  extensive  barcode  analysis  was 
performed for one selected culture at weeks 1 and 5. To generate monoclonal BM 
cultures, single eGFP+Sca-1+CD48−EPCR+ cells from day 7 transduction cultures of 
C57Bl/6 BM were sorted into 96-well round-bottom plates, and clones reaching 
population sizes of ~30.000 were selected for further analysis.20  
Transplantation and cell purification
LC and HC-barcoded C57Bl/6.SJL BM cells (transduction efficiencies 35% and 
50% respectively) were transplanted into lethally irradiated (9,5Gy, IBL 637 137Cs 
γ-source,  CIS  Biointernational)  C57Bl/6  mice  without  prior  sorting  for  eGFP 
expression.  Of  both  the  LC-  and  the  HC-barcoded  cells  106  and  5x106  were 
transplanted into two recipients each. At 8, 17 and 33 weeks after transplantation, 
blood samples were taken from the retro-orbital plexus. Erythrocytes were lysed 
in ammonium chloride solution and the remaining cells were stained with APC-
conjugated antibody to Gr-1 (clone RB6-8C5) and PE/Cy7-conjugated antibody 
to  CD3ε  (clone  145-2C11,  both  from  BD  Biosciences  Pharmingen).  eGFP+ 
granulocytes (Gr-1hi, SSChi) and T cells (CD3+, SSClo) were sorted using a MoFlo 
flow cytometer and were stored in RNAlater (QIAGEN) for barcode analysis. One 
of the mice transplanted with 106 LC-barcoded cells (recipient 2) was excluded 
from further analysis, because the number of eGFP+ cells that could be isolated 
was not sufficient for barcode analysis.
Barcode recovery and identification
Genomic DNA was extracted from cultured 32D and BM cells using the GenElute 
Mammalian Genomic DNA Miniprep Kit (Sigma-Aldrich). From the purified blood 
cells, genomic DNA was extracted using the REDExtract-N-Amp Tissue PCR Kit 
(Sigma-Aldrich) followed by a clean-up step using the Nucleospin Plasma XS kit 
(BioKe, Macherey-Nagel). Total RNA was isolated from cultured 32D cells using 
the  RNeasy  Mini  kit  (QIAGEN)  and  standard  cDNA  synthesis  (Invitrogen)  was 
performed. Barcode sequences were amplified using primers directed against 
internal vector sequences (SF91 eGFP forward and SF91 WPRE reverse; MIEV 
eGFP  forward,  5’-CTGCCCGACAACCACTACCTG-3’,  and  MIEV  long  terminal 
repeat reverse, 5’-CCAAACCTACAGGTGGGGTCTTTCATTC-3’). The mixture of 
equal-sized PCR products (i.e. “crude” PCR product) was purified and sequenced 
as already described. To obtain individual barcodes for sequencing, the “crude” 
PCR products were subcloned into pCR4-TOPO-TA (Invitrogen) and transformed 
into 10-beta competent E.coli cells (New England Biolabs). 129 CELLULAR BARCODING TOOL FOR CLONAL ANALYSIS
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Binomial distribution modeling
To  estimate  barcode  frequencies  we  applied  a  binomial  model.  The  binomial 
distribution determines the probability P(k;n,p) of observing a particular barcode 
k times in n sequencing trials, given a probability p of observing this barcode in 
a single trial. Under the assumption that all barcodes have an equal chance of 
being selected, the probability p equals the inverse of the barcode complexity 
B (ie, p=1/B) for all barcodes. Assuming independence of the individual barcode 
detections, the expected frequency of observing some barcode k times within n 
sequencing trails has been estimated by multiplying the number of barcodes B with 
P(k;n,1/B). To estimate the barcode complexity B we minimized the mean square 
distance between the expected and the experimentally observed frequencies.
Integration site analysis
To  simultaneously  identify  barcodes  and  retroviral  integration  sites,  inverse 
PCR  was  performed.  0.1  µg  of  DNA  from  monoclonal  MIEV-transduced  BM 
cultures  was  digested  with  TatI  (Fermentas),  followed  by  heat  inactivation. 
DNA fragments were then diluted to a concentration of 0.7 ng/µl and ligated 
overnight  with  10U  T4  DNA  ligase  (Fermentas).  After  purification  of  circular 
fragments  (Bioke),  a  first  round  of  PCR  amplification  (1-PCR)  was  initiated 
with  9  ng  of  DNA  and  PCR  master  mix  (Fermentas),  under  the  following 
conditions: 94°C x 2 min; 30 cycles: 94°C x 1 min, 59°C x 1 min, 72°C x 3.5 
min; 72°C for 10 min (forward, 5’-ACCTGTAGGTTTGGCAAGCTAGCTTAAG-3’; 
reverse,  5’-CAAACCTACAGGTGGGGTCTTTCATTC-3’).  A  second  round  of 
PCR amplification was initiated with 2 µl of 1-PCR reaction, under the following 
conditions: 94°C x 2 min; 20 cycles: 94°C x 1 min, 58°C x 1 min, 72°C x 3 min; 
72°C  for  10  min  (forward,  5’-GTTTGCATCCGAATCGTGGACTC-3’;  reverse, 
5’-CCTCACTGGCCGTCGTTTTAC-3’). After electrophoresis, observed fragments 
were cut from the gel, subcloned in pCR4-TOPO-TA (Invitrogen) and sequenced. 
Subsequently, retroviral integration sites were identified for 2 monoclonal cultures 
performing  a  Mouse  BLAT  Search  on  the  University  of  California  Santa  Cruz 
Genome Browser (Assembly July 2007, NCBI Build 37).21
RESULTS
Construction of barcoded vector library
Random sequence tags or “barcodes” were generated by annealing 2 synthetic 
oligonucleotides  consisting  of  sets  of  random  nucleotides  separated  by  fixed 
triplets.  The  resulting  double-stranded  linker  was  then  ligated  into  different 
types of retroviral vectors (Figure 1A). The fixed triplets in the barcode linker 
served a dual purpose. First, they enabled the annealing of forward and reverse 
primers into the barcode linker during initial construction of the barcoded vector 130 CHAPTER 7
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library. Second, the fixed triplets facilitated the analysis of sequencing results by 
providing an internal standard to evaluate the quality of each sequence trace. 
The primer binding site was added to the barcode sequence so that barcode-
positive and -negative clones could be easily distinguished with the use of PCR. 
Although in theory more than 4 million (410 X 22) possible linker variants could 
be generated, in practice the number of variants was restricted to the number of 
bacterial clones generated upon transformation. By combining different numbers 
of  bacterial  clones,  vector  libraries  of  different  complexities  (ie,  consisting  of 
different  numbers  of  barcodes)  were  generated.  From  each  resulting  vector 
library, barcode sequences were amplified using primers directed against internal 
vector sequences, after which the resulting mixture of equal-sized PCR products 
was sequenced. The resulting “crude” sequence traces suggested that a largely 
random mixture of sequence tags was generated, because N and S positions 
were found to be essentially equal in all 4 (A, T, C, and G) or 2 channels (C, and 
G), respectively (Figure 1A). Using both restriction analysis and PCR, we could not 
detect unbarcoded vectors, demonstrating that the efficiency of vector barcoding 
was close to 100% (data not shown).
Validation of barcoded vector library
To validate the complexity of the prepared barcode libraries, we transformed   
a high complexity vector batch (created by combining ~800 bacterial clones) 
back into E. coli and performed monoclonal sequence analysis. Of 88 sequencing 
trials, 78 represented unique barcodes. By combining the sequence traces of all 
88 trials the “crude” PCR sequence trace could be reconstructed (Figure 1B), 
confirming that the insertion of nucleotides at each variable position was close to 
random. We next applied a binomial model to approximate the total complexity 
of the library (for details see “Binomial distribution modeling”), and estimated 
it to be ~440 (Figure 1C). It should be noted that this prediction of the barcode 
complexity is only a rough estimate, because the number of sequencing trials 
was much lower than the complexity of the barcoded library. The accuracy of 
this prediction becomes progressively higher as the number of sequencing trials 
approaches or exceeds the number of barcodes in the library. 
We also assessed the number of nucleotide differences between the 78 unique 
barcodes identified in the vector library, and found that most barcodes differed 
Figure  1.  Construction  and  validation  of  barcoded  vector  library.  (A)  Insertion  of 
the barcode linker into retroviral vectors SF91 and MIEV. The linker contains a variable 
sequence part that consists of pairs of degenerate nucleotides (N or S) flanked by fixed 
triplets.  The  “crude”  PCR  sequence  trace  of  the  resulting  vector  batch  suggests  the 
random insertion of nucleotides at N and S positions. (B) The HC vector library, created by 
combining ~800 bacterial clones, was re-transformed into Escherichia coli. By combining 
the sequence traces of the 88 resulting clones the “crude” PCR sequence trace could be 
reconstructed. (C) Distribution plot showing observed and expected barcode frequencies 131 CELLULAR BARCODING TOOL FOR CLONAL ANALYSIS
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for the HC vector library; given that 88 sequencing trials were performed. Binomial distribu-
tion modeling estimates a barcode complexity of ~440. (D) Distribution plot showing the 
observed number of nucleotide differences between all 78 barcodes in the HC library by 
performing pairwise comparisons. Also shown is the distribution of the predicted number 
of differences based on the simulation of 78 random barcodes (average of 10 simulations). 
LTR indicates long terminal repeat; Psi, packaging signal; eGFP, enhanced green fluores-
cent  protein;  WPRE,  woodchuck  hepatitis  virus  post-transcriptional  regulatory  element; 
pPGK, phosphoglycerate kinase promoter; IRES, internal ribosome entry site. 132 CHAPTER 7
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in 9 of 12 variable nucleotides. When this was compared to data generated by 
simulating the generation of 78 random barcodes, the frequency distributions 
were almost identical (Figure 1D). Together, these data confirmed that the number 
of bacterial clones that are combined to generate vector libraries can be used as 
a rough estimate of the complexity of these libraries, and that the generated 
vector libraries are indeed composed of vectors marked with randomly generated 
barcodes.
Clonal analysis of polyclonal 32D culture
As  a  first  validation  of  the  cellular  barcoding  method,  we  performed  clonal 
analysis on an immortalized cell line that is known to be highly susceptible for 
retroviral transduction, with high transduction efficiencies and multiple retroviral 
integrations per cell. We transduced 32D cells with a barcoded vector library, 
and  initiated  a  polyclonal  culture.  After  2  weeks  of  culture,  the  “crude”  PCR 
sequence trace revealed a complex barcode signature that was comparable to the 
sequence trace of the barcoded vector library. Subclone sequencing confirmed 
the  high  degree  of  polyclonality  in  this  culture,  because  77  unique  barcodes 
were identified of 105 sequencing trials. After 3 additional weeks of culture with 
semiweekly  passaging,  68  unique  barcodes  were  identified  of  95  sequencing 
trials (Figure 2A). By applying a binomial model, we were able to estimate that 
the complexity of this culture decreased slightly from ~210 at week 2 to ~160 at 
week 5 (Figure 2B). Nevertheless, as would be expected for an immortalized cell 
line, the barcoded culture largely retained its polyclonal nature over time. 
Enumeration of integration sites in 32D monoclones
We also initiated monoclonal cultures with single transduced 32D cells. Genomic 
DNA was isolated from 2 selected monoclonal cultures, and barcode sequences 
were amplified. The “crude” PCR sequence traces of these 2 cultures revealed 
dissimilar  levels  of  complexity,  although  both  were  noticeably  simpler  than 
the  polyclonal  culture  (Figure  2C).  Subclone  sequencing  was  then  performed 
to  identify  the  underlying  barcodes.  The  monoclonal  culture  with  the  simpler 
“crude” PCR signature (monoclone I) was found to contain 2 different barcodes 
whereas  the  more  complex  (monoclone  II)  was  found  to  contain  9  different 
barcodes (Figure 2D). Because these cultures were initiated with single cells, each 
identified barcode represents a unique retroviral insert. It could be determined 
with confidence that the barcodes detected represented the actual number of 
integrations, because the probabilities of having missed a third integration site 
in monoclone I or a tenth integration in monoclone II were only 0.035 and 0.022, 
respectively. Compared to traditional methods for integration site analysis, the 
barcoding method can determine the actual number of integrations in monoclonal 
populations with greater confidence. Overall, the “crude” PCR signatures proved 
to  be  a  good  representation  of  the  actual  underlying  barcodes,  because  by 133 CELLULAR BARCODING TOOL FOR CLONAL ANALYSIS
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combining the individual barcode sequence traces the “crude” PCR sequence 
trace could be reconstructed (Figure 2D). 
Transgene expression analysis in 32D monoclones
Because the barcode tag is positioned immediately downstream of the eGFP 
coding  sequence,  each  eGFP  mRNA  molecule  contains  the  same  barcode  as 
the DNA from which it was transcribed. As such, the presence of barcodes at 
the RNA level permits the direct analysis of clone-dependent and/or integration 
site-dependent eGFP expression. To demonstrate this, the proportion of eGFP 
expression corresponding to each of the integrated vectors in the 2 monoclones 
was  measured  by  isolating  RNA  and  amplifying  the  expressed  barcode 
sequences. This transgene expression analysis showed that in both monoclones 
eGFP molecules could be detected that were driven from each of the different 
integration sites (Figure 2E). Although 1 of 9 barcodes from monoclone II (marked 
by an asterisk) appeared to be overrepresented on the RNA level, this finding 
did  not  reach  statistical  significance  (p=0.066),  in  part  because  the  number 
of  subclones  sequenced  was  relatively  small  compared  with  the  number  of 
integrations. Nevertheless, if a sufficient number of subclones are sequenced, 
the barcoding method will be able to identify clones and/or integrations that 
dominate expression within mixed cell populations.
Clonal analysis of primary bone marrow cell culture
To further validate the cellular barcoding method, we performed clonal analysis 
on primary BM cultures that are less susceptible to retroviral transduction and 
would probably exhibit decreased clonal complexity over time. BM cells were 
transduced with a barcoded vector library, and the barcode compositions of the 
cultures were measured at 2 different points in time. One culture was selected for 
barcode analysis, and its clonal complexity was measured over time (Figure 3A). 
After 1 week of culture, the estimated barcode complexity was ~110, and the 
observed and expected barcode frequency distributions were almost identical 
(Figure 3B, left panel). In contrast, after 4 additional weeks of culture one barcode 
was clearly found to dominate in the culture, being found in 36 of 50 sequencing 
trials.  When  this  obviously  overrepresented  barcode  was  removed  from  the 
observed frequencies, the estimated complexity of the remaining culture was 
~20, assuming that the remaining barcodes were equally distributed (Figure 3B, 
right panel).
Integration site identification in bone marrow monoclones
To show that clonal analysis can be complemented with integration site analysis, 
we purified single MIEV-transduced BM progenitor cells by fluorescence-activated 
cell sorting and initiated monoclonal cultures. Genomic DNA was isolated from 
several  of  these  cultures,  and  inverse  PCR  was  performed  to  simultaneously 134 CHAPTER 7
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identify integration sites and corresponding barcodes of the inserted retroviral 
vector (2 examples are shown in Figure 3C). 
clonal analysis of repopulation dynamics in vivo
Having established the feasibility of using cellular barcoding as a tool for clonal 
analysis in vitro, we next used this method to track hematopoietic repopulation 
dynamics in vivo following transplantation of barcoded HSCs. First, to track general 
trends in hematopoietic reconstitution, we transduced BM cells with a relatively small 
number of barcodes (LC, ~50) and transplanted 5 million cells. Second, to directly 
track the clonal behavior of individual HSCs, we transduced BM cells with a relatively 
high number of barcodes (HC, ~800) and transplanted only 1 million cells. At 8, 17 
and 33 weeks after transplantation, eGFP+ granulocytes and T cells were sorted from 
the peripheral blood and barcode analysis was performed by sequencing 19 to 30 
subclones from each blood cell type at each time point (Figure 4). 
In both mice, the barcode signature was dominated by relatively few barcodes 
at all time points, suggesting that within the eGFP+ population only a few stem/ 
progenitor cells were the main contributors of granulocytes and T cells. It should 
be noted that the LC-barcoded mouse probably contains multiple HSC-derived 
clones marked with the same barcode, and so it is likely that the actual number of 
clones in this mouse exceeds the number of clones in the HC-barcoded mouse. 
In both recipients, the barcode signatures of the T cells isolated at 8 weeks 
after  transplantation  differed  substantially  from  the  signatures  of  T  cells  and 
granulocytes at all other time points. This might be explained by the long life 
Figure 2. barcode analysis of polyclonal and monoclonal 32D cell cultures. (A) Tracking 
the complexity of a polyclonal 32D cell culture over time. Subclone sequencing revealed 
77 unique barcodes of 105 sequencing trials after 2 weeks of culture, and 68 of 95 after 5 
weeks of culture. White bars represent barcodes that were identified at 1 time point only, 
and colored/patterned bars represent barcodes that were found at both time points. (B) 
Distribution plots showing the observed and expected barcode frequencies for the 2 time 
points. Binomial distribution modeling predicts that the barcode complexity in this culture 
remained complex over time. (C) “Crude” PCR sequence traces of 2 monoclonal cultures 
provide an estimate of the total number of retroviral integrations per cell. The sequence 
trace for monoclone I shows that all variable positions in the barcode are restricted to 1 
or 2 nucleotides, suggesting the presence of only 2 integration sites. The sequence trace 
for monoclone II is more complex, but 1 nucleotide is missing at several of the variable 
positions. (D) Subclone sequencing identified the unique barcodes that underlie the “crude” 
PCR sequence traces. Different barcodes are represented by different colors. Monoclone I 
contains 2 integrated retroviral vectors per cell, whereas monoclone II contains 9 integrated 
retroviral vectors per cell. Also shown are the actual barcode sequences identified for both 
monoclones. The sequence consensus pictograms show how the “crude” PCR sequence 
traces in panel B can be reconstructed by combining all identified barcodes in silico. (E) 
Gene expression analysis identified barcodes that were present at the RNA level. One of 
9 barcodes in monoclone II (marked with an asterisk) appears to be overrepresented on 
the RNA level, but this finding does not reach statistical significance. Note that identical 
barcodes in panels D and E of this figure are represented using matching colors.135 CELLULAR BARCODING TOOL FOR CLONAL ANALYSIS
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Figure 3. barcode analysis of primary bone marrow cell cultures.  (A) Tracking the clonal 
complexity of a primary BM culture over time. Subclone sequencing reveals 54 unique 
barcodes of 78 sequencing trials after 1 week of culture, and only 11 of 50 after five weeks 
of culture. White bars represent barcodes that were identified at 1 time point only, and 
colored bars represent barcodes that were found at both time points. (B) Distribution plots 
showing the observed and expected barcode frequencies for the 2 time points. Binomial   
distribution  modeling  predicts  that  the  barcode  complexity  in  the  culture  markedly 
decreased over time. Note that the model for week 5 excludes the outlier that was found 
36 times and is therefore calculated for 14 trials only. (C) Inverse PCR identifies the integra-
tion site and the corresponding barcode for 2 monoclonal cultures initiated with single 
transduced BM progenitor cells. LTR, long terminal repeat.137 CELLULAR BARCODING TOOL FOR CLONAL ANALYSIS
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span of T cells relative to granulocytes. T-lineage cells produced in the first few 
weeks  by  transduced  multipotent  or  lineage-restricted  progenitors  might  still 
result in T cells to be present in the blood at 8 weeks after transplantation. In 
contrast,  most  or  all  multipotent  or  myeloid-restricted  progenitors  targeted 
during  the  transduction  procedure  would  not  continue  producing  peripheral 
blood granulocytes for 8 weeks after transplantation. In addition, some barcodes 
were present in granulocytes at early time points, but appeared in T cells only 
at later time points. This might also reflect the difference in life span of both 
cell types, in combination with the difference in time required for these cells to 
undergo maturation and migrate to the peripheral blood.
Whereas some barcodes marked both granulocytes and T cells, others were 
identified in only 1 of the 2 cell types. It is possible that these barcodes may 
have distinguished multi-potent HSCs that contributed to both myelopoiesis and 
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Figure 4. Clonal dynamics of in vivo hematopoiesis. Clonal composition of peripheral 
blood granulocytes and T cells over time in one recipient that received a transplant with 
5x106 LC-barcoded BM cells (A) and a second recipient that received a transplant with 106 
HC-barcoded cells (B). White bars represent barcodes that were found in only 1 cell type 
and time point, and colored bars represent barcodes that were found in both cell types 
and/or multiple time points.138 CHAPTER 7
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lymphopoiesis from those that were myeloid-biased or lymphoid-biased in their 
lineage contributions. 
Combined, these data suggest that cellular barcoding can be used for the 
simultaneous tracking of clones contributing to hematopoiesis. Depending on 
the complexity of the vector library and the number of subclones sequenced, the 
resolution of this technique could be increased to track minor clones with more 
confidence.
clonal analysis of long-term hsc activity in vivo
Next, we used the barcoding method to measure the relative activity of individual 
HSCs in a polyclonal BM transplantation setting. As a surrogate measurement for 
stem cell activity, we analyzed the barcodes present in granulocytes, which have a 
short life span and must therefore be constantly replenished by the currently active 
HSC clone(s). eGFP+ granulocytes were isolated at 33 weeks after transplantation 
from the peripheral blood of 3 recipients of LC-barcoded cells and 4 recipients 
of HC-barcoded cells, and 33 to 54 barcodes were sequenced from each sample 
(Figure 5A). In all recipients at least 1 major clone could be identified that was 
represented at a level higher than would be expected by chance because of 
random sampling error from an equally distributed population. Conversely, at 
least 1 and up to 8 barcodes were detected only once. This suggests that long-
term hematopoiesis is for the most part maintained by a few HSC-derived clones, 
but that underneath these major clones a whole spectrum of minor clones may 
exist. Indeed, the fact that several barcodes were only seen once suggests that the 
number of identified minor clones is likely to be an underestimation of the actual 
number of minor clones in the population. By increasing the depth of sequencing 
a more accurate snapshot of the HSC compartment can be taken.
As would be expected, a much higher proportion of barcodes was found to be 
shared between the LC-barcoded mice (5 of 15 barcodes shared between 3 mice) 
than the HC-barcoded mice (1 of 37 barcodes shared between 4 mice; Figure 
5B). This indicates that redundantly marked HSCs were indeed transplanted into 
the LC-barcoded mice, whereas the complexity of the HC library was sufficient to 
mark almost all HSCs uniquely.
DISCUSSION
In this study, we demonstrate that cellular barcoding can be used as a powerful tool 
for clonal analysis in the hematopoietic system. This method overcomes many of the 
limitations of the Southern blot- and PCR-based techniques that were used for clonal 
analyses in the past, because the sequencing-based barcode detection system does 
not depend on restriction digestion or probe hybridization, and is less prone to 
unequal PCR amplification. Therefore, we can identify with greater confidence both 
major and minor clones within complex cell populations in vitro and in vivo. 139 CELLULAR BARCODING TOOL FOR CLONAL ANALYSIS
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Figure  5.  barcode  profiles  of  long-term  HSC  activity.  (A)  Clonal  composition  of 
granulocytes at 33 weeks after transplantation in 3 recipients of LC-barcoded cells and 4 
recipients of HC-barcoded cells. White bars represent barcodes that were identified in 1 
recipient only, and colored bars represent barcodes that were shared between recipients. 
(B) Venn diagrams showing the degree of redundant barcoding between multiple recipients 
receiving the same starting cells. Recipients 1 and 2 received a transplant with 1 million 
cells, recipients 3 and 4 received a transplant with 5 million cells. Note that a portion of 
the barcodes shown for LC recipient 4 and HC recipient 1 are also presented in Figure 4.
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The  data  presented  here  provide  important  insight  into  the  spectrum  of 
active stem cell clones in a transplantation setting. In particular, our observations 
suggest that hematopoiesis at any given time appears to be dominated by a 
few HSC-derived clones, with additional contributions from a number of minor 
clones. Although the exact number of minor clones that are contributing at any 
given time remains undefined because of a lack of sequencing depth, it is still 
interesting to speculate about their biological identity. Although their behavior 
could be due to simple stochastic variation, they might represent one or more 
functionally distinct HSC subtypes. A further implication is that current functional 
definitions for HSCs may need to be reconsidered, given that the output of some 
minor clones might not exceed the commonly used thresholds for repopulation.
Cellular  barcoding  can  also  be  applied  to  help  resolve  other  outstanding 
questions  in  HSC  biology.  For  example,  the  concept  of  lineage-biased  HSCs 
has been suggested,6;22 but is still controversial. By tracking barcodes in various 
cell types, lineage-biased clones could be directly confirmed in a competitive 
polyclonal setting. Similarly, the concept of dormant or hibernating HSCs has 
been suggested by several groups.23-25 Cellular barcoding has the potential to 
measure the differentiated cell output from individual HSCs at different points 
in time, thereby enabling the identification of dormant or hibernating HSCs. It 
would  be  interesting  to  continue  tracking  these  same  clones  after  subjecting 
them  to  serial  transplantation  or  other  hematopoietic  insult,  to  determine 
whether or not their properties can be reset or modified. In addition, different 
subpopulations  of  the  primitive  hematopoietic  hierarchy  could  be  purified  by 
fluorescence-activated  cell  sorting  from  a  recipient  that  received  a  transplant 
with barcoded HSCs, and the clonal relationships between the cell compartments 
could be analyzed. Compared to previous studies using single-cell transplants, 
the amount of information that could be gleaned from one transplant recipient 
would be considerable. As well, such data would be useful to corroborate or 
further  inform  long-standing  theoretical  concepts  and  quantitative  models  on 
the clonal dynamics of HSCs.26;27 Collectively, these applications of the cellular 
barcoding method have the potential to greatly increase our understanding of 
clonal dynamics in a BM transplantation setting. 
In  2  recent  reports,  cellular  barcoding  was  coupled  to  a  high-throughput 
microarray-based detection system to study lineage relationships between T-cell 
subsets28 and T-cell recruitment and expansion in response to infection.29 Although 
this approach does allow clonal analysis to be performed on the population level, 
it requires a labor-intensive selection of barcodes and custom-made microarrays. 
In contrast, the approach described in this study can be more easily implemented. 
At the same time, a limitation of the approach presented here is that the resolution 
by which minor clones in a complex mixture can be identified is restricted by 
the number of subclones sequenced. To overcome this limitation, we are in the 
process of coupling the method to a high-throughput sequencing-based detection 141 CELLULAR BARCODING TOOL FOR CLONAL ANALYSIS
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system, which will permit the simultaneous measurement of all uniquely marked 
clones at the population level. 
Although retroviral vectors have already been used for decades as tools to 
introduce new genetic material into HSCs8-10 it has become clear only recently 
that  insertional  mutagenesis  from  the  retroviral  integrations  themselves  can 
trigger  clonal  expansion  of  HSCs.18;30  Particularly  in  this  context  it  is  of  great 
added value to barcode retroviral vectors in such a way that clonal analysis can 
be complemented with transgene expression and integration site analysis. To 
streamline this process in future experiments, we have now designed a next-
generation vector in which the barcode is placed closer to the long terminal repeat. 
By first enriching for retroviral inserts, followed by high-throughput sequencing, 
we  anticipate  that  integration  sites  and  their  corresponding  barcodes  can  be 
recovered simultaneously. At the same time, barcoded cDNA from the same cell 
populations could be sequenced. By normalizing the barcodes found in the cDNA 
to those found in the DNA, expression could be determined for each integration 
site in the entire population. Such multi-level analysis would be impossible using 
unbarcoded vectors. 
Recently, a successful HSC gene therapy trial involving 2 patients with X-linked 
adrenoleukodystrophy was reported,31 which has renewed interest and optimism 
in the gene therapy field.32;33 It is exciting to consider how future applications of 
clinical gene therapy protocols would benefit from the use of barcoded vectors 
because this would allow a simple and sensitive detection of clonal dominance. 
For this purpose, the complexity of the library need not be particularly high, 
because  the  events  triggering  clonal  dominance  are  rare.  For  example,  a 
barcode-to-HSC ratio of 10:1 would already result in an average of ~90% uniquely 
marked cells (assuming equal representation of barcodes and disregarding the 
possibility of multiple integrations per HSC). Increasing this ratio to 20:1 or 40:1 
would only result in an additional 5% or 7% uniquely marked cells, respectively. 
In the adrenoleukodystrophy gene therapy trial, patients were transplanted with 
~250 transduced HSCs (assuming 25 kg of body mass, HSC frequency of 1 in 105 
transfused cells, and 17% gene transfer efficiency into HSCs). A barcode library 
with a complexity of ~2500, which could be generated within a week in a regular 
laboratory, would uniquely mark ~90% of the transduced HSCs in these patients, 
with the remaining HSCs sharing a barcode with only 1 or 2 others. This would 
be easily sufficient to detect clonal dominance, even in its early stages. Because 
of the simple and flexible nature of the barcoding method, it is applicable to 
other viral (or even non-viral) gene delivery approaches, and to systems other 
than hematopoietic. Therefore, we advocate the use of barcoded vectors in all 
future clinical gene therapy protocols. 142 CHAPTER 7
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SUMMARY
The  overall  aim  of  the  research  described  in  this  thesis  was  to  improve  our 
understanding of the mechanisms governing stem cell fate decisions and lineage 
commitment  within  the  hematopoietic  system.  We  tried  to  achieve  this  goal 
by exploiting two types of genetic variation in the mouse: naturally occurring 
genetic variation (chapters 2-6) and induced genetic variation (chapter 7). Here I 
summarize and discuss the work described in this thesis, and I conclude with an 
outlook on how the field may develop in the future.
Natural genetic variation
In part I of this thesis, we exploited naturally occurring genetic variation between 
the regular inbred mouse strains C57BL/6 (B6) and DBA/2 (D2) and across BXD 
(offspring  B6  X  D2)  recombinant  inbred  mouse  strains.  We  aimed  to  identify 
the  genetic  basis  of  variation  in  hematopoietic  stem/progenitor  cell  (HSPC) 
traits, gene expression and microRNA expression, and to integrate the results. 
Changes in hematopoietic cell fate occur over time and are mediated by changes 
in regulatory networks. Yet, most studies of regulatory networks have provided 
“snapshots” usually at one potential regulatory level. In this thesis we analyzed 
network dynamics during the course of changes in hematopoietic cell fate, from 
Lin−Sca-1+c-Kit+  (LSK)  multilineage  cells  to  Lin−Sca-1−c-Kit+  progenitor  cells  to 
either TER-119+ erythroid cells or Gr-1+ myeloid cells. Also, we measured dynamic 
changes at multiple molecular levels. See Figure 1 for an illustrated summary of 
part I of this thesis.
In chapter 2 we introduced the concepts of classical quantitative trait locus 
(QTL) mapping and expression QTL (eQTL) mapping. We reviewed past studies 
in which transcriptional profiling and/or genetic linkage analysis were performed 
on hematopoietic cells, and we discussed several potential future applications of 
eQTL mapping. 
In chapter 3 we performed an eQTL mapping study on four hematopoietic 
cell types isolated from the BXD mouse panel. This analysis allowed us to analyze 
eQTL  robustness/sensitivity  across  different  cellular  differentiation  states.  We 
distinguished between “static” eQTLs that were consistently active in all four 
cell types and “dynamic” eQTLs that were sensitive to cell stage. Although we 
identified  a  large  number  (365)  of  static  eQTLs,  we  identified  a  much  larger 
number (1,283) of dynamic eQTLs. In total, we identified 140, 45, 531 and 295 
eQTLs that were preferentially active in LSK, progenitor, erythroid, and myeloid 
cells, respectively. A detailed investigation of those dynamic eQTLs revealed that 
in the majority of cases the genes with a cell-type-specific eQTL were also most 
highly expressed in that particular cell type. We did not identify target genes 
that  were  regulated  by  distinct  eQTLs  in  different  cell  types,  suggesting  that 
large-scale changes within functional regulatory networks are not common. Our 147 SUMMARIZING DISCUSSION
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results demonstrate that the influence of genetic variants on gene expression is 
highly sensitive to the developmental stage of the cell population under study. 
Even when the purified cells were only separated by a few cell divisions, eQTLs 
demonstrated a remarkable plasticity. As the eQTL field is now moving to human 
(clinical) studies it is important to understand how eQTLs behave, and how they 
can be of use to study the etiology of disease. Therefore, it is imperative that 
future eQTL mapping studies are realized on multiple well-defined and highly 
purified cell types, ideally even on the scale of individual cells. 
In chapter 4 we introduced a method that infers combinatorial association 
logic networks in multimodal genome-wide screens, and applied it to the myeloid 
gene  expression  dataset  described  in  chapter  3.  Unraveling  (transcriptional) 
regulatory  networks  by  inferring  complex  associations  necessitates  algorithms 
that take into account possible interactions. Therefore, instead of detecting direct 
associations between genetic loci and transcript levels (chapter 3), we detected 
associations between transcript levels and the outputs of small Boolean logic 
networks that combine multiple genetic loci. We identified 9 gene clusters that 
were significantly associated through a logical combination of genomic loci rather 
than a single eQTL. Notably, without incorporating interactions, these associations 
would have gone unnoticed. 
In chapter 5 we exploited the naturally occurring genetic variation in the BXD 
mouse panel to construct gene networks that operate in successive stages of 
cellular development. We made use of the gene expression and eQTL datasets 
described  in  chapter  3.  We  first  reconstructed  an  experimentally  validated 
gene network, consisting of Gata1, Gata2, Pu.1, Tal1 and Zfpm1. We identified 
correlations between pairs of genes within this network, and superimposed these 
correlation measures on the predicted network model. Remarkably, we confirmed 
many of the proposed positive and negative interactions, either as positive or 
as negative correlations. Next, we constructed a novel gene network for those 
52  transcripts  that  were  most  highly  expressed  in  LSKs  and  down-regulated 
during  both  erythroid  and  myeloid  differentiation.  We  used  GeneNetwork  to 
create an association network based on their pairwise correlation coefficients. 
Also,  we  extracted  shared  eQTLs  and  superimposed  this  information  on  the 
association network. We found that several transcripts were regulated by a region 
on chromosome 18, containing Zfp521, one of the 52 network members. Zfp521 
itself was cis-regulated and therefore predicted to be upstream of the distantly 
co-regulated transcripts. Strikingly, the phenotypic trait hematopoietic stem cell 
(HSC) pool size had previously been mapped to this exact same locus, thereby 
pointing to Zfp521 as a candidate regulator of this trait. Functional studies on 
Zfp521 in HSPCs are ongoing.
In chapter 6 we determined whether variation in microRNA expression could 
be responsible for the observed variation in HSPC traits and gene expression 
across the BXD mouse panel. Therefore, we performed a genome-wide microRNA 148 CHAPTER 8
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expression study on four hematopoietic cell types isolated from the B6 and D2 
parental  mouse  strains.  We  identified  131  microRNAs  that  were  differentially 
expressed between cell types and 15 that were differentially expressed between 
mouse strains. Of special interest was an evolutionary conserved microRNA cluster 
located on chromosome 17 consisting of miR-99b, let-7e and miR-125a. All cluster 
members were most highly expressed in LSKs and down-regulated during both 
erythroid and myeloid differentiation. In addition, these microRNAs were higher 
expressed in D2 cells compared to B6 cells. To assess whether the differential 
expression of this microRNA cluster could be functional we overexpressed miR-
99b, let-7e and miR-125a in primitive cells and quantified CFU-GM self-renewal, 
CAFC frequencies and LT-HSCs. In a way, we introduced genetic variation here, 
as we introduced extra copies of the microRNA cluster members. Bone marrow 
cells overexpressing the microRNA cluster showed increased replating capacity in 
CFU-GM assays and dramatically increased day-35 CAFC frequency. Furthermore, 
we found that mice reconstituted with these cells developed myeloproliferative 
neoplasms  that  occasionally  progressed  to  leukemia.  Finally,  we  identified  11 
candidate functional downstream targets of the microRNA cluster.  
Induced genetic variation
Instead of exploiting naturally occurring genetic variation, in part II of this thesis 
we introduced genetic variation into HSCs, with the aim to quantify the exact 
number of HSCs that actively contribute to hematopoiesis and to simultaneously 
analyze  the  behavior  of  multiple  individual  HSCs  in  a  competitive  polyclonal 
setting.
In chapter 7 we introduced genetic variation in HSPCs by implementing a novel 
cellular barcoding technique. This technique makes use of retroviral plasmids that 
are labeled with random sequence tags or “barcodes”. Upon retroviral integration, 
each vector introduces a unique, identifiable and heritable mark into the host cell 
genome, allowing the clonal progeny of each cell to be tracked over time. In 
this chapter, we first validated our approach by performing clonal analyses on an 
immortalized cell line and a primary bone marrow culture. As expected, we found 
that the cell line retained its polyclonal nature over time, and that the primary 
cell culture exhibited decreased clonal complexity over time. Next, we used the 
barcoding technique to track hematopoietic repopulation dynamics in vivo after 
transplantation of barcoded HSPCs. Finally, we showed how clonal analysis can 
be complemented with transgene expression and integration site analysis. See 
Figure 1 for an illustrated summary of part II of this thesis.149 SUMMARIZING DISCUSSION
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FUTURE PERSPECTIVES
Natural genetic variation
In this thesis we analyzed variation in phenotypic, cell biological and molecular 
traits in the classical inbred mouse strains C57BL/6 and DBA/2 and in recombinant 
inbred BXD mouse strains. Disadvantages of utilizing the BXD mouse panel are 
its limited genetic diversity and low number of recombinations (low mapping 
resolution). To overcome these limitations, future studies could utilize a “hybrid” 
strategy including classical inbred strains as well as recombinant inbred strains. 
The inbred strains would provide mapping resolution (fine-mapping) while the 
recombinant  inbred  strains  would  provide  power.  A  mouse  panel  especially 
assembled  for  this  purpose  has  been  coined  “Hybrid  Mouse  Diversity  Panel 
(HMDP)” and consists of 100 commercially available inbred strains (i.e. 1 set of 
classical inbred strains, and 3 sets of recombinant inbred strains). These strains 
have all been fully genotyped and are renewable so that data can be collected 
ad infinitum. An alternative to the use of the HMDP would be to use outbred, 
heterogeneous stocks of mice. An advantage of using outbreds is that there is no 
limit to the number of genetically distinct animals, while the HMDP is limited to 
the number of available inbred strains. Disadvantages of using outbreds are the 
cost of high-density genotyping and the fact that they are not renewable.
Future studies could also utilize the Collaborative Cross (CC), a randomized 
cross of 8 inbred mouse strains: A/J, C57BL/6J, 129S1/SvImJ, NOD/LtJ, NZO, 
CAST/Ei, PWK/Ph, and WSB/Ei. The CC is characterized by high genetic diversity, 
large size (for high statistical power), and large number of recombinations (high 
mapping resolution). The target population size is 1,000 CC lines. This mouse 
panel will be more representative of the quantity of genetic variation present 
in human populations. By examining the phenotypic consequences of naturally 
occurring genetic variation in the mouse, insight into human complex diseases 
will be provided.
Many eQTL studies have reported the existence of eQTL hotspots (eQTLs 
regulating large numbers of transcripts). Interestingly, in chapter 3 we observed 
that these hotspots became more prevalent as differentiation from primitive to 
mature cell types ensued. Although the exact molecular nature of the hotspots 
remains unresolved at present, their increased potency as differentiation from 
stem cells to mature cells proceeds is compatible with the concept of multilineage 
priming of stem cells. Our data could suggest that relatively small transcriptional 
modules are active in primitive cells and that few, but potent, lineage specific 
regulators become activated during differentiation. However, this finding needs 
to be interpreted with caution, given the well-known volatility of eQTL hotspots. 
Although eQTL hotspots have been documented in multiple studies it remains 
unclear by which molecular mechanism they emerge. In the simplest scenario they 
arise from polymorphisms in protein-coding genes that have multiple downstream 151 SUMMARIZING DISCUSSION
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targets (e.g. transcription factor) or in microRNAs. Alternatively, eQTL hotspots 
may  result  from  phenotypic  buffering  or  widespread  compensatory  effects  in 
response to local polymorphisms. It should be stressed that although a large 
collection of variable blood cell traits has been documented for the mouse strains 
analyzed in this thesis, they all display in essence normal blood cell production. 
The highly genotype-dependent gene expression patterns are therefore possibly 
compensating/buffering  potential  detrimental  effects  of  naturally  occurring 
polymorphisms, thereby ensuring normal blood cell production. Such a buffering 
system allows for highly stable gene networks and suggests substantial genetic 
redundancy. 
Many challenges remain in the field of (e)QTL mapping. The past decade 
has been one of descriptive systems genetics studies. Many (e)QTLs have been 
identified, yet relatively few have been experimentally validated. Additionally, 
the subsequent identification of the polymorphisms that underlie those (e)QTLs 
is often hampered by large numbers of genes in the (e)QTL intervals and a high 
background of what is thought to be irrelevant sequence variation. 
Induced genetic variation
In this thesis we validated a novel cellular barcoding technique for clonal analysis 
of complex cell populations in vitro and in vivo. We coupled the barcoding method 
to a Sanger sequencing-based detection system. A limitation of this approach 
is that the resolution by which minor clones in a complex population can be 
identified is restricted by the number of subclones sequenced. To overcome this 
limitation, ongoing studies in the lab focus on coupling the barcoding method 
to  a  high-throughput  sequencing-based  detection  system.  To  make  the  high-
throughput sequencing runs more cost-effective the lab also focuses on designing 
and validating multiplexing protocols that would allow the simultaneous analysis 
of tens to potentially hundreds of samples in a single sequencing run. In these 
protocols all barcoded samples are given unique identifiers by labeling them with 
different primers (“barcoding the barcode”). Preliminary results show that up to 
75 samples could be simultaneously analyzed in a single Solexa sequencing run 
and that 4,000 to 2,000,000 sequence reads could be obtained per sample. This 
already allowed a quantitative, high-resolution assessment of clonal fluctuations 
in cultures of primary bone marrow cells. Future studies will focus on the detailed 
tracking of the behavior of multiple individual HSCs in a competitive polyclonal 
transplantation setting. Combining the barcoding method to a high-throughput 
sequencing-based detection system will offer a hitherto unprecedented sensitivity 
in analyzing cell population dynamics, making it especially suitable for detailed 
monitoring of gene-modified hematopoiesis in clinical gene therapy protocols.152 CHAPTER 8
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Natural and induced genetic variation united
Global expression analyses have revealed that HSCs are “primed” for commitment 
by  co-expression  of  multiple  lineage-specific  genes.  As  HSCs  differentiate, 
“appropriate” lineage-specific genes are up-regulated, whereas “inappropriate” 
genes, specific for other lineages, are down-regulated. It is imperative that the 
gene expression changes that direct HSC fate decisions and lineage commitment 
are tightly controlled, as loss of this control results in hematopoietic disorders 
such as leukemias.
An interesting future study would be to perform a genetic analysis to identify 
leukemia-modulating genes. In such a study, both natural and induced genetic 
variation would be exploited to search for genes and gene networks that modify 
the progression of leukemia in mice. HSCs would be isolated from a large collection 
of genetically distinct mouse strains that have been densely genotyped. These 
HSCs would be transduced with a retroviral vector containing a (mild) oncogene 
and a barcode, and subsequently transplanted into recipients. The presence of 
the oncogene would make that these mice develop hematologic malignancies, 
and the presence of the barcode would make that the disease progression and 
type can be closely monitored over time. In addition, the barcode would allow 
transgene expression and integration site analysis. The transplanted mice would 
be carefully monitored and leukemic cell populations would be characterized and 
purified. Genome-wide studies would subsequently be implemented to detect 
changes in mRNA, microRNA and/or epigenetic levels. Finally, the relationships 
between genotype, molecular phenotypes and cell biological phenotypes would 
be analyzed.
Such  a  project  would  result  in  1)  the  identification  of  genomic  loci/genes 
that modulate (enhance or suppress) the development of leukemia, which may 
provide targets for therapy, 2) the generation of leukemic gene networks and how 
they associate with disease, which will contribute to the generation and validation 
of  predictor  profiles,  and  3)  the  identification  of  haplotype-specific  retroviral 
integration sites. appeNDICeS
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Bloed is één van de meest bestudeerde weefsels in het menselijk lichaam en 
bestaat uit cellen en plasma. De verschillende typen cellen in het bloed vervullen 
uiteenlopende  functies.  Zo  zijn  rode  bloedcellen  verantwoordelijk  voor  het 
zuurstoftransport in het lichaam, witte bloedcellen voor de afweer en bloedplaatjes 
voor de bloedstolling. Omdat veel bloedcellen een beperkte levensduur hebben 
moeten ze continu vervangen worden. Hiervoor zijn bloedvormende stamcellen 
verantwoordelijk.
Bloedvormende stamcellen kenmerken zich door een unieke combinatie van 
twee specifieke eigenschappen: zelfvernieuwing en differentiatie. Als een stamcel 
zich deelt ontstaan er twee dochtercellen, die elk voor een keuze staan. Ze kunnen 
een stamcel blijven (zelfvernieuwing), of zich ontwikkelen tot een gespecialiseerde 
bloedcel (differentiatie). Het is belangrijk dat er, gemiddeld genomen, een goede 
balans bestaat tussen zelfvernieuwing en differentiatie. Als de balans verschuift 
naar teveel zelfvernieuwing zal de stamcel populatie zich uitbreiden, wat op de 
lange termijn zal leiden tot leukemie. Echter, als de balans verschuift naar teveel 
differentiatie  zal  de  stamcel  populatie  uitputten,  wat  op  de  lange  termijn  zal 
leiden tot een tekort aan bloedcellen. 
Stamcellen  moeten  continu  kiezen:  inactief  blijven,  of  juist  delen.  Als  ze 
gaan  delen  moeten  ze  vervolgens  ook  nog  kiezen  tussen  zelfvernieuwing  of 
differentiatie. De keuzes die stamcellen maken worden beïnvloed door signalen 
van binnen en van buiten de cel. Voor een beter begrip van de normale - maar 
ook de abnormale - bloedvorming is het van belang om uit te zoeken hoe die 
keuzes precies gemaakt worden. Die informatie zou ons mogelijk ook in staat 
stellen om de keuzes van stamcellen te beïnvloeden. 
In dit proefschrift is de bloedvorming bestudeerd door gebruik te maken van 
genetische variatie. Dit betekent niets anders dan variaties in het DNA, de drager 
van  erfelijke  informatie.  Op  het  DNA  bevinden  zich  ongeveer  30.000  genen, 
die allemaal via RNA (een soort boodschappers van het DNA) vertaald kunnen 
worden in één of meerdere eiwitten. DNA en RNA bestaan uit vier verschillende 
bouwstenen. Elke drie opeenvolgende bouwstenen vormen een soort drieletter 
'woord'  dat  bepaalt  welk  aminozuur  in  een  eiwit  wordt  ingebouwd.  Een  fout 
in de bouwstenen van het DNA kan dus leiden tot een fout eiwit, waardoor er 
problemen kunnen ontstaan. Hoewel vrijwel alle cellen in ons lichaam hetzelfde 
DNA bevatten en dus dezelfde genen, vervullen niet alle cellen dezelfde functie. 
Dat komt omdat in elk van die verschillende celtypen een andere combinatie van 
RNA en (dus) eiwitten tot expressie komt.
Natuurlijke genetische variatie
Ieder  mens  heeft  een  andere  DNA  code,  een  soort  unieke  genetische 
vingerafdruk. Dit noemen we natuurlijke genetische variatie. Deze variatie zorgt 
ervoor dat we allemaal van elkaar verschillen. Denk bijvoorbeeld aan verschillen in 
lichaamslengte, lichaamsbouw, sportiviteit, muzikaliteit, intelligentie en gedrag, 
maar ook aan verschillen in aanleg om ziektes zoals kanker te ontwikkelen. Het 163 aPPendIces
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betreft  hier  allemaal  complexe  eigenschappen  die  bepaald  worden  door  een 
samenspel van meerdere genen en de omgeving. In dit proefschrift is natuurlijke 
genetische  variatie  gebruikt  om  de  (complexe)  bloedvorming  in  muizen  te 
bestuderen. 
In hoofdstuk 3 werden vier verschillende typen bloedcellen uit 25 verschillende 
muizenstammen onderzocht: stamcellen, voorlopercellen, rode bloedcellen en 
witte bloedcellen. In elk van deze celtypen werd eerst gekeken welke van de 30.000 
genen tot expressie kwamen. Veel van deze genen kwamen niet alleen verschillend 
tot expressie tussen de celtypen, maar ook tussen de muizenstammen. Door in elk 
van de celtypen variaties in het DNA van de 25 verschillende muizenstammen te 
vergelijken met variaties in genactiviteit, konden stukjes DNA gevonden worden 
die een effect hadden op de activiteit van genen. Deze stukjes DNA bevatten 
dus waarschijnlijk een soort regelaars van genactiviteit. Sommige stukjes DNA 
bleken in alle vier celtypen hetzelfde effect te hebben op de activiteit van genen. 
Er waren echter veel meer stukjes DNA die vooral in één, twee of drie van de vier 
celtypen een effect hadden op de genactiviteit. 
De 25 verschillende muizenstammen zijn vele jaren geleden gemaakt door 
twee  duidelijk  verschillende  muizenstammen  met  elkaar  te  kruisen.  Deze 
muizenstammen verschilden bijvoorbeeld in vachtkleur, maar ook in gemiddelde 
levensduur  en  meer  specifiek  in  het  aantal  bloedvormende  stamcellen  in  het 
beenmerg. Door het nageslacht van deze muizen herhaaldelijk te kruisen werden 
uiteindelijk 25 verschillende muizenstammen gecreëerd. Het DNA van elk van 
deze stammen bestaat uit een unieke mix van het DNA van de ouderstammen. 
Met  behulp  van  zogenaamde  moleculaire  merkers  kon  worden  vastgesteld 
welk deel van het DNA van deze stammen afkomstig was van elk van de twee 
ouderstammen. 
Het is bekend dat variaties in het DNA een rol kunnen spelen bij het ontstaan 
van ziektes zoals leukemie. Het onderzoek in dit proefschrift laat zien dat variaties 
in het DNA niet altijd hetzelfde effect hebben op de activiteit van genen, maar 
dat dit effect sterk afhankelijk is van het celtype. Dit betekent dat in toekomstige 
genetische studies zoveel mogelijk verschillende celtypen bestudeerd moeten 
worden. Dat is de enige manier om goed te kunnen onderzoeken hoe variaties in 
het DNA kunnen leiden tot variaties in genactiviteit of zelfs tot de ontwikkeling 
van ziektes.
Bij de activiteit van genen kan het ook zo zijn dat meerdere (samenwerkende) 
regelaars een rol spelen. Daarom is er in hoofdstuk 4 ook gezocht naar genen 
waarvan  de  activiteit  beïnvloed  wordt  door  meerdere  regelaars  tegelijkertijd. 
Door variaties in het DNA van de 25 verschillende muizenstammen op een andere 
manier  te  vergelijken  met  variaties  in  genactiviteit,  konden  enkele  (groepen) 
genen gevonden worden die door meer dan één regelaar beïnvloed worden. 
De stamcellen die bestudeerd zijn in deze studie kunnen zich ontwikkelen 
tot  voorlopercellen  die  zich  op  hun  beurt  weer  kunnen  ontwikkelen  tot  rode 
bloedcellen of witte bloedcellen. Door voor elk van de vier celtypen de genen 164 aPPendIces
&
– en hun mogelijke regelaars – die in dat celtype tot expressie kwamen in kaart 
te  brengen,  konden  netwerken  gecreëerd  worden  die  betrokken  zijn  bij  het 
bloedvormingsproces. Zo is er in hoofdstuk 5 een groep genen gevonden die 
heel actief is in stamcellen, veel minder actief is in voorlopercellen en nauwelijks 
meer actief is in rode en witte bloedcellen. Dit doet vermoeden dat de activiteit 
van deze genen verantwoordelijk zou kunnen zijn voor de unieke eigenschappen 
van stamcellen. In deze groep genen werd één gen gevonden dat niet alleen heel 
actief was in stamcellen, maar ook nog eens een mogelijke regelaar was van de 
activiteit van een aantal andere genen in deze groep. Dit gen was Zfp521. 
Opmerkelijk was dat er ook al ander bewijs was dat Zfp521 een belangrijke 
rol in stamcellen zou kunnen spelen. Naast dat variaties in het DNA van de 25 
verschillende muizenstammen vergeleken kunnen worden met de activiteit van 
genen, kunnen ze ook vergeleken worden met variaties in specifieke eigenschappen 
van deze muizen. In het verleden was op deze manier al een stukje DNA – met 
daarin een mogelijke regelaar – gevonden dat verantwoordelijk zou kunnen zijn 
voor variaties in het aantal stamcellen in het beenmerg van deze muizen. Zfp521 
was één van die mogelijke regelaars. Op dit moment wordt verder onderzocht of 
Zfp521 inderdaad een belangrijke rol speelt in stamcellen.
MicroRNAs zijn minuscule afgeleide deeltjes van RNA die in staat zijn om aan 
RNA te binden en dit te inactiveren, waardoor dit RNA niet meer omgezet kan 
worden  in  eiwit.  Specifieke  microRNAs  herkennen  specifieke  RNA  moleculen. 
In  hoofdstuk  6  werd  onderzocht  of  verschillen  in  microRNA  expressie  tussen 
muizenstammen  verantwoordelijk  zouden  kunnen  zijn  voor  de  verschillen 
in  genactiviteit  en  de  verschillen  in  het  aantal  bloedvormende  stamcellen 
in het beenmerg van deze muizen. Om dit te kunnen bepalen werd eerst de 
expressie van alle microRNAs gemeten in de eerder genoemde vier celtypen 
uit de verschillende muizenstammen. Er werden veel microRNAs gevonden die 
verschillend tot expressie kwamen tussen celtypen en enkele die verschillend tot 
expressie kwamen tussen muizenstammen. In deze studie werd een heel interessant 
microRNA cluster gevonden, bestaande uit drie microRNAs: 99b, let-7e en 125a. 
Dit  cluster  was  heel  actief  in  stamcellen,  minder  actief  in  voorlopercellen  en 
nauwelijks meer actief in gespecialiseerde bloedcellen. Ook was het cluster het 
meest actief in de muizenstam met de meeste bloedvormende stamcellen in het 
beenmerg. Deze twee bevindingen impliceerden dat dit cluster een belangrijke 
rol zou kunnen spelen in stamcellen.
De functie van dit microRNA cluster werd onderzocht door het tot overexpressie 
te  brengen  in  beenmergcellen  en  deze  cellen  vervolgens  op  verschillende 
manieren te testen. In celkweek experimenten werd gevonden dat overexpressie 
van  het  microRNA  cluster  cellen  vasthoudt  in  een  soort  stamcel-staat.  Verder 
werd gevonden dat de bloedvorming in muizen die getransplanteerd werden 
met deze cellen ontspoorde: sommige muizen ontwikkelden zelfs leukemie. Ook 
zijn in deze studie een aantal RNA moleculen gevonden waaraan de microRNAs 165 aPPendIces
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uit het cluster zouden kunnen binden, wat het omzetten van deze RNA moleculen 
in eiwit zou blokkeren. Mogelijk is het microRNA cluster via deze RNA moleculen 
in staat om de keuzes van stamcellen te beïnvloeden.
Geïntroduceerde genetische variatie
Naast dat de bloedvorming bestudeerd kan worden door gebruik te maken van 
natuurlijke genetische variatie, kan genetische variatie ook geïntroduceerd worden 
in het systeem. In hoofdstuk 7 is genetische variatie in bloedvormende stamcellen 
van muizen geïntroduceerd door random DNA volgordes of “barcodes” te laten 
integreren in het DNA van deze cellen. Dit resulteert erin dat elke cel voorzien 
wordt van een uniek label dat overgegeven wordt van moeder- op dochtercel. De 
DNA volgorde van het label kan gelezen worden met behulp van een zogenaamde 
sequencing techniek. Op deze manier kan het lot van bloedvormende stamcellen 
en hun nakomelingen gevolgd worden na transplantatie in muizen. Deze techniek 
is  zeer  veelbelovend  voor  het  monitoren  van  bloedvorming  in  toekomstige 
klinische gentherapie studies in de mens.
Een gouden combinatie voor de toekomst?
Een interessante toekomstige studie zou zijn om de bloedvorming te bestuderen 
door tegelijkertijd gebruik te maken van natuurlijke en geïntroduceerde genetische 
variatie.  Zo  zouden  stamcellen  afkomstig  uit  verschillende  muizenstammen 
voorzien kunnen worden van een barcode. Deze barcode maakt dat het lot van 
deze stamcellen na transplantatie gevolgd kan worden. Op deze manier zou de 
invloed van genetische variatie op specifieke stamceleigenschappen op een heel 
dynamische manier bestudeerd kunnen worden. Nog een stap verder zou zijn 
om naast een barcode ook een oncogen in te bouwen in deze stamcellen. Het 
oncogen maakt dat de bloedvorming op den duur ontspoort. Op deze manier 
zou ook de invloed van genetische variatie op het ontstaan en de ontwikkeling 
van leukemie bestudeerd kunnen worden.dankwoord&168 aPPendIces
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Eindelijk is het dan zover: mijn proefschrift is een feit! Het voelt alsof ik in een 
extreme achtbaanrit heb gezeten; een zinderende attractie vol hoogte-, maar 
soms ook dieptepunten, die elkaar continu afwisselden. Nu deze rit langzaamaan 
ten einde komt, is het hoog tijd voor een dankwoord. Het schrijven van een 
dankwoord is echter zo gemakkelijk nog niet, omdat het lastig is om gevoelens 
van dankbaarheid in woorden uit te drukken. Toch wil ik dat graag proberen.
gerald, bedankt dat je het vertrouwen in me stelde om me als AiO aan te nemen 
en me te introduceren in de wondere wereld van de stamcellen, hematologie 
en genetica. Dankzij jou heb ik in de afgelopen jaren vele aspecten die komen 
kijken  bij  het  verrichten  van  wetenschappelijk  onderzoek  mogen  ervaren.  Ik 
prijs mij gelukkig dat ik me met mijn onderzoek op vele niveaus heb mogen 
begeven: van DNA tot (micro)RNA tot eiwit tot cel tot organisme. Ik heb me dan 
ook een velerlei aan technieken eigen mogen maken, en zelfs mogen snuffelen 
aan de bioinformatica. Ik dank je dat je me deze vrijheid hebt gegeven. Bedankt 
ook dat je me de kans gegeven hebt om mijn werk te presenteren op tal van   
(inter)nationale congressen. Op deze congressen heb ik altijd vele inspirerende 
mensen  mogen  ontmoeten.  Je  deur  stond  altijd  open  om  van  gedachten  te 
wisselen over het onderzoek. Liep ik bijvoorbeeld even binnen met de vraag of 
ik beter A of B kon doen, was het antwoord vaak: A én B en misschien ook nog 
C, D en E. Er waren immers nog zoveel vragen onbeantwoord. Je enthousiasme 
voor de wetenschap werkte altijd zeer aanstekelijk. Je deur stond ook altijd open 
om  van  gedachten  te  wisselen  over  persoonlijke  zaken.  Dat  heb  ik  altijd  erg 
gewaardeerd. Gerald, bedankt voor een onvergetelijke tijd! 
leonid, thank you for being my daily supervisor from the start and for the 
countless scientific discussions we had. Your scientific and technical knowledge 
is unsurpassed, and combined with your ‘thinking outside the box’ mentality this 
has led to the development of new ideas, concepts and techniques. These were 
invaluable for the research described in this thesis. I also thank you for being 
critical towards my work; it helped me strive for improvement. 
Graag wil ik de leden van de beoordelingscommissie, Prof. dr. c. wijmenga, 
Prof.  dr.  J.n.J.  Philipsen  en  Prof.  dr.  I.  röder,  bedanken  voor  het  lezen  en 
beoordelen van mijn proefschrift. 
In het bijzonder wil ik mijn paranimfen ellen en lisette bedanken. Fijn dat jullie 
naast me willen staan op deze speciale dag. Ellen, een groot deel van het werk 
dat beschreven staat in dit boekje komt mede uit jouw handen. Bedankt voor de 
altijd fijne en gezellige samenwerking. Lisette, soms leer je via je opleiding/werk 
mensen kennen waar je zo’n klik mee hebt dat het vrienden worden en blijven. 
Sinds de dag dat ik op het MDL lab kwam, klikte het tussen ons. Ik hoop nog vaak 
samen (met Arjan en Pim natuurlijk) af te spreken!
Veel dank ben ik verschuldigd aan mijn stamcelbiologie collega’s met wie ik 
onderzoeks-lief-en-leed heb gedeeld. brad, I couldn’t have wished for a better 
roommate. I feel lucky to have had you as a coach, mentor, but most importantly 
as a friend during my PhD studies. Thank you for your everlasting enthusiasm 169 aPPendIces
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and  optimism  and  for  your  kind  words  when  I  needed  them.  I  wish  you  the 
best of luck in your career, wherever it may take you. Without any doubt life 
will have great things in store for you. sandra o, wereldrecordhoudster CAFC 
scoren! Volgens mij ken ik geen hardere werkster dan jij! Bedankt voor al je hulp 
en onze fijne gesprekken. mathilde, bedankt voor de honderden - wat zeg ik - 
misschien wel duizenden, prepjes! Als je nog geen wereldrecordhoudster bent, 
ben je in ieder geval hard op weg om dat te worden. Bedankt voor alle keren 
dat we samen gelachen hebben. Jaring, bedankt voor je hulp bij de vele FACS 
kleuringen en analyses en voor je FACS-for-dummies protocollen toen je de wijde 
wereld verkoos boven het stamcellab. bertien, jij bent één van de mensen die 
het stamcellab draaiende houdt. Bedankt voor je hulp bij grote experimenten 
en bij alle bureaucratische muizen-rompslomp. bert, je dacht toch niet dat ik 
je vergeten was? Ik heb het altijd ontzettend fijn gevonden om met je samen 
te  werken,  en  heb  onze  leuke  gesprekken  en  je  humor  dan  ook  erg  gemist 
nadat je van je pensioen bent gaan genieten. martha, gelukkig was jij er om het 
stokje van Bert over te nemen. Bedankt voor je goede zorgen voor de dieren 
en voor de gezellige muizenuurtjes. erik, waar ik soms beren op de weg zag 
bij het analyseren van grote datasets, zag jij daarin juist een uitdaging. Dat is 
wat jou waarschijnlijk een bioinformaticus maakt, en mij (slechts) een bioloog. 
Veel plezier en succes bij het verder analyseren en integreren van alle datasets! 
marta, evgenia, karin and visnja, thank you for the enjoyable time in the lab and 
at scientific meetings (at locations ranging from Schiermonnikoog to Australia). 
Good luck finishing your PhDs (I am looking forward to reading your booklets) 
and in the next phase of your lives! Marta; I couldn’t wish for a better person to 
continue with the microRNA project. It feels good to know that I left everything in 
good hands. sandra r, we started our PhD studies around the same time, visited 
a  lot  of  (inter)national  scientific  meetings  together  and  will  now  also  defend 
our  thesis  around  the  same  time.  Thank  you  for  your  support  and  friendship 
throughout these years. Your ability to successfully balance work and family life is 
truly inspirational. I wish you and your beautiful family a bright and happy future, 
and I hope we will stay in touch. ronald, bedankt voor je input in mijn project, 
maar ook voor de nodige vrolijkheid (o.a. het zingen) op de werkvloer. hein en 
evert-Jan, jammer dat ik maar zo kort met jullie heb mogen werken. Dan zijn daar 
nog Piet, vincent, kyrjon, leonie, Joyce, anita, Isabelle, esmee, olya, marcel en 
tobias, bedankt voor jullie input en gezelligheid! Niet te vergeten; annet, gerry 
(en later ook yvon) en Jan, jullie rol was misschien vaak op de achtergrond, maar 
o zo belangrijk. Bedankt voor jullie ondersteuning. En last but not least, natuurlijk 
dank aan de studenten die ik (mede) heb mogen begeleiden: emiel, Joke, rinse 
en bjorg. Het ga jullie allemaal goed! 
Ook  buiten  de  stamcelbiologie  heb  ik  veel  hulp  gehad.  Ik  wil  graag  mijn 
collega’s van de straling & stress celbiologie bedanken voor de prettige tijden 
op het lab en daarbuiten. Dank ook aan mijn collega’s van de hematologie (in het 
bijzonder wil ik hier edo, JJ, gerwin en bart-Jan noemen) en de kinderoncologie 170 aPPendIces
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voor jullie input en de leerzame discussies tijdens de maandagochtend seminars. 
Dan zijn daar nog de medewerkers van het cdP, bedankt voor jullie ondersteuning 
en de goede zorgen voor de dieren! Daarnaast wil ik graag henk, geert, harold 
en  roelof-Jan  bedanken  voor  alle  celsorteringen.  Wat  heb  ik  vele  uren  met 
jullie doorgebracht! Toch was er altijd wel wat om over te praten. Zonder jullie 
hadden veel van de experimenten beschreven in dit proefschrift niet uitgevoerd 
kunnen worden en had dit proefschrift er heel anders uitgezien. bruno, yang, 
rainer and ritsert, thank you for introducing me into the world of bioinformatics. 
Although sometimes it may have felt that we were speaking different languages 
– biology versus bioinformatics – I think this type of interdisciplinary research is 
the science of the future! Jeroen, ik heb de samenwerking met jou als heel prettig 
ervaren; bedankt voor je frisse kijk op het onderzoek! Joost en anke, microRNAs 
waren eerst een gesloten boek voor mij. Bedankt dat jullie dat voor mij hebben 
geopend. bart en susanne, we hebben dan wel niet echt samengewerkt, maar 
wel een geweldige ervaring gedeeld in de jungle van Australië! A special thanks 
goes to the Leipzig/Dresden group: Ingo (see above), Ingmar, tilo and nico, 
we visited many scientific meetings together and somehow we always ended up 
having dinner or drinks together. Thank you for the many great discussions we 
had about science and the world outside of science. I wish you all the best for 
everything that is to come! 
Kort wil ik nog het woord richten tot de mensen die de Topmaster mPdI 
tot  een  groot  succes  gemaakt  hebben.  Bedankt  voor  jullie  bijdrage  aan  mijn 
wetenschappelijke  vorming.  Het  waren  twee  ontzettend  leuke  jaren,  vol  met 
uitdagingen.  anke,  dankzij  jou  was  alles  altijd  goed  georganiseerd.  han, 
bedankt voor de leuke en leerzame tijd op het MDL lab! harrie, ook tijdens mijn 
promotieonderzoek bleef je geïnteresseerd in hoe het me verging. Ik heb onze 
gesprekken altijd als heel fijn ervaren. elise, willemien en marieke, bedankt voor 
de gezelligheid tijdens ons Topmaster avontuur!
Naast oud-collega’s in het UMCG in Groningen, zijn er ook nieuwe collega’s 
in  de  Isala  klinieken  in  Zwolle.  Medewerk(st)ers  van  het  klinisch  chemisch 
laboratorium, mijn start bij jullie liep helaas heel anders dan gedacht. Ik wil jullie 
graag bedanken voor jullie begrip en voor de ruimte die jullie me de afgelopen 
periode gegeven hebben. In het bijzonder wil ik hier bert, robbert, winy, Ilse, 
niels  en  michel  noemen,  bedankt  dat  jullie  me  opgenomen  hebben  in  jullie 
groep. Ik hoop dat ik in Zwolle net zo’n leuke en leerzame tijd mag hebben als in 
Groningen. erna, harde werkster! Heel veel succes (en natuurlijk plezier) met het 
verdedigen van je (mooie!) proefschrift!
Hoewel de eerder genoemde personen vooral een directe invloed hebben 
gehad op de inhoud van dit proefschrift, was ook de indirecte steun van vrienden 
en familie onontbeerlijk voor het uiteindelijke resultaat. annemiek en gerjan, 
lisette (zie boven) en arjan, karin, marianne en rolf, Peter en chantal, minke, 
Jeroen, Jessie, anneke k, martine, mieke, anneke z en aukje, ook al wonen jullie 171 aPPendIces
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allemaal een eindje weg en zie ik jullie lang niet zo vaak als dat ik zou willen: jullie 
vriendschap is me erg dierbaar. Ik wil jullie bedanken voor alle mooie momenten 
die we tot dusver al hebben gehad en alvast voor alle mooie momenten die nog 
komen gaan! familie hekman, bedankt voor jullie steun en interesse de afgelopen 
jaren. Dat er nog maar vele eier-eet-competities en barbecues mogen volgen! 
Lieve schoonouders, harm en truus, geweldig hoe jullie ons helpen. Niets is 
teveel, altijd staan jullie voor ons klaar. 
Jan gerard, je bent mijn enige broer(tje) en daarom natuurlijk ook meteen de 
liefste. Hoewel je het altijd ontzettend druk hebt, heb je (of maak je) altijd tijd om 
anderen te helpen. Zo ook mij. Bedankt daarvoor! nienke, ik ken je nog niet zo 
lang, maar wilde je hier toch noemen. Ik hoop je snel beter te leren kennen. Ik 
wens jullie alle liefde en geluk van de wereld!
Lieve robert, dankzij jou is dit proefschrift nu een feit. Als geen ander heb jij van 
dichtbij gezien hoe dit proefschrift vorm kreeg. Bedankt voor je bijdrage aan dit 
proefschrift, maar veel meer nog voor alle andere (niet-proefschrift-gerelateerde) 
grote en kleine dingen. Veel is er het afgelopen jaar gebeurd en jij bleef mijn rots 
in de branding. Hiervoor ben ik je onbeschrijflijk dankbaar. Bedankt voor alles wat 
was, is en nog komen zal. 
Lieve Papa en mama, jullie onvoorwaardelijke liefde, steun, vertrouwen en 
betrokkenheid  vormen  de  basis  voor  dit  alles.  Daarom  draag  ik  mijn  boekje 
aan jullie op. Jullie hebben me altijd gestimuleerd om te worden wat ik wilde 
worden, om te doen wat ik wilde doen en om te zijn wie ik ben. Lieve Papa, het 
valt onmogelijk in woorden uit te drukken hoeveel je voor mij betekend hebt en 
nog steeds betekent. Jij bent in alles mijn inspiratie geweest en dat zal je ook 
altijd blijven. Wat hebben we het vaak gehad over mijn experimenten, artikelen, 
proefschrift, stellingen en ook mijn promotie. Wie had toen kunnen voorspellen 
dat jij deze promotie niet meer mee zou maken. Ik zal jou en je trotse glimlach 
ontzettend missen op deze speciale dag. Je hebt nog net meegemaakt dat ik in 
Zwolle begonnen ben als klinisch chemicus in opleiding. Ook dit nieuwe avontuur 
had ik graag met jou willen aangaan. Juist met jou. Het zou een prachtig avontuur 
geworden  zijn.  Lieve  Papa,  ik  ben  ongelooflijk  dankbaar  en  trots  dat  ik  jouw 
dochter heb mogen zijn. In mijn hart leef je nog volop. Lieve Mama, bedankt dat 
je mij (en JG) altijd zo’n fijn thuis gegeven hebt. Je stond (en staat) altijd klaar met 
een advies of gewoon een luisterend oor. Ik had me geen betere moeder kunnen 
wensen! Liefste Mama, samen staan we sterk en slaan we ons erdoor.
Alice Gerrits
Zwolle, juli 2011bIografIe
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bIOGRAFIE
Alice Gerrits werd geboren op 29 juli 1981 te Hardenberg. Na het behalen van 
haar  VWO  diploma  aan  het  Vechtdal  College  te  Hardenberg  in  1999,  begon 
zij  met  de  opleiding  ‘Chemie,  Biologie  en  Laboratoriumonderzoek’  aan  de 
Hogeschool Drenthe te Emmen. Na het behalen van haar propedeuse vervolgde 
zij  in  2000  haar  studie  aan  de  Rijksuniversiteit  Groningen  met  de  opleiding 
‘Medische Biologie’. In 2003 rondde zij deze opleiding cum laude af met een 
Bachelor diploma, waarna zij geselecteerd werd voor de Topmaster opleiding 
‘Medical and Pharmaceutical Drug Innovation’ van de Rijksuniversiteit Groningen, 
waar zij in een intensief 2-jaars programma voorbereid werd op een solide start in 
het onderzoek. Tijdens haar Master opleiding heeft ze twee onderzoeksprojecten 
afgerond  bij  de  afdeling  Maag-,  Darm  en  Leverziekten  en  de  afdeling 
Stamcelbiologie, beide in het Universitair Medisch Centrum Groningen. In het 
kader van deze opleiding heeft ze onder begeleiding van Prof. dr. Gerald de Haan 
een voorstel voor een AiO-project geschreven, welke werd gehonoreerd door de 
onderzoeksschool GUIDE. In september 2005 rondde ze de Topmaster opleiding 
cum laude af, waarna zij begon als promovenda op het bovengenoemde project 
bij de afdeling Stamcelbiologie in het Universitair Medisch Centrum Groningen. 
In  haar  onderzoek  maakte  ze  gebruik  van  natuurlijke  en  geïntroduceerde 
genetische variatie om het bloedvormend systeem te bestuderen. Dit onderzoek 
vond plaats in de context van twee Europese Unie projecten: 1) EUrythron, met 
de focus op de aanmaak van rode bloedcellen, en 2) EuroSyStem, met de focus 
op stamcellen en systeem biologie. De resultaten van haar promotieonderzoek 
staan beschreven in dit proefschrift. Sinds november 2010 werkt Alice als klinisch 
chemicus in opleiding in de Isala klinieken te Zwolle.176 aPPendIces
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bIOGRAPHY
Alice Gerrits was born on July 29, 1981 in Hardenberg, The Netherlands. After 
receiving  her  pre-university  degree  from  the  Vechtdal  College  in  Hardenberg 
in 1999, she spent one year in the ‘Chemistry, Biology and Medical Laboratory 
Research’ program at the University of Applied Sciences in Emmen. Starting in 
2000 she studied ‘Medical Biology’ at the University of Groningen, obtaining her 
Bachelor’s degree cum laude in 2003. Thereafter, she was selected to participate 
in the Topmaster program ‘Medical and Pharmaceutical Drug Innovation’ of the 
University of Groningen, in which she – in an intensive two-year program – was 
prepared for a solid start in research. During her Masters studies she completed 
research  projects  at  the  department  of  Gastroenterology/Hepatology  and  the 
department of Stem Cell Biology, both in the University Medical Center Groningen, 
and graduated cum laude in 2005. In the final stage of her Topmaster program she 
wrote a PhD project proposal under supervision of Prof. dr. Gerald de Haan, which 
was funded by the Graduate School GUIDE. As a result, in September 2005 she 
began her PhD studies at the department of Stem Cell Biology in the University 
Medical Center Groningen. In her research project she made use of natural and 
induced  genetic  variation  to  study  the  process  of  blood  cell  formation.  This 
project took place in the context of two European Union projects: 1) EUrythron, 
with the focus on red blood cell formation, and 2) EuroSyStem, with the focus on 
stem cells and systems biology. The results of her PhD research are presented 
in this dissertation. In November 2010 Alice entered a clinical chemistry training 
program in the Isala Clinics in Zwolle.177 aPPendIces
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ATTENDED MEETINGSiii
1.  Annual International Society for Hematology and Stem Cells (ISEH) meetings 
2007, Hamburg, Germany (O); 2010, Melbourne, Australia (O) 
2.  Annual  International  Society  for  Stem  Cell  Research  (ISSCR)  meetings   
2006, Toronto, Canada (P); 2007, Cairns, Australia (O); 2008, Philadelphia, 
US (O) 
3.  Annual Stem Cells in Development and Disease (SCDD) meetings 
2007, Amsterdam; 2008, Amsterdam (P); 2009, Rotterdam (O)
4.  Annual Dutch Hematology meetings  
2005, Lunteren; 2007, Arnhem (O); 2009, Arnhem (O) 
5.  EUrythron meetings
  - Annual consortium meetings  
2006, Rotterdam (O); 2007, Paris, France (O); 2008, Groningen (O);   
2009, Lisbon, Portugal (O)
  - Workshop molecular control of erythropoiesis, 2005, Rome, Italy (O)
  - Career event in molecular cell biology and medicine, 2008, Porto,    
Portugal
6.  EuroSyStem meetings
  - Annual consortium meetings 
2009, Cambridge, UK (P); 2010, Schiermonnikoog (O) 
  - Workshop computational approaches in stem cell biology, 2009,    
Leipzig, Germany (O)
7.  Other meetings
  - Dutch Chromatin Meeting, 2006, Rotterdam (O)
  - Complex Trait Consortium meeting, 2007, Braunschweig, Germany (P)
  - Royal Netherlands Academy for Arts and Sciences (KNAW) meeting:  
role  of  DNA polymorphisms in complex traits and diseases, 2008, Amsterdam 
  - European  summer  school:  stem  cells  and  regenerative  medicine,  2008, 
Hydra, Greece (P) 
  - European  Molecular  Biology  Organization  (EMBO)  meeting:  stem  cells, 
systems and synthetic biology, 2009, Cambridge, UK (P)
 
ii(O) = Oral presentation, (P) = Poster presentation179 aPPendIces
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FUNDING AND AwARDS
1.  2005 – Graduate School GUIDE funding for PhD project 
2.  2006 – ISSCR Junior Investigator poster award
3.  2006 – New York Stem Cell Foundation travel award
4.  2007 – ISEH travel award
5.  2007 – ISEH Young Investigator award/ Dirk van Bekkum award
6.  2007 – ISSCR travel award
7.  2008 – ISSCR travel award
8.  2010 – ISEH travel awardNow this is not the end. It is not even the beginning of the end. 
But it is, perhaps, the end of the beginning. 
Winston Churchill